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Abstract
Genomic datasets are fundamental to broaden our understanding of human biology
in the context of health and disease. However, the high-dimensional nature of gene
expression and other molecular traits poses a challenge when attempting to find as-
sociations of these data types with human phenotypes. To this end, this thesis relies
on statistical learning tools to mitigate the curse of dimensionality and link the hu-
man transcriptome with phenotypes at different orders of complexity: from RNA, to
computationally-inferred cell type enrichments, and finishing with histological images
and their corresponding free-text descriptions. We make four specific contributions.
First, we built computational models based on gene expression of post-mortem hu-
man tissues in order to derive estimates of post mortem interval. Second, we redefined
the basic histological types of tissue classification based on five broad transcriptional
programs which define major cell types: epithelial, endothelial, mesenchymal, neu-
ral, and blood. We generated computational estimates for the enrichment of these
major cell types and validated them through the analysis of histological images and
free-text pathology reports, finding that departures from normal cellular enrichment
correlate with disease-associated histological phenotypes. Third, we characterized the
landscape of human sex-differential gene expression, finding that effects are small but
ubiquitous and tend to be tissue-specific, with some of these genes being involved in
biological and molecular functions related to disease and clinical phenotypes. Fourth,
we proposed an in-silico methodology to spatially deconvolute gene expression from
matched sample pairs of whole slide histological images and bulk RNA-seq gene ex-
pression, with the goal of replicating the spatial transcriptomics experimental tech-
nology. Within this study, we also developed a software tool to effortlessly process
whole slide histological images into tiles for machine learning applications.
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Resumen
Los conjuntos de datos genómicos son fundamentales para ampliar nuestra compren-
sión de la biología humana en el contexto de la salud y la enfermedad. Sin embargo,
la alta dimensionalidad de la expresión génica y otros rasgos moleculares constituye
un desafío para vincular estos tipos de datos con fenotipos humanos. Esta tesis
se apoya en herramientas de aprendizaje estadístico para mitigar el problema de la
dimensionalidad y vincular el transcriptoma humano con fenotipos a diferentes nive-
les de complejidad: desde el ARN, pasando por enriquecimientos de tipos celulares
inferidos computacionalmente, y terminando con imágenes histológicas y sus corre-
spondientes anotaciones en formato de texto libre. Hacemos cuatro aportaciones
específicas. Primero, construimos modelos computacionales basados en la expresión
génica de tejidos humanos post-mortem para realizar estimaciones del intervalo post-
mortem. En segundo lugar, redefinimos los tipos histológicos básicos de clasificación
de tejidos con base en cinco amplios programas transcripcionales que definen tipos
celulares principales: epitelial, endotelial, mesenquimal, neural y sanguíneo. Gener-
amos estimaciones computacionales para el enriquecimiento de estos tipos celulares
principales y las validamos mediante el análisis de imágenes histológicas e informes
de patología en formato de texto libre, encontrando que las desviaciones respecto a
la normalidad en los enriquecimientos celulares correlacionan con fenotipos histológi-
cos asociados con enfermedades. En tercer lugar, caracterizamos el panorama de la
expresión diferencial de los genes respecto al sexo en humanos, y descubrimos que los
efectos son pequeños pero ubicuos y tienden a ser específicos al tejido, con algunos de
estos genes involucrados en funciones biológicas y moleculares relacionadas con en-
fermedades y fenotipos clínicos. En cuarto lugar, hemos propuesto una metodología
in-silico para deconvolucionar espacialmente la expresión génica a partir de muestras
emparejadas de imágenes histológicas y expresión génica (bulk RNA-seq), con el ob-
jetivo de replicar la tecnología experimental de transcriptómica espacial. Dentro de
este estudio, también desarrollamos una herramienta de software para procesar imá-





I would like to thank my thesis director, Roderic Guigó, for all his feedback, and for
providing a research environment that was intellectually stimulating and in which I
could sharpen my skills and views on science. My research was also co-supervised by
Jan Graffelman, to whom I am also grateful for the feedback and for his guidance in
the teaching component of my PhD.
My collaborators have been crucial for the work performed in this thesis. I would
like to particularly thank Meritxell Oliva, Sarah Kim-Hellmuth, Barbara Stranger,
Pedro Ferreira, Alessandra Breschi, Valentin Wucher, and Vasilis Ntasis. I learned so
much by doing research with you. I would also like to thank the GTEx consortium for
the repeated opportunities to present my work and for providing a very interesting
data resource to work with; as well as Ferran Marques and Verónica Vilaplana from
the UPC Image Processing group for useful discussions. The suggestions provided
by the Guigó lab members and from my thesis committee (Cedric Notredame and
Guillaume Filion) through the years have also been useful to improve the contents of
this work. I would also like to thank Romina Garrido, whose administrative support
has always been exceptional, and Emilio Palumbo for all the help with computing
topics.
The following non-exhaustive list of people shaped the experiences I had in the
years of my PhD, and for that, I am thankful:
Ferran Reverter, for your mentorship during the early stages of my time at CRG
and help in navigating the learning curve into the field of computational biology, I
learned a lot from you about statistics but also about how to discuss results with
others.
Meritxell Oliva, it was a lot of fun doing science together, your insights helped
realize the importance of trying to see the big picture of what we do.
Raziel Amador, for the fun hackaton times we shared, solving problems that were
different to the ones we are used to was very refreshing.
Diego Garrido and Beatrice Borsari, for your friendship and all the adventures we
vii
had through the PhD, it has been quite the journey and I feel glad for having being
able to share it with you.
Valentin Wucher, for all the technical, but especially, personal advice through
these years. I will always cherish our scientific and meta-scientific conversations, you
are truly an example of how fun science can be when done with friends.
Alejandra Arámburo, Luis Abraham Castro, Fernando Campos and Claudia Monge,
despite the distance, you have always been a positive presence in my life.
Miguel Rodríguez, for all the spider pranks and jump scares, and from ‘saving’
me from the worst food-related choking episode ever.
Armando Reyes, for always checking up on me and being someone with whom I
can place my undivided trust.
Zara Alaverdyan, for our trips and adventures, listening to my random and often-
times repetitive nonsense, and simply for being the best.
Mikel Muñoz, I cannot put into words how much you have helped me get to this
point. I will always be grateful for that, as well as for your occasional reminders
about the things that really matter.
Kaiser Co, for helping me think out stuff so many times, but most importantly,
for being my best friend. I am lucky to have you in my life.
Finalmente, y sobre todo, quiero agradecer a mi familia por todo el apoyo incondi-








1.1 Perspectives on human phenotypes . . . . . . . . . . . . . . . . . . . 1
1.1.1 Phenotypes and the quantification of biological units . . . . . 2
1.1.2 Phenotypes and gene expression . . . . . . . . . . . . . . . . . 7
1.1.3 Phenotypes and the curse of dimensionality . . . . . . . . . . 10
1.1.4 Inferring cellular composition from gene expression . . . . . . 16
1.1.5 Quantifying biological knowledge from text . . . . . . . . . . . 23
1.1.6 High-dimensional phenotypes: histological images . . . . . . . 26
1.2 The Genotype-Tissue Expression project . . . . . . . . . . . . . . . . 34
1.2.1 Individual and sample characterization . . . . . . . . . . . . . 34
1.2.2 Gene expression characterization . . . . . . . . . . . . . . . . 35
1.2.3 Histological image characterization . . . . . . . . . . . . . . . 38
1.3 From RNA to higher-order human phenotypes: thesis objectives and
structure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
2 Statistical learning methods in genomics 45
2.1 Dimensionality reduction . . . . . . . . . . . . . . . . . . . . . . . . . 46
2.1.1 Principal Component Analysis . . . . . . . . . . . . . . . . . . 46
2.1.2 t-Distributed Stochastic Neighbor Embedding . . . . . . . . . 51
2.1.3 Uniform Manifold Approximation and Projection . . . . . . . 54
2.2 Statistical learning . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
2.2.1 Hierarchical clustering . . . . . . . . . . . . . . . . . . . . . . 60
2.2.2 Gradient boosting . . . . . . . . . . . . . . . . . . . . . . . . . 62
xi
2.2.3 Hyperparameter search with Bayesian optimization . . . . . . 66
2.2.4 Shapley values . . . . . . . . . . . . . . . . . . . . . . . . . . . 69
2.3 Deep learning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
2.3.1 Convolutional neural networks . . . . . . . . . . . . . . . . . . 78
2.3.2 Integrating histopathology with molecular features . . . . . . 80
3 The effects of death and post-mortem cold ischemia on human tissue
transcriptomes 83
4 A limited set of transcriptional programs define major cell types 101
5 The impact of sex on gene expression and its genetic regulation
across human tissues 119
6 In-silico spatial transcriptomics 157
6.1 A framework for in-silico spatial transcriptomics . . . . . . . . . . . . 160
6.2 Image preprocessing . . . . . . . . . . . . . . . . . . . . . . . . . . . 162
6.2.1 Tile extraction generalities . . . . . . . . . . . . . . . . . . . . 162
6.2.2 Tile extraction for spatial transcriptomics . . . . . . . . . . . 175
6.3 Feature learning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 177
6.3.1 Conceptualizations . . . . . . . . . . . . . . . . . . . . . . . . 177
6.3.2 Model training . . . . . . . . . . . . . . . . . . . . . . . . . . 178
6.4 Linking image features with molecular traits . . . . . . . . . . . . . . 190
7 Discussion and conclusions 195
7.1 Distilling high-dimensional spaces to examine human phenotypes . . . 195
7.2 A data-driven approach to human histology . . . . . . . . . . . . . . 201
7.3 The road to precision medicine . . . . . . . . . . . . . . . . . . . . . 205
7.4 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 207
A List of contributions 209
B Supplementary tables 213
xii
C Supplementary figures 215
D Notes 229
xiii
THIS PAGE INTENTIONALLY LEFT BLANK
xiv
List of Figures
1-1 Genotype-phenotype mapping . . . . . . . . . . . . . . . . . . . . . . 2
1-2 Central dogma of molecular biology . . . . . . . . . . . . . . . . . . . 3
1-3 Differential expression . . . . . . . . . . . . . . . . . . . . . . . . . . 8
1-4 The curse of dimensionality . . . . . . . . . . . . . . . . . . . . . . . 13
1-5 Model complexity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
1-6 Cell type deconvolution . . . . . . . . . . . . . . . . . . . . . . . . . . 18
1-7 Single-cell RNA sequencing profiling of lung cells . . . . . . . . . . . 22
1-8 Text feature encoding . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
1-9 Part-of-speech tagging . . . . . . . . . . . . . . . . . . . . . . . . . . 25
1-10 Early analysis of cell images . . . . . . . . . . . . . . . . . . . . . . . 27
1-11 ML-based histopathology image analysis . . . . . . . . . . . . . . . . 29
1-12 GTEx tissue sampling sites . . . . . . . . . . . . . . . . . . . . . . . . 36
1-13 GTEx RNAseq samples . . . . . . . . . . . . . . . . . . . . . . . . . . 37
1-14 Histological image of a stomach sample . . . . . . . . . . . . . . . . . 38
1-15 Pyramidal structure of an SVS histological image . . . . . . . . . . . 40
1-16 Thesis outline . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
2-1 Principal Component Analysis example . . . . . . . . . . . . . . . . . 48
2-2 Image reconstruction with PCA . . . . . . . . . . . . . . . . . . . . . 50
2-3 Effect of perplexity in t-SNE . . . . . . . . . . . . . . . . . . . . . . . 53
2-4 UMAP parameters . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
2-5 VC dimension of a classifier . . . . . . . . . . . . . . . . . . . . . . . 58
2-6 Bias-variance tradeoff . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
xv
2-7 Decision boundaries in gradient boosted trees . . . . . . . . . . . . . 65
2-8 Bayesian optimization . . . . . . . . . . . . . . . . . . . . . . . . . . 68
2-9 SHAP values in skin type classification . . . . . . . . . . . . . . . . . 71
2-10 Feature attributions for breast ductal carcinoma . . . . . . . . . . . . 72
2-11 Neural networks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
2-12 Activation functions . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
2-13 Convolutional Neural Networks . . . . . . . . . . . . . . . . . . . . . 78
6-1 Visium (10x Genomics) spatial transcriptomics . . . . . . . . . . . . . 159
6-2 In-silico spatial transcriptomics pipeline . . . . . . . . . . . . . . . . . 160
6-3 Tile label assignment . . . . . . . . . . . . . . . . . . . . . . . . . . . 163
6-4 Tile extraction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 176
6-5 Data augmentation . . . . . . . . . . . . . . . . . . . . . . . . . . . . 180
6-6 Learning rate tuning . . . . . . . . . . . . . . . . . . . . . . . . . . . 183
6-7 Multi-class confusion matrix at the tile level . . . . . . . . . . . . . . 184
6-8 Label-probability visualization for a testis WSI . . . . . . . . . . . . . 185
6-9 Label-probability visualization for liver and adipose WSIs . . . . . . . 186
6-10 UMAP of tile activations in the test set . . . . . . . . . . . . . . . . . 188
6-11 Correlation heatmap of mean activations . . . . . . . . . . . . . . . . 189
6-12 Neuron attributions in a testis sample . . . . . . . . . . . . . . . . . . 192
C-1 Cost of human genome sequencing through time . . . . . . . . . . . . 216
C-2 Overlap of xCell cell type signatures . . . . . . . . . . . . . . . . . . 217
C-3 Individual medical history . . . . . . . . . . . . . . . . . . . . . . . . 218
C-4 GTEx sample availability . . . . . . . . . . . . . . . . . . . . . . . . . 219
C-5 GENCODE v26 gene types . . . . . . . . . . . . . . . . . . . . . . . . 220
C-6 Protein coding and lincRNA gene expression distribution . . . . . . . 221
C-7 PCA and UMAP of GTEx RNA-Seq samples . . . . . . . . . . . . . 222
C-8 Correlation between tissue transcriptional profiles . . . . . . . . . . . 223
C-9 Histological image size distribution . . . . . . . . . . . . . . . . . . . 224
C-10 WSI snapshot of an adipose tissue sample . . . . . . . . . . . . . . . 225
xvi
C-11 ResNet-50 performance metrics at the tile level . . . . . . . . . . . . 226
C-12 ResNet-50 performance metrics at the slide level . . . . . . . . . . . . 227
C-13 Multi-class confusion matrix at the slide level . . . . . . . . . . . . . 228
xvii
THIS PAGE INTENTIONALLY LEFT BLANK
xviii
List of Tables





1.1 Perspectives on human phenotypes
A phenotype is defined as the set of measurable and observable traits in an organism
[1], encompassing properties such as behavior, development and morphology. In hu-
mans, some immediate examples are height, weight, and eye color. Phenotypes exist
not only at the macroscopic scale: RNA and proteins are also examples of phenotypes
that are expressed at the molecular level.
The genome sequence of an organism is the collection of nucleotides (A, C, G and
T in the case of DNA genomes) that make up the genetic material of a species, mate-
rialized in the form of chromosomes, for which humans have 23 pairs. Some regions
of the chromosomes contain genes, which are regions of DNA that can encode molec-
ular phenotypes. By means of mutations, different arrangements of these nucleotides
can exist within a given gene, leading to variants called alleles. The combination of
these alleles defines the genetic composition of an organism, also known as the geno-
type. Environment refers to the circumstances that surround an organism, such as
weather, pollution, diet, and other biotic and non-biotic components. At all scales,
the manifestation of a specific phenotype will be mediated by two main factors [2]:
Phenotype← Genotype + Environment + Genotype× Environment
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1.1.1 Phenotypes and the quantification of biological units
A fraction of phenotypic variation is attributed to the genotype, especially with re-
gards to an organism’s morphology [3]. For many other traits, phenotypes and geno-
types are not always correlated, and thus, they cannot be considered as equivalent.
A component of the variation is also explained by environmental factors that play
a direct role in how a phenotype is expressed. Finally, the interaction of both the
genotype and the environment can lead to complex associations that regulate pheno-
types: an example of a well documented interaction is how sunlight (environment)
affects different skin tones (gene/genotype that regulates pigmentation) and their
relationship with cancer risk (phenotype) [4].
Mapping the relations between genotypes and phenotypes (Fig. 1-1) is an impor-
tant task since understanding which variants lead to which traits is paramount to
understanding disease. For this reason, in recent years, a large amount of research
has been devoted to completing this knowledge graph through Genome Wide Associ-
ation Studies (GWAS), which seek to relate single nucleotide polymorphisms (SNPs)
with disease [5]. By 2020, 186,000+ associations with almost 125,000 SNPs have been
indexed in the NHGRI-EBI GWAS catalog [6].
𝐺1 𝐺2 𝐺3 𝐺4
𝑃1 𝑃2 𝑃3
Figure 1-1: Genotype-phenotype mapping. A genotype 𝐺𝑖 may influence a phe-
notype 𝑃𝑗, either individually or in conjunction with other genotypes.
One layer of abstraction above the genotype we find gene expression, which refers
to the generation of a functional gene product (RNA or protein). To put this into
context, let us remind that Francis Crick introduced in 1957 the central dogma of
molecular biology [7], where the information flow between molecules in a cell is stated:
from DNA to RNA and finally to proteins (Fig. 1-2). During the process of protein-
2
coding gene transcription, messenger RNA (mRNA) is produced. These molecules
are the link between genes and proteins since they dictate how the latter will be




Figure 1-2: Central dogma of molecular biology. Crick’s central dogma estab-
lished that information in a cell flows from DNA (which is itself copied through the
process of replication), then transcribed to RNA and finally translated into proteins.
In order to obtain a quantifiable representation of mRNA and other biological
units, researchers rely on sequencing technologies, especially on Next-Generation Se-
quencing (NGS), which refers to a group of DNA sequencing technologies that super-
seded the Sanger DNA sequencing method that was prevalent three decades after its
emergence in 1977 [8]. NGS techniques have changed the way in which biological re-
search is performed since they allow to sequence a large amount of DNA fragments (in
the order of millions) in a parallel way, which has led to speed increases to sequence
full genomes at lower costs [9]. As an illustrative example, sequencing the complete
human genome in 2019 was around 100,000x times cheaper than when compared to
the cost in 2002 (Fig. C-1) [10].
Several applications are possible with NGS sequencing platforms: genome sequenc-
ing and resequencing, analyzing DNA-protein interactions, epigenome sequencing and
transcriptomic profiling via RNA-seq [11]. Out of these techniques, RNA-Seq is of
particular interest to this thesis work: with this approach it is possible to obtain
precise transcript level measurements. These aid in the characterization of functional
elements in the genome as well as in understanding the molecular composition of cells
and tissues [12].
Turning raw sequencing data into an usable numerical form for statistical analyses
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requires several steps. First, the reads, which are raw sequences that are generated
when a sample is processed by a sequencing instrument [13] have to be aligned to the
reference genome of the species of interest (note that it is also possible to assemble
reads from species without a reference genome, which is a process called de novo
assembly [14], and not covered here). Before actually performing this step, quality
control statistics for the reads should be generated to assess if additional preprocess-
ing is necessary before performing the alignment. Second, expression is quantified
with summaries such as count tables that are generated at the level of the units of
interest (genes, transcripts, exons, etc.) based on the mapped reads [15]. Due to the
complexity of the process and to encourage analysis reproducibiltiy, bioinformatic
pipelines such as GRAPE [16] aim to put together all the software tools required to
go from raw data to quantification.
Gene expression quantifications usually require further normalization, since a part
of measurement variability may be attributed to technical factors which should be
accounted for in order to recover the true biological variation. Some of these factors
are inherent to the sequencing process such as sequencing depth, mapping bias and
errors. Other factors relate to the variability that might be introduced by different
technicians performing the experiments. Lastly, gene length and sequence composi-
tion also need to be accounted for [17].
Gene length is particularly important to correct for, since this characteristic is
directly linked to the estimation of gene abundances and has consequences when
making comparisons across genes: a larger gene has a higher probability of capturing
more reads during the sequencing process than a smaller gene. One of the first
normalization methods that arose to account for gene length is RPKM, which refers
to “reads per kilobase of exon model per million mapped reads” and was introduced
by Mortazavi et al. [18]. Let 𝑟𝑔𝑖 = reads mappings to the sequence of gene 𝑖, fl𝑔 =
sequence length for gene 𝑖 and 𝑅 = total of mapped reads for a library. RPKM for









where 103 normalizes for differences in gene length while 106 normalizes for differences
in sample sequencing depth. Another unit related to RPKM is FPKM (Fragments per
Kilobase of Transcript per Million fragments mapped), which is used for paired-end
sequencing since a fragment is a pair of reads whereas initially reads were single-end
[19]. RPKM and FPKM became widely used, but Wagner et al. [20] noticed that there
were statistical biases present in RPKM normalization: average RPKM was similar
among technical replicates but this was not the case across samples. They found that
this was due to usage of the total number of reads in the normalization, which omitted
the fact that 𝑅/106 is not a measure of the total transcript number but a proxy that
will depend on the length distribution of the RNA transcripts across samples. For
this reason, they proposed the transcripts per million (TPM) normalization:
TPM(𝑔𝑖) =








where rl refers to the read length and 𝐺 refers to the set of all genes measured in the
experiment, with the rest of the values being the same as in the calculation for RPKM.
The authors have shown that TPM is invariant among samples and is a proportional
measure for average relative molar concentration. Since there is no consensus on a
standard unit for transcript level quantification [21], all the three units are frequently
reported in the literature [22], with a preference for TPM in the last years.
A different source of concern when analyzing gene expression quantifications re-
lates to possibility of having batch effects in the data. This term is generally used to
refer to sources of technical variation that are more on the side of experiment design
and sample processing. Examples of batch effects include different processing times,
data coming from different laboratories and generated with different sequencing in-
struments or by different technicians, among other factors which can be confounded
with explanatory variables in the data [23]. Although the distribution of sample gene
expression can be corrected with the normalization methods described above, they
cannot fully account for batch effects [24].
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Besides simple linear models, families of algorithms exist that attempt to deal
with batch effect correction in one way or another. For example, Johnson et al. [24]
introduced the ComBat methodology in the context of microarray data integration
across studies, which relies on parametric and non-parametric empirical Bayes to
perform batch correction in situations with small sample sizes. Other approaches
such as surrogate variable analysis [25] focus on capturing components of expression
heterogeneity that can distort true associations when examining gene expression.
6
1.1.2 Phenotypes and gene expression
Human disease can be the product of the interactions between genes and the envi-
ronment [26]. To understand the complexity of diseases, their mechanisms of action,
and consequently their causes, examining gene expression is vital, since sets of genes
can behave differently in healthy vs. diseased individuals with respect to a particular
pathology or phenotype: we call this differential expression. Highly expressed genes
with tissue specificity can have associations to disease, as is the case of MYH6, MYH7
and TNNI3, three genes which show expression specificity in heart and that are re-
lated to cardiac diseases [27]. These sets of differentially expressed genes (see, for
example, Fig. 1-3) have the potential to be used as a signature for tasks such as di-
agnostic procedures, therapeutic target identification and phenotype characterization
[28]. Although discrepancies in single genes can be linked to disease, co-expression
networks can also provide valuable information which can be used, for example, to
refine pairs of gene-disease associations from GWASs [29]. Gene expression data is
not limited to the context of the disease: it can also be used to characterize transcrip-
tomic dynamics during development and normal organism physiology (for example,
to establish baseline profiles for normal tissues [12]).
In the past, microarrays were the most common method to generate measurements
of gene expression levels [30] to perform differential expression and related analyses.
Examples of early gene expression studies include the identification of cell cycle-
regulated genes of saccharomyces cerevisiae [31], molecular profiling of breast tumors
[32] and characterization of human lung carcinomas into distinct adenocarcinoma
subclasses [33]. Microarrays have been replaced by RNA-Seq in the last decade, with
the change propelled by the cost decreases discussed in Section 1.1.1.
However, genes are not expressed in the same way across cells. For example,
although a human pancreatic cell and a keratinocyte have the same genetic content
(DNA sequence), the difference in the cells’ is at the expression level of their genes,
which in turn may translate into functional and structural differences that are also
mediated at some degree by epigenetics and other regulatory mechanisms that control
7
how genotypes are activated or inhibited. Gene expression is also dynamic: expression
profiles can change over time with respect to the environment, development and
other processes and therefore when gene expression is measured, it is a snapshot
that is representative only of that specific time point and might or not generalize
to other time points [34]. Since gene expression levels are directly measurable, they
are also considered quantitative phenotypic traits themselves. Due to these reasons,
a considerable amount of effort has gone into investigating cell-type specific gene
expression and its relationship with other complex traits [35], including diseases.
This has been possible due to the emergence of single-cell RNA sequencing (scRNA-
seq), which is a sequencing method that allows to measure transcriptome-wide gene
expression at the single-cell resolution, enabling the identification of cell-type clusters,



















Figure 1-3: Differential expression. Illustrative example of a synthetic gene ex-
pression dataset where a subset of the genes (columns) show differential expression
with respect to two groups of samples (rows).
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The generation of these types of large datasets coupled with the increase of com-
putational power has led the field of biology to also take part of the big data phe-
nomenon that was previously prevalent mostly in physics and astronomy [37], with all
the statistical benefits and practical disadvantages that come with processing these
large volumes of data (see Section 1.1.3). Genomics datasets can also be useful for
research purposes that are not directly related to the scope of the original research
project that produced the data. This has led to the now commonplace practice of
depositing high-throughput functional genomics data in databases such as the Gene
Expression Omnibus (GEO) [38], ArrayExpress [39] and the Sequence Read Archive
[40]. These are examples of repositories that function as archives that allow users to
visualize and query relevant data for a particular topic of interest. The existence of
such databases encourages data mining and knowledge discovery, meta-analyses by
aggregating summary statistics across multiple experiments, and also fosters statis-
tical analysis reproducibility. Nevertheless, these databases are not without caveats:
data are usually generated via different protocols, metadata descriptions are usually
not consistent across studies, reference annotations can vary across versions or even
suffer from software-related encoding issues [41], among other problems that can make
data integration a task that is not at all trivial [42].
9
1.1.3 Phenotypes and the curse of dimensionality
Transcriptomics datasets tend to be high-dimensional with a number of features (ex-
planatory variables) 𝑝 usually much larger than the sample size 𝑛. For example,
GENCODE, which is an encyclopedia of genes and gene variants [43] reports in its
latest annotation (version 35) a total of 60,656 genes in the human genome, out of
which 19,954 are protein coding and 17,957 are long non-coding RNA genes. Reach-
ing a sample size within a uniform, unbiased experimental setting that matches these
numbers is still uncommon: as a point of comparison, The Cancer Genome Atlas
(TCGA) has performed molecular characterization of approximately 10,000 human
tissue specimens, but they are stratified over 33 different cancer types [44].
Identifying the effects of transcriptomic changes in the phenotypic space can prove
difficult. In Section 1.1.1 we discussed how the genotype can affect the phenotype:
to give an example of how large the genotype space is, consider that there are around
3 × 109 bases in the human genome, with each base being one out of four possible
nucleotides. This means that there are at most 43×109 possible combinations of geno-
types. Although this is a very simplistic calculation (since we would need to account
for the valid moves in the genotypic space, like genetic rearrangements, sexual recom-
bination, etc. [45]), even if we considered the fact that the existing variation between
two individuals is around 0.6% of the total number of base pairs [46], we would still
find that 41.8×108 is a very large number of possibilities.
To motivate why these large amounts of variables can be a problem in the context
of predictive function estimation, let’s consider the framework introduced in [47]: an
input vector 𝑋 ∈ R𝑝 with an output variable 𝑌 ∈ R and a joint distribution 𝑃 (𝑋, 𝑌 ),
with the goal of estimating a function 𝑓(𝑋) to predict 𝑌 . We first need to define
a way to quantify the error of our predictions: this is done through a loss function
𝐿(𝑌, 𝑓(𝑋)). A common example used in many statistical learning tasks is the squared
error: 𝐿(𝑌, 𝑓(𝑋)) = (𝑌 − 𝑓(𝑋))2. The expected squared prediction error (EPE) for
10
𝑓 is then:
EPE(𝑓) = 𝐸 (𝑌 − 𝑓(𝑋))2 (1.3)
=
∫︁
[𝑦 − 𝑓(𝑥)]2 𝑃 (𝑑𝑥, 𝑑𝑦) (1.4)
If we factor the joint density, we can rewrite this in terms of the conditional expec-
tation:
EPE(𝑓) = 𝐸𝑋𝐸𝑌 |𝑋
(︁
[𝑌 − 𝑓(𝑋)]2 |𝑋
)︁
(1.5)
When this is minimized pointwise, we obtain the regression function. In other words,
at a given realization 𝑥, the best prediction for 𝑌 (as measured by the mean squared
error) will be given by the conditional mean:
𝑓(𝑥) = argmin𝑐𝐸𝑌 |𝑋
(︁
[𝑌 − 𝑐]2|𝑋 = 𝑥
)︁
(1.6)
= 𝐸(𝑌 |𝑋 = 𝑥) (1.7)
Methods like 𝑘-nearest neighbors leverage this to make predictions: consider a point
𝑥, its 𝑘-neighborhood 𝑁𝑘(𝑥) (i.e. the 𝑘-th closest points) and 𝜇 being the mean;
we can then approximate the expectation by simply averaging the 𝑦𝑖’s over the data
within a given region surrounding 𝑥:
𝑓(𝑥) = 𝜇(𝑦𝑖|𝑥𝑖 ∈ 𝑁𝑘(𝑥)) (1.8)
With a large sample size it is more likely that the 𝑁𝑘(𝑥) points are closer to any
given point 𝑥, and the greater the 𝑘, the more stable the average. However, as 𝑝
(data dimensionality) increases, the size of the neighborhood increases as well, making
nearest neighbors quite unstable if the sample size is not very large, which, in practice,
is usually the case. To intuitively understand this, let’s consider a 𝑝-dimensional unit
hypercube. In this hypercube, we can define a neighborhood that captures a fraction
𝑟 of its volume with a given edge length 𝑒𝑝. This relation is given by 𝑒𝑝(𝑟) = 𝑟1/𝑝.
It is easy to observe (see Fig. 1-4a) that as we increase 𝑝, the hypercube edge
11
length required to capture the same fraction of volume 𝑟 also increases: therefore,
in higher dimensions, data is distibuted sparsely and local neighborhood estimation
starts breaking down since we would need to cover a large part of the input range to be
able to capture the same amout of volume than when compared to lower dimensions.
Even if we reduced 𝑟 we would observe large variances.
The effect of dimensionality on sparsity can already be observed in low-dimensional
spaces [48]. To demonstrate this, we generate a set of 500 normally distibuted points
(𝑋, 𝑌 ) with both coordinates sampled from 𝒩 (𝜇 = 0, 𝜎 = 1) (see Fig. 1-4b). For the
purpose of illustration, let’s consider a neighborhood of 1𝜎 around (−1,−1). In two
dimensions, only 18.2% of the points fall within 1𝜎 of (−1,−1), indicated with blue
color inside the circle in the figure. When the data is projected independently on the
x and y axes, 45.8% and 47.6% of all the points fall within 1𝜎 of -1, a fraction that is
considerably larger than when compared to two dimensions. With a higher number
of dimensions, this percentage would rapidly decrease, as shown previously on Fig.
1-4a.
In practical terms, this means that whenever we want to estimate a phenotype
(response variable) from any transcriptomic data type (for example, gene expression,
or the genotype) for which the dimensionality is high, we would need an extremely
large sample size to have an unbiased characterization of the joint distribution of
the data. Assessing outliers becomes difficult due to sparsity, and other confounding
effects like multicolinearity can occur. A related problematic is model complexity,
especially overfitting (Fig. 1-5, third column), which can easily occur in the context
of predictive function estimation: in short, this term refers to the model tightly fitting
the noise (either technical or biological) that is part of each sample besides the under-
lying data relationships [49]. On the other hand underfitting (Fig. 1-5, first column)
can also occur when the model is too simple that it fails to capture the generalities
of the underlying true model. The relationship between underfitting/overfitting and
model complexity will be formalized in Section 2.2.
However, not all is lost. Many methods have been developed to deal with the prob-














































Figure 1-4: The curse of dimensionality. (a) Edge length of a p-dimensional
unit hypercube (y-axis) needed to reach a certain fraction of volume (x-axis). Curves
are shown for 𝑝 = 1 up to 𝑝 = 10. (b) 500 randomly-generated points, with each
dimension (x and y) following 𝒩 (𝜇 = 0, 𝜎 = 1). Marginal distributions are shown
with black marks on the left and bottom sides of the plot. The subset of the marginal
distribution for the points inside the circle is shown in blue marks on the right and
top sides of the plot.
dimensionality reduction techniques, which are discussed in Section 2.1, encode the
data into a reduced number of factors in such a way that the data properties are
retained. Other common practices in the context of gene expression analysis (but
also generalizable to other data types) include gene filtering while data preprocessing
(for example, with minimum variance thresholding, removing genes that are lowly ex-
pressed, or also through more sophisticated wrapping and filtering methods [50]), gene
weighting, gene ranking, and projection search. Thanks to these, it has been possible
to perform discrimination of cancer types in leukemias, lymphomas and brain tumors
[51] and in some cases yielding clear decision boundaries with a reduced number of
genes.
Another different, but related type of problem, is the one of multiple comparisons
and false positives. In the context of differential expression each gene is subjected to a
statistical hypothesis test in order to determine if a difference exists in the expression
of that gene between control and case groups. Each of these tests yields a p-value
13
Underfitted, high-bias SVM Bias-variance tradeoff SVM Overfitted, high-variance SVM
Underfitted, high bias (deg = 1) Bias-variance tradeoff (deg = 3) Overfitted, high-variance (deg = 10)
Figure 1-5: Model complexity. The top row shows a classification (2 classes)
problem with a support vector machine (SVM) using a radial-basis function kernel;
the decision boundary is shown in green. The trade-off between the bias and the
variance is controlled through the 𝐶 parameter in the SVM model (increasing, from
left to right). The bottom row shows a regression problem (polynomial function
estimation). The trade-off between the bias and the variance is controlled through
the degree of the adjusted polynomial (increasing, from left to right).
which is associated with the specificity of that test (e.g. with the prevalent significance
level of 𝛼 = 0.05, the specificity of the test is 0.95). Many genes are tested at the
same time, and with a lenient significance level, false positives are bound to happen.
This can be illustrated very easily: if we want to test as few as 50 genes for differential
expression at 𝛼 = 0.05, the probability of observing at least a significant result by
chance is already quite large:
𝑃 (at least one significant) = 1− 𝑃 (none significant) (1.9)
= 1− (1− 0.05)50
≈ 0.923
14
This is unacceptable, considering that the objective of these tests could possibly be
to provide information towards diagnostic testing. To this end, multiple adjustment
procedures have been developed [52]: one of the first is the Bonferroni correction,
which simply adjusts the significance cutoff to be 𝛼/𝑛 where 𝑛 is the number of
tests. In the example above, the Bonferroni-adjusted significance cutoff would then
be 0.001, and the probability of at least one significant would then be close to the
original level of 𝛼: 1 − (1 − 0.001)50 ≈ 0.0488. However, this adjustment method is
considered too strict [53] and other methods are more widely used in bioinformatics
instead, such as the False Discovery Rate (FDR) which aims to control the expected
proportion of incorrect rejections of the null hypothesis [54].
In summary, classical statistics and statistical learning methods are powerful tools
to extract biological knowledge from large databases. Both have withstood the test
of time, however, domain expertise will always be necessary in the interpretation of
the results: even if a specific hyphotesis or model is numerically sound, it does not
necessarily mean that it is biologically plausible. The issue of high-dimensionality pre-
sented here is inherent to all the case studies that compose this thesis work, although
treated in a different way in each chapter.
15
1.1.4 Inferring cellular composition from gene expression
When analyzing bulk RNA-seq data from tissues, one must consider the fact that the
measured gene expression levels represent a tissue average, since many different cell
types can compose a tissue, and genes can be expressed differently in each of these
cell types. Thus, a possibility exists that when we observe differential expression in
a gene, the change in expression is confounded only because the underlying propor-
tions of cell types are not uniform across samples, for example, with the abundant
cell types masking the effect of those that are not as abundant [55]. This issue can
be particularly troublesome in the case of cancer, where tumor cell type composi-
tion is quite often not homogeneous and can affect treatment outcomes [56] and can
be quite different when compared to healthy tissues. In an attempt to correct for
cell type abundances when performing gene expression analyses, as well as to link
cell type abundance estimates with phenotypic traits, a series of methods have been
developed to computationally estimate the levels of these cells from bulk RNA-seq
data. This problem can be conceptualized and approached from two different angles:
deconvolution and enrichment.
In cell type deconvolution, we assume that gene expression for a sample is a linear
combination of expression values of each cell type present in the sample. In other
words, this is:
𝐺 = 𝑆𝑃 (1.10)
where 𝐺 ∈ R𝑝×𝑛 is a gene expression matrix for 𝑝 genes across 𝑛 samples, 𝑆 ∈ R𝑝×𝑘 is
a cell-type specific “signature matrix” that contains average expression values for each
gene-cell type pair, and 𝑃 ∈ R𝑘×𝑛 is the matrix of mixing proportions for 𝑘 cell types
across the 𝑛 samples. There are two main approaches to deconvolute 𝐺: supervised
and unsupervised [57]. In the supervised approach, 𝐺 is available, but also either 𝑆
or 𝑃 and thus we are concerned with the estimation of only one matrix. Linear and
ordinary least squares methods are commonly used to minimize the differences (sum





Note that this is stated as an unconstrained optimization problem, and as such,
a proportion for a cell type 𝑖 in sample 𝑗 can have sign(𝑝𝑖𝑗) ∈ {−1, 0, 1} which is
not entirely sound since a negative proportion does not have a biological meaning.
For this reason, a non-negativity constraint and a sum-to-one constraint are enforced
while estimating the vector of proportions for each sample. This is a convex quadratic
programming problem and can be solved, for example, via non-negative least squares
(see, for example, [58]) or constrained least squares [59]. Here, we proceed to illustrate
an example of the latter with a synthetic gene expression dataset.
Consider a matrix 𝐺 ∈ R100×150 of bulk RNA-seq gene expression levels (Fig. 1-
6a) with the expression for each sample being an underlying mixture of 6 cell types.
In order to generate 𝐺, we need to specifiy a true model for 𝑆 ∈ R100×6. The gene
expression for each cell type in 𝑆 is generated as 𝒩 (𝜇, 𝜎 = 0.5), with the cell type
means specified in Fig. 1-6b. Finally, we generate the matrix of proportions 𝑃 ∈
R6×150 partitioning the samples in three groups, with each group showing specificity
exclusively for two cell types, while the rest of the cell types have a a proportion of
zero (Fig. 1-6c). Within each group of samples, the proportions for the first cell type
(i.e. cell types 1, 3 and 6) were generated as 𝒰(0.5, 1), while the second cell type
was generated as the complement so that the proportions for both group-specific cell
types added up to 1. Finally, 𝐺 is constructed as the matrix product of the cell type
expression signature and the mixing proportions, plus an error term:
𝐺 = 𝑆𝑃 + 𝐸 with 𝐸·𝑗 ∼ 𝑁(𝜇 = 0.1, 𝜎 = 0.5) (1.12)
Most constrained least squares implementations (for example, lsqlincon from the
pracma R package [60] which is used in this example to perform deconvolution) are
not vectorized, and thus, here we reformulate the problem at the sample-level for the
sake of consistency. Let g𝑖 = [𝑔1, . . . , 𝑔100]𝑇 be a column vector representing a sample
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Figure 1-6: Cell type deconvolution. (a) Gene expression matrix, with samples
divided into three groups, with each group having a mixture of two cell types. (b)
Signature matrix for the cell types. (c) True cell type proportions for 6 cell types in
150 samples. (d) PCA over the deconvoluted cell type proportions for all the samples.
(e) Real vs. estimated proportions for each cell type across all samples.
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With the problem set up, we now proceed to perform deconvolution for each
sample 𝑖 ∈ {1, . . . , 150} by setting constraints over (1.11):
min
𝑃
‖g𝑖 − 𝑆p𝑖‖2 (1.13)
subject to 𝐴p𝑖 = 1
0 ≤ p𝑖 ≤ 1
where 𝐴 = 1 is used to enforce linear equality constraints over the proportions,
while the last constraint enforces their non-negativity. Afterwards, we can verify that
cell type specificity is reflected adequately on the estimated proportions across the
samples by performing PCA over 𝑃 𝑇 as shown in Fig. 1-6d, where it can be seen
that the three groups of samples are separated, as expected, with the corresponding
cell type loadings associated to each group. Note that within each group, the angle
between the cell type loadings is close to zero since in this toy example one cell type
is dominating and the other one is linearly dependent as they must add up to 1. On
Fig. 1-6e the estimated vs. real (simulated) proportions are shown for each cell type.
Other supervised methods, such as CIBERSORT [61] which is based on support
vector regression, minimize an objective function that besides computing a loss func-
tion also penalizes model complexity through the incorporation of a regularization
term. In the unsupervised approach, also called reference free deconvolution, the
estimation of 𝑆 and 𝑃 is performed at the same time using only 𝐺 as an input. Un-
supervised methods include non-negative matrix factorization (NNMF) which tends
to be quite sensitive to the initial seed values for 𝑆 and 𝑃 [62], and Bayesian frame-
works that tackle the problem through different formulations (see [63] for an example).
With unsupervised approaches, it is necessary to perform additional analyses to map
each deconvoluted component to an existing cell type by analyzing the marker genes
that drive each component. In general, supervised methods tend to have a better
performance than their unsupervised counterparts [57].
In the framework of enrichment, as opposed to deconvolution, we do not consider
the cell type abundances as a composition that needs to add up to 1, therefore, any
19
estimated value is not considered a proportion but rather just a value that can be used
to compare cell type abundances between samples. An example of such a method is
xCell [64] which aggregates sets of marker genes (i.e. genes that are characterisically
expressed in a given cell type) for 64 different celltypes using six different data sources.
More than one set of marker genes can be associated with any given cell type. Of
note, only the gene name identifiers are used without relying on any actual expression
value. In Fig. C-2, a hierarchically-clustered heatmap is shown with the overlap of
the marker gene sets (the marker list for each cell type is considered here to be the
union of all marker sublists for that cell type) for each pair of cell types 𝐴 and 𝐵
as measured by the Jaccard index 𝐽(𝐴, 𝐵) = |𝐴 ∩ 𝐵|/|𝐴 ∪ 𝐵|, where it can be seen
that related cell types tend to share marker genes. In xCell, an enrichment score for
each cell type marker sublist within each cell type is calculated using single-sample
Gene Set Enrichment Analysis (ssGSEA) [65], which, in short, is a score calculated
based on the position of the cell type markers within the sorted gene expression vector
for a given sample. In other words, if the cell type is abundant within the sample,
the marker genes are expected to be near the top of sorted gene expression vector.
Finally, a raw enrichment cell type score for a sample is calculated as the average
ssGSEA score across the cell type marker gene sets for a given cell type.
Although deconvolution and enrichment methods are a reasonable way to control
for cell-type specific expression in bulk RNA-seq, gold standards of the cell type
proportions are rarely available, and thus, the estimated cell type levels need to be
validated with orthogonal measures. In relation to this, generating experimental data
for single cells began in 2009, when Tang et al. [66] made the first description of a
single-cell transcriptome analysis characterizing mouse cells in early developmental
stages. Since then, flow-activated cell sorting (FACS) has become the most common
strategy to isolate purified single cells, but other strategies such as laser capture
microdissection and microfluidic technologies are also used [67]. Single-cell RNA-
seq has been used to understand the role of gene expression in cellular states and
functions both in healthy and diseased organisms, as well as delineating cell lineage
relationships [68]. Identifying outlier cells has also been pointed out as means to aid in
20
characterizing drug resistance and relapse in cancer [69]. In terms of computational
experiments, cell-type specific gene expression signatures derived from scRNA-seq
have also been used to perform deconvolution in bulk RNA-seq data [70].
With the goal of briefly illustrating the initial steps that can be performed as
part of an exploratory single-cell RNA-seq gene expression analysis to determine cell-
type organization, here we use data generated by Braga et al. [71] that was used in
their work to characterize the cellular landscape of the respiratory airways and lung
parenchyma in healthy human lungs. In this example, we analyze a subset of 10,358
cells. First, we require a minimum number of expressed genes per cell (here, 200 genes)
and filter out those cells that have a more than a certain threshold of their reads (here,
20%) coming from the mitochondrial genome (i.e. mitochondrial genes); this is done
since low quality or dying cells usually present mitochondrial contamination. Second,
the expression of each cell is normalized by the total expression, multiplied by a scale
factor and then log-transformed. Third, with the aim of keeping the most informative
genes and reducing the dimensionality, the top 2000 most variable genes across the
cells are kept. Fourth, the expression of each gene is scaled so it has a mean of 0 and
variance of 1 across cells, to avoid highly-expressed genes from dominating. Fifth,
t-SNE dimensionality reduction (see Section 2.1.2) is performed over the processed
data matrix, as shown in Fig. 1-7a-b. In those panels, cells are colored by the airway
region of origin, and by the cell type labels devised by Braga et al., respectively. Note
that in an exploratory analysis, the ground truth label for the cells is usually not
known, and different techniques (for example, examining PCA loadings) are used to
identify marker genes that might be related with a specific cell type, similar to the case
of enrichment methods that keep a list of cell type marker genes. Finally, since the
expression of each gene is known at the cell level, it is possible to visualize if specific
cell type clusters show or not specificity for a given gene (Fig. 1-7c-d). Pipelines such
as Seurat [72], which was used in this example, integrate the common operations
that are involved in a single-cell analysis, such as feature scaling and normalization,
metadata storage, dimensionality reduction and clustering, visualization, as well as























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 1-7: Single-cell RNA sequencing profiling of lung cells. In all the
panels, t-SNE based on single-cell expression of 16,147 genes across 10,358 cells is
shown. (a) Cells colored by the respiratory airway section of origin. (b) Cells colored
by their inferred cell type clusters. (c) Expression of APOBEC3A at the cell level.
(d) Expression of TPSAB1 at the cell level. Figures produced with single-cell gene
expression data generated by Braga et al. [71].
In Chapter 4 we address the problem of estimating cell type enrichments and
associating them to histological phenotypes that correlate with disease states, as well
as analyzing single-cell data from Mus musculus to demonstrate similarities with
humans with respect to cellular composition clusters. Sex differences in human cell
type abundances are covered in Chapter 5.
22
1.1.5 Quantifying biological knowledge from text
Biological data that can be mined for research is not limited to that generated by
massive parallel sequencing technologies. Besides the large amounts of medical liter-
ature, patients’ clinical data is often available as unstructured text reports [73] that
are commonly stored in electronic health records. These can be leveraged, for exam-
ple, to study disease co-morbidities and to track clinical outcomes on large cohorts of
patients.
An important hurdle to overcome when mining clinical data is that the informa-
tion is usually not readily available in a tabular form or organized in any other way
that facilitates statistical analyses. Instead, it tends to be stored as free-form text
that needs to be parsed in order to identify and annotate concepts of interest such as
medical phenotypes, clinical symptoms, pathology review comments from tissue sam-
ples, radiological findings, among many others. Transforming these into a structured
database is not trivial, since there are many issues that can arise: typographical and
other random text errors, sparseness, high dimensionality, text incompleteness, biases
[74], as well as interoperability issues in dataset integration [75].
Knowledge extraction and annotation of health records has been conventionally
performed through manual review by clinicians, but recently, machine learning tech-
niques such as Natural Language Processing (NLP) have been successfully used to
develop pipelines with the goal of providing support for decision making in clini-
cal practice, for example, in the estimation of coronary artery disease risk [76] and
detection of adverse drug reactions [77].
The task at hand will determine how to extract and/or encode text into numerical
features, as well how to use these for further analysis. For example, simple statisti-
cal features from a text corpus such as n-grams (which are a contiguous sequence of
tokens) can be used to identify keywords in a text with the goal of document classi-
fication [78]. Other approaches rely on the creation of numerical vectors to represent
text; bag-of-words is a one of the first methods that arose to do this, and consists in
summarizing a sentence with a vector that counts the occurrences of each token in the
23
sentence, with the word position given by a dictionary of possible words occuring in
a corpus of text. Examples of n-grams and bag-of-words are shown in Fig. 1-8. The
bag-of-words approach, however, has the issue of generating very high-dimensional
and sparse representations and for this reason, newer methods (as in [79]) make use of
dimensionality reduction or neural networks to generate mappings that encode text
into compressed lower-dimensional embeddings.
Sentence 1: Adenocarcinoma is a type of cancerous tumor.
Sentence 2: Glioblastoma is a type of brain cancer.
1-grams of Sentence 1: Adenocarcinoma, is, a, type, of, cancerous,
tumor
2-grams of Sentence 1: Adenocarcinoma is, is a, a type, type of,
of cancerous, cancerous tumor.
Bag order: [’Adenocarcinoma’, ’Glioblastoma’, ’a’, ’brain’, ’
cancer’, ’cancerous’, ’is’, ’of’, ’tumor’, ’type’
Bag 1: [1, 0, 1, 0, 0, 1, 1, 1, 1, 1]
Bag 2: [0, 1, 1, 1, 1, 0, 1, 1, 0, 1]
Figure 1-8: Text feature encoding. Examples of n-grams (𝑛 = {1, 2}) and bag-
of-words. In the bag-of-words example, the length of the vector is determined by the
union of the sets of tokens in the corpus (here, a set refers to the unique tokens of
each example sentence). Then, each sentence is a transformed into a vector of counts
for each of the possible words in the dictionary.
Other language processing tasks are more concerned with the identification of
the parts of speech in a text corpus taking into account linguistic knowledge about
the definition of the token and its context, as well as the syntactic dependencies
between these tokens. An example of this is shown in Fig. 1-9, where the tagging is
performed through a multi-task convolutional neural network pretrained on a large
text corpus that encompasses different genres of text, including structural information
and semantics [80].
In this line, there are specific NLP systems for knowledge extraction tailored to a
particular domain instead of using a generic model like the one mentioned above. An

























Figure 1-9: Part-of-speech tagging. Example of part-of-speech tagging for each
token in sentence describing histological findings on a brain sample. The syntactic
dependencies (arrows) between each token are also shown.
[81] that addresses text parsing tailored to the clinical domain. Besides part-of-speech
tagging, these systems can perform tasks including, but not limited to, named entity
recognition, rule-based tokenization, phrasal chunking, dependency parsing, negation
detection, among many others.
In biomedical sciences (and also in other domains), issues can arise when try-
ing to automatically interpret concepts, since these can be encoded in different ways
depending on the knowledge subdomain, as well as due to variability attributed to
whoever is tasked with encoding these concepts. To aid in the interpretation and
translation of concepts between different terminology systems, compendiums of con-
trolled vocabulary have been created. An example of this is UMLS (Unified Medical
Language System) which is an ontology that aggregates biomedical vocabulary which
also serves as a thesaurus [82]. Ontologies can serve as a base for uniformizing text
and ensuring clinical texts are properly encoded: correct representations have been
shown to lead to increases in machine learning classifier accuracies [83].
In Chapter 4, histological phenotype retrieval from pathology texts in free-form
is performed, together with their usage in downstream analysis to associate changes
in cellular composition with disease.
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1.1.6 High-dimensional phenotypes: histological images
The field of histology is concerned with studying tissues and their microanatomic
composition, focusing on cell structure and arrangement and their relation to organ
function. To this end, tissue sections have to be prepared in such a way that its
structural features are preserved for their posterior visual examination through the
use of microscopes. The preparation usually involves i) fixating the tissue in a solution
that allows the preservation of cell structure by inactivating degradative enzymes, ii)
removing water from the tissue using alcohol solutions, iii) removing the dehydration
solutions used in the previous step, iv) placing the tissue in paraffin within a mold to
allow it to harden, and v) trimming/sectioning the paraffin block using a microtome
to expose the tissue. Cells and their extracellular matrix usually do not have color,
and thus, a dye has to be applied to distinguish tissue components. This process is
called staining, and one of the most popular methods is hematoxylin and eosin (H&E)
which stains cytoplasmic structures and collagen in pink, while DNA in the cell and
other elements are colored with a purple/dark blue tint [84]. Tissue characterization
through histopathology is an important diagnostic tool in detecting and diagnosing
cancer and its malignancy level [85] as well as to identify infectious organisms [86].
The first attempts that relied on numerical methods to quantify cell morphology
heavily depended on human intervetion and parameter tweaking to identify pattern
classes (for example, to distinguish cell types). An example is shown in Fig. 1-10,
where Prewitt et al. [87] used a cytophotometer to record scanned fields as matrices
of grayscale optical density values. By analyzing the frequency of the optical density
in these matrices (Fig. 1-10b-c), it was possible to determine boundaries for the
background, cytoplasm and the nucleus. In this work, the idea of concatenating sets
of parameters (contrast, nuclear area, cytoplasmic area) as numerical vectors was also
explored in order to perform cell type discrimination in a multidimensional space.
With the increase in computational power and decreasing costs of data storage,
pathology departments around the world are switching towards digital imaging tech-




Figure 1-10: Early analysis of cell images (a) Photomicrograph of a monocyte.
(b) Computer printout of (a) using a 32-level grayscale scheme. (c) Local minima
thresholding of (b) to generate a 3-level grayscale image. Image adapted from Prewitt
et al. [87].
and analysis [88]. The term whole slide imaging is used to refer to the digitization
of glass slides of tissue sections so that they can be explored computationally, as if
emulating conventional light microscopy. Digitization of slides through whole slide
scanners started around the 1990s [89]. It has been pointed out to be superior in sev-
eral respects when compared to their printed/static counterparts, especially in terms
of image resolution and their annotation and data mining capabilities [90], as well as
facilitating data sharing among different physical locations.
Image files generated by digital whole slide image (WSI) scanners are of high-
resolution (determined mainly by the microscope’s objective), typically resulting in
files that can be up to several gigabytes in size [88]. Unfortunately, the digital pathol-
ogy community has not yet adopted a standard format to encode these WSIs, even
if open-source formats have already been proposed [91]. Proprietary file formats
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designed by scanner manufactures are still the norm, with each format supporting
different metadata fields, making interoperability difficult and expensive to support
from the application perspective. As a consequence, software to analyze and pro-
cess WSIs also tends to be vendor-specific. Open source libraries such as OpenSlide
[92] aim to mitigate this issue by integrating support for several proprietary formats,
making the low-level operations needed to read and process WSIs transparent to the
end-user. Examples of popular WSI formats include Aperio (.tiff, .svs), Hamamatsu
(.vms, .ndpi) and Leica (.scn). In Section 1.2.3 an example of the pyramidal image
structure used by the Aperio SVS format is described.
Image analysis techniques have advanced considerably since the example shown
in Fig. 1-10. Many of the first advances were centered in feature extraction methods
based on human intuition. The way we, as humans, interpret images is object-based
in the sense that we associate specific visual patterns with specific concepts. As such,
we can answer questions such as: how many cells are in the image, what is their
size and distribution? In computer vision, the representation of an image is pixel-
based and there is no inherent meaning to the pixels that compose it. But statistical
descriptors of the morphological appearance (of the human conceptualization) of these
objects can be derived, for example, cell areas, bounding boxes, perimeter, radii, hue,
distances, etc. Besides the object descriptors, structural information about cellular
arrangements can also be quantified with graph-theoretical metrics such as the degree
of a node or betweenness centrality (where the node is the object of interest, for
example, a cell) that convey information about how other nearby cells are arranged
with respect to a specific node. Sets of features related to spatial arrangements can be
generated through structures such as minimum spanning trees, k-NN graphs, among
others [93]. These features are termed handcrafted features since the selection of the
objects to characterize and the process to generate summary statistics for these objects
is human-guided [94]. The extraction of these features (Fig. 1-11a) was considered to
be an independent problem to that of learning a model that seeks to solve a specific
task (Fig. 1-11b).
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Figure 1-11: ML-based histopathology image analysis. (a) A region 𝑥 of a
WSI is encoded into a numerical representation R𝑝 by a function 𝜑(𝑥). These feature
vectors can then used for specific tasks. (b) Overview of common learning types in
histopathology image analysis. Supervised methods include classification, regression
and segmentation; weakly-supervised methods are mostly based on multiple instance
learning, and unsupervised methods are based on the general principle of autoen-
coders. The segmentation image was retrieved from [95], while the rest of the images
are of samples from the GTEx project [96].
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Although handcrafted features can still be useful for several applications, feature
extraction and model development have since mostly merged into a single step through
the usage of deep (convolutional) neural networks. When training a deep learning
model to optimize a set of parameters, input images are implicitly converted into
lower-dimensional representations that are generated in such a way that a specific loss
function is minimized, obviating the need of human intervention to decide which image
patterns are of relevance to solve a specific task. The quantification of histological
images in the form of feature vectors, either handcrafted or through automated means,
can then be used in many different tasks (see Fig. 1-11b). At the applied level, these
include, but are not limited to, cell detection, cancer classification and grading, tumor
segmentation and survival prognosis. An expected benefit of these computational
models is to reduce the inter-pathologist variability that might occur when evaluating
an histological image, for example, when using the Gleason score or the Nottingham
score to assess prostate and breast cancer, respectively [89].
As discussed before, WSIs at their native resolution have very large dimensions
which are usually in the order of 10,000 to 50,000 pixels for either coordinate (width
or height). Such large sizes make the processing of a WSI as a single unit intractable:
current deep learning architectures already tend to be computationally costly in terms
of parameter storage at training time when processing images that are much smaller
than WSIs, rendering the direct usage of the latter infeasible. For this reason, many
of the current deep learning methods and their applications rely on the extraction of
smaller-sized image tiles (also called patches) from the WSI [97]. Depending on the
application, a random sampling of tiles from the WSI might be sufficient, otherwise,
the slide can be divided into a grid of tiles and all the tiles corresponding to tissue
foreground can be kept. In Chapter 6, we further describe the problem of tile extrac-
tion from WSIs, and a software solution is presented to automatically extract tiles
from the foreground (tissue slices) of the WSI.
The literature covering other approaches that do not completely depend (at least
towards the end-stages of the learning task) on image tiles is still scarce. Most
of these alternative approaches focus in exploting the spatial relationships between
30
the tiles (see, for example, [98]) or performing meta-learning with tiles extracted at
different resolutions of the WSI. Attention models that rely on dynamic selection of
tiles without the need to load the complete WSI into memory have also been explored
[99].
Another relevant aspect to consider is the availability of image annotations, at
least for the applications that require it, which mostly fall into the realm of supervised
learning. Oftentimes, these ground truth annotations are only available at the WSI
level. For example, a WSI can be marked as “healthy tissue” or “diseased tissue”,
but no further information is available about which particular regions of the WSI are
affected. On the other hand, patch level annotations (for example, creating masks
for specific cells, or delineating the boundary regions of a tumor) are most commonly
used in strongly supervised settings, but these types of annotations are more scarce
since they are costly: pathologists have to manually annotate the regions of interest
in each patch.
Now that the key considerations have been laid out, we can proceed to describe
the fundamental aspects of each of the learning tasks in (Fig. 1-11b), following the
scheme presented in [89]:
1. Supervised learning: in this category, each observation is associated with a
ground truth label that can exist at different levels (WSI, tile, or pixels), and
the goal is to predict the label. Three main paradigms exist for using labeled
data. Although an applied task can be (and often is) shared across these, the
way that the problem is formulated will vary, in the sense of what the network
architecture and objective function are and how the latter will be optimized:
• Classification: At the global level (WSI or tile), it can be used to decide if
the unit of interest is affected by a specific pathology, for example, cancer.
Alternatively, at the local (pixel-based) level, common tasks include cell
and mitosis detection through sliding-window approaches. Most commonly
addressed using convolutional neural networks (CNNs) and derivative ar-
chitectures.
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• Regression: commonly used to perform object detection and localization
(predicting a position) of specific objects in an image. Can be used, for
example, for cell and mitosis detection. As opposed to classification, in the
regression approach pixel constraints are enforced to take into account the
neighborhood with respect to a specific pixel (which is commonly the center
of the object of interest). Regression tasks can also be about predicting
the severity score of a specific pathology. Most commonly performed at
the tile level, and modeled using CNNs, fully-connected networks (FCNs)
and derivative architectures.
• Segmentation: in semantic segmentation, the goal is to generate biolog-
ically meaningful masks to delineate histological primitives. Commonly
addressed at the tile level through FCNs and U-Nets [100].
2. Weakly-supervised learning: refers to the inference of granular annotations (at
the tile or pixel level) from the annotations/labels available exclusively at a less
granular level, which is usually the WSI. For example, a label of either “dis-
eased” or “healthy” can be assigned to the WSI, but it is not known exactly
which regions contribute to the “diseased” label. With this paradigm, annota-
tions for granular regions that contribute to the WSI label can be inferred. This
can potentially be of help to pathologists who need to perform manual annota-
tions. The standard methodology to perform this is multiple-instance learning
(MIL) [101], and although several specific subdefinitions exist, the general idea
is based on the concept of a “bag”, which refers to a set of “instances” (either
tiles or pixels) that are extracted from a WSI that has a label available only
at the coarse level. The instances will inherit the label of the WSI they are
extracted from. For example, in the weakly-supervised learning section of Fig.
1-11b, bags are illustrated with the ovals, and the instances (pixels/tiles) are
shown with squares and triangles. A bag is said to be positive if it contains at
least one instance coming from a WSI that is labeled positive, and it is negative
if it contains only instances coming from WSIs that are labeled negative. Then,
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a model can be trained that predicts a label at the bag level but which can
also infer which instances contribute to the bag prediction. In other words, this
means identifying which granular units (pixels or tiles) contribute the most to
the bag label prediction. MIL is considered global when the goal is to identify
a specific pattern in a slide (is the tissue affected by cancer or not?) while it
is considered local when identification is performed at a granular level (which
parts of the tile are cancerous tissue?).
3. Unsupervised learning: in this learning type the aim is to generate lower-
dimensional representations of the input images to detect the presence of clus-
ters or observation groups without using any preexisting labels. This is typi-
cally performed through autoencoders and their variants: these consist in an
“encoder” that maps the input data into a subspace, and a “decoder” that can
reconstruct the input data based on the compressed representation (Fig. 1-11b,
unsupervised learning). The “bottleneck”, which is in-between the encoder and
the decoder, contains the feature vectors with the compressed representation of
the data. These vectors can then be stacked across all observations to perform
visualizations through dimensionality reduction (for example, PCA, t-SNE or
UMAP).
In Section 2.3 we briefly describe the key principles of deep learning for image
processing that are relevant to the problem of linking gene expression variation with
patterns in histological images, which is discussed in Chapter 6.
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1.2 The Genotype-Tissue Expression project
In order to set the context for the case studies in this thesis, this section describes
the relevant parts of the Genotype-Tissue Expression (GTEx) project dataset, which
is used in most analyses. The GTEx project was conceived in 2010 by the National
Institutes of Health (NIH) [102] with the goal of building a resource for the scientific
community that would aid in the characterization of human gene expression and its
relationship to genetic variation and disease. Samples from up to 54 different tissues
would be obtained and sequenced, producing different data types: gene expression
levels, genotypes, individual medical history, and histological images with their cor-
responding pathology review comments. To test the feasibility of obtaining this data,
GTEx first began with a 2.5-year pilot phase for sample collection through a rapid
autopsy program, expecting to have around 900 post-mortem donors at the end of
the project lifecycle [103]. Through the years, anonymized versions of the data have
been released by the GTEx portal (see [104]), while restricted data elements such as
certain individual and sample metadata are only available through data freezes in the
Database of Genotypes and Phenotypes (dbGaP, see [105]).
1.2.1 Individual and sample characterization
In the final data freeze (version 8), there are 948 participating individuals (636 males
and 312 females) with 17,382 RNAseq samples obtained from 54 different tissues. The
tissue samples were extracted from donors in three different cohorts: post-mortem,
organ donors, and surgical donors, with 515, 419 and 14 individuals, respectively.
The individuals are mostly white (804), followed by black/african-american (121),
with the remaining identifying under other geographically-based categories. Only
adult individuals are included, with the age distribution skewing towards older ages
(minimum, median and maximum age is 20, 55 and 70, respectively). Medical history
for these individuals was also collected: there are 88 non-zero binary medical pheno-
types, each occurring in at least one individual. The co-occurrence of these is shown
in Fig. C-3. Details on biospecimen sample collection and processing are available
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on the latest GTEx release [96].
1.2.2 Gene expression characterization
We define the gene expression tensor as 𝐺 ∈ R𝑛×𝑝×𝑞, with 𝑛 = individuals, 𝑝 =
genes, 𝑞 = tissues. In the final data freeze, 𝑛 = 948, 𝑝 = 56,200 and 𝑞 = 54. Consider
an entry 𝐺𝑖𝑗𝑘 to be the expression level of gene 𝑗 for individual 𝑖 in tissue 𝑘. For a
given tissue 𝑘, not all individuals 𝑖 ∈ {1 . . . 𝑛} are available (see Fig. C-4). However,
for the available individuals, it is guaranteed that the expression of all 𝑗 = {1 . . . 𝑝}
genes will be available. Muscle-Skeletal is the tissue with the largest individual sample
size, while Kidney-Medulla has the lowest (803 and 4 samples, respectively; see Fig.
1-13a). 𝐺 is sparse, with only 34% of the data available.
The 𝑝 genes are divided into 45 categories (gene types) according to the GEN-
CODE v26 annotation [43], with protein-coding genes being, naturally, the most
abundant, followed by processed pseudogenes and lincRNAs (with 19,291, 10,141 and
7433 genes, respectively, see Fig. C-5). The expression of protein-coding genes is, in
general, higher than that of lincRNAs (Fig. C-6). Although the distribution of gene
expression within a single gene type is similar across tissues, each tissue has a distinc-
tive transcriptional profile that is partially driven by tissue-specific gene expression
[106]. The existence of these profiles becomes evident when reducing gene expres-
sion to a latent representation (Fig. 1-13b): by performing t-distributed Stochastic
Neighbor Embedding (t-SNE, see Section 2.1.2), we observe that samples are mostly
grouped together by their tissue of origin. Sample clustering is preserved when using
different dimensionality reduction methods (Fig. C-7). Sample mixtures exist for tis-
sue subtypes that belong to the same broad category, for example, skin (subtypes: sun
exposed and not sun exposed), adipose tissue (subtypes: subcutaneous and visceral)
and the brain tissues. This is due to these tissue pairs having closer transcriptional
profiles when compared to other tissues (see Fig. C-8).
Besides tissue specificity, gene expression differences can also be observed with
respect to other factors. Two examples are ischemic time and sex, which are studied
in detail in Chapters 3 and 5, respectively.
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Nucleus accumbens (basal ganglia)
Putamen (basal ganglia)
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Heart - Atrial Appendage
Artery - Coronary
Heart - Left Ventricle
Esophagus - Mucosa
Esophagus - Muscularis









Cells - EBV transformed lymphocytes
Artery - Tibial
Nerve - Tibial
Figure 1-12: GTEx tissue sampling sites. Tissue sampling sites from GTEx
donors. Each tissue has been assigned an unique color and abbreviation by the GTEx
consortium (see Table B.1), these are used throughout the rest of this thesis work.






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 1-13: GTEx RNAseq samples. (a) RNAseq sample size per tissue. (b)
t-SNE of 17382 RNAseq samples based on the expression of protein coding genes.
Each dot corresponds to one sample.
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1.2.3 Histological image characterization
Histology slides for each GTEx sample were created by the Comprehensive Biospeci-
men Resource (CBR), which received tissue specimens from the Biospecimen Source
Sites (BSS). A high-resolution digital image of each slide was also generated by the
CBR and sent to the Pathology Resource Center (PRC) for review by an American
Board of Pathology-certified anatomic pathologist. As part of this assessment, the
pathologists confirmed that the intented tissue morphology was present in image,
identified the degree of autolysis if any, as well as the presence of other pathologic
findings (such inflammation or hemorrhage). During the review process, issues such
as sampling errors and image mislabeling were also resolved. Based on this review,
biospecimens were deemed as “Acceptable” or “Unacceptable” for further use in the
GTEx project. Additional information on the histology analysis protocol is available
on the Standard Operating Procedures of the NIH’s Biorepositories & Biospecimen
Research Branch [107].
Figure 1-14: Histological image of a stomach sample. A downsampled version
of an histological image corresponding to stomach sample GTEX-11DXX-1326. The
associated pathology review comment is: “6 pieces, mild chronic active gastritis”.
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Each histological image may contain several sections from the specimen that was
used to perform RNA-Seq (if applicable, since not all the histological images have
associated sequencing data; for an image example see Fig. 1-14). These images were
produced using Aperio Digital Pathology Slide Scanners with 20x objective power at
0.4942 microns-per-pixel (mpp). For the analysis performed in this thesis work, a
set of 25,446 initially available histological images is considered. From these, 23,952
are deemed as acceptable, while the rest have quality issues. Only these acceptable
images will be used as the starting set of images in any analysis. The largest slide
has a native resolution of 109,559 × 50,518 pixels, while the smallest one has 5975 ×
4743 pixels. The size distribution of these histological images will vary depending on
the tissue (Fig. C-9).
Histological images are encoded into Aperio’s SVS file format, which is a single-
file pyramidal tiled TIFF image with associated metadata. In a SVS file, different
resolutions of the same image are encoded, with each level in the pyramid containing
a downsampled version of the full-resolution version of the image which is always
present at level 0 (Fig. 1-15). In some SVS files, a level is reserved for an overview
image of the glass slide used to obtain level 0. Loading a full-resolution image is often
not possible due to large memory requirements, and depending on the application,
certain techniques are necessary to be able to visualize and/or process the image.
This is explored in Chapter 6.
A pathology review comment in free-text form is also associated with each histo-
logical image, as in the example shown in Fig. 1-14. These comments often contain
useful histological phenotype information that can be potentially used to perform
statistical association tests with other data types, such as gene expression or cell type
composition. In Chapter 4, we examine how to retrieve useful keywords from these









Example of resolution levels encoded for stomach sample GTEX-11DXX-1326:
GTEX-11DXX-1326.svs[0] TIFF 65735x39211 65735x39211+0+0 8-bit sRGB 494.4MB
GTEX-11DXX-1326.svs[1] TIFF 1024x610 1024x610+0+0 8-bit sRGB 494.4MB
GTEX-11DXX-1326.svs[2] TIFF 16433x9802 16433x9802+0+0 8-bit sRGB 494.4MB
GTEX-11DXX-1326.svs[3] TIFF 4108x2450 4108x2450+0+0 8-bit sRGB 494.4MB
GTEX-11DXX-1326.svs[4] TIFF 2054x1225 2054x1225+0+0 8-bit sRGB 494.4MB
GTEX-11DXX-1326.svs[5] TIFF 1600x629 1600x629+0+0 8-bit sRGB 494.4MB
Figure 1-15: Pyramidal structure of an SVS histological image. Level 0 corre-
sponds to the full resolution image of the tissue sample, while consecutive levels are
downsamples of level 0 by a factor (in this case, 64x, 4x, 16x, and 32x). Level 5 is a
snapshot of the glass slide (shown below the pyramid) used to obtain level 0.
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1.3 From RNA to higher-order human phenotypes:
thesis objectives and structure
The two main objectives of this thesis work are to:
• Relate variation in the human transcriptome with phenotypic traits through the
use of statistical learning methods at the following orders of magnitude:
– RNA: How can gene expression be used to predict a human phenotype?
– Cell-types: How can cell-type abundance estimations be extracted from
gene expression and linked to disease?
– Tissues and organs: What is the role of cell-type composition in tissue
identity?
– Higher-order phenotypes (text and images): How can histological images
from human tissues and their pathology text reports be linked to variation
in gene expression?
• Determine and develop methods to encode abstract biological data (such as
free-form text and images) into numerical representations.
To this end, four case studies were developed. The structure of this thesis work
is as follows (see Fig. 1-16 for a graphical abstract of the topics):
Chapter 2 introduces the theoretical background and generalities for the statis-
tical and computational methods used throughout the case studies.
Chapter 3 is an exploration on using gene expression profiles to describe a human
phenotype: ischemic time, which is defined as the time elapsed since death until the
preservation of a tissue sample for an individual. Using these profiles across many
tissues, we construct gradient boosted tree models to predict ischemic time at the
sample and individual levels.
Chapter 4 is an integrative study that describes: i) the problem of estimating
cellular composition and enrichment based on gene expression profiles, ii) the extrac-
tion and normalization of biological knowledge from text annotations in such a way
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that it can be used to perform statistical tests of association with molecular traits,
iii) how departures from normality in cellular composition can be linked to disease,
and iv) inferring high-dimensional feature vectors from histological images to validate
cellular composition and disease states.
Chapter 5 presents a catalog of sex differences in gene expression with the
aim of furthering the understanding of the molecular mechanisms that underlie sex-
differentiated phenotypes.
Chapter 6 explores how to encode histological images to perform more complex
tasks than the one explored in Chapter 4: first, we propose a computational pipeline
to preprocess histological images into a usable form for downstream analyses. Second,
we define a methodology to relate changes in histological patterns with variation in
gene expression.













Chapter 4:  Cellular composition of tissues 
Chapter 5:  Sex-differences 











Chapter 4:   Estimation of cellular enrichments  
in human 
Chapter 4:   Single-cell analysis of the  
mouse transcriptome 
Chapter 4:   Pathology text 
processing 
Chapter 6:  Histological image 
processing and feature encoding 
Chapter 4,  5:  Cell 
types and disease 
Figure 1-16: Thesis outline. Graphical abstract of the key topics covered in this
thesis work.
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Chapter 2
Statistical learning methods in
genomics
When analyzing transcriptomics datasets, the objective is usually to acquire biological
insights about the data. A common task is to identify transcripts that have opposite
behaviours in groups of individuals with respect to a phenotype: this is usually carried
out by performing differential gene expression, which encompasses specific statistical
models to test if the counts for a transcript vary across these groups. Other times, we
are concerned with exploring the global structure of the data. Since it is not possible
to visualize all the transcriptome dimensions at once, we use dimensionality reduction
techniques that summarize the information contained in the data into a reduced
number of latent variables. Another set of methods that fall under the umbrella term
of statistical learning (of which dimensionality reduction is also a part of) deal with
the estimation of a predictive function 𝑓 that can model an outcome. Many methods
to estimate 𝑓 are based on machine learning algorithms, whose application in the field
of transcriptomics is relatively new when compared to traditional statistical methods.
Statistical learning does not only deal with prediction but also with understanding
the relationship between unlabelled data observations. Along these lines, this chapter
presents an exposition of different categories of methods that can have a role while
performing transcriptomic studies. The specific methods described here were used in
the development of the case studies in this thesis.
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2.1 Dimensionality reduction
Multivariate data is pervasive in genomics, where we oftentimes aim to discover global
and local structure in the data. Grasping these structures by performing simple oper-
ations like exploring the individual variances (or covariances) of the explanatory vari-
ables in the data is a task not always as intuitive as, for example, inferring knowledge
from a visual representation and its associated properties. To this end, dimensional-
ity reduction seeks to create compact representations of high-dimensional data that
allow us to perform tasks such as comparing the similarity between observations or
classifying them into groups. In this section, we delve into the fundamental concepts
of the three different dimensionality reduction methods that are used throughout the
case studies described in this thesis. Although all of these methods seek to reduce
the input data into a low-dimensional embedding, each method optimizes a different
objective, and thus, they lead to different maps that capture distinct aspects of the
structure in the data.
2.1.1 Principal Component Analysis
Principal Component Analysis (PCA) is a classical unsupervised dimensionality re-
duction technique that aims to explain as much variation as possible in a dataset
with a new set of uncorrelated variables called principal components. The first de-
scriptions of PCA are considered to be given by Pearson [108] and Hotelling [109].
This technique has been widely used in biology and genomics for tasks like population
structure and outlier identification in genome-wide SNP studies [110], identification of
sample clusters in analyses based on gene expression [111] and cell type identification
in scRNA-seq [112].
Consider a vector of random variables x ∈ R𝑝. In PCA, we find a set of weights
𝛼 ∈ R𝑝 such that a linear function 𝛼𝑇 x has maximum variance:





We call 𝛼𝑇1 x the first principal component. Then, another set of weights 𝛼2 is
sought such that 𝛼𝑇2 x has maximum variance and is uncorrelated with 𝛼𝑇1 x. The
process is repeated for 𝑘 sets of linear combinations 𝛼𝑇1 x, 𝛼𝑇2 x, . . . , 𝛼𝑇𝑘 x, up to a
maximum of min(𝑛−1, 𝑝) components, where 𝑛 is the number of samples in the data.
Several methods exist to compute PCs, for example, the Power method, via Lagrange
multipliers, the QL algorithm, and the Singular Value Decomposition (SVD) [113].
Here, we introduce the last formulation due to its ubiquity in computational software.
First, we consider the sample covariance matrix S ∈ R𝑝×𝑝 of a column-centered data




and since S is symmetric, it can be diagonalized as:
S = AΛA𝑇 (2.3)
with Λ being a diagonal matrix with non-increasing eigenvalues 𝜆𝑖, and A being a
matrix of eigenvectors that constitute the principal axes (or directions) of the data.
The principal components (also called scores) are defined by the projection XA of
the data onto the principal axes. The 𝑘th column of this matrix corresponds to the
𝑘th principal component. We now examine how SVD can be used to compute the
PCs by decomposing the centered data matrix X:
X = ULA𝑇 (2.4)
where U ∈ R𝑛×𝑟 corresponds to the matrix of left singular vectors of X, A ∈ R𝑝×𝑟
are the right singular vectors and L ∈ R𝑟×𝑟 is a positive diagonal matrix of singular

























































































































































Class ● ● ●setosa versicolor virginica
Figure 2-1: Principal Component Analysis example. PCA performed over the
classical “iris” dataset.
that:





from which it can be seen, together with (2.3) that there is a relationship between
the singular values in L and the eigenvalues in Λ through 𝜆𝑖 = 𝑙2𝑖 /(𝑛 − 1). Finally,
it is also clear from (2.4) that XA = ULA𝑇 A = UL, thus UL are the principal
components when computed through SVD.
Besides its application in many fields of biology (see, for example, in Fig. 2-1 a
classical illustration of PCA with the well-known “Iris” dataset [114], and provided
here only as means of comparisons with other dimensionality reduction methods,
since the sample groups for this dataset are known, whereas PCA is generally used
for exploratory data analysis), PCA has also found applications in the field of image
processing, for example, in the task of face recognition [115]. Here we introduce an
example of image manipulation and compression using PCA as it will be relevant for
Chapter 6.
Consider a black and white image represented by an array of pixels I ∈ R𝑚×𝑞,
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where each entry 𝐼𝑖𝑗 denotes a pixel intensity value in the interval [0, 255]. This can
be vectorized to obtain a 1-dimensional row vector
vec(I)𝑇 = [𝐼11, . . . , 𝐼1,𝑞, 𝐼2,1, . . . , 𝐼2,𝑞, . . . , 𝐼𝑚,1, . . . , 𝐼𝑚,𝑞] (2.7)
A set of 𝑛 images {vec(Ii)𝑇 ,∀𝑖 ∈ {1, . . . , 𝑛}} can then be vertically stacked to obtain
a matrix X ∈ R𝑛×𝑚𝑞. Afterwards, a PCA of X is performed to obtain a matrix
T = UL of principal components. Notice that we can fully recover X with TA𝑇 .
If we consider the case of using only a limited set of 𝑘 components, we can obtain





Fig. 2-2 shows an example of image reconstruction using tiles from an histological
image from a colon tissue sample, using a limited set of principal components. In
this example, a set of 603 tiles (samples) of original dimensionality 224 × 224 is
used, but resized with anti-aliasing to 96 × 96 only for illustrative purposes. These
are vectorized into a matrix X ∈ R603×9216. Then, truncated PCA is performed to
retrieve only the first 500 principal components. As expected, the reconstruction
X𝑘 is closer to the original when a larger number of principal components 𝑘 is used.
Although workarounds exist to incorporate color information with PCA (for example,
by vectorizing the 3-way array used to represent a color image), in practice, PCA is a
limited option to perform complex image processing tasks since the relation between
pixels is lost when performing vectorization of an image, in addition to complications
related to wide variations in the images. For these reasons, it tends to work well only
over uniform datasets with few variations in positioning and lighting.
49
Figure 2-2: Black and white image reconstruction with PCA. Six histology
image tiles from a GTEx colon sample (first row, corresponding to tiles of sample
GTEX-11DXX-1825) are reconstructed with a given number of PCs, shown on the
left side on each of the rows.
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2.1.2 t-Distributed Stochastic Neighbor Embedding
t-Distributed Stochastic Neighbor Embedding (t-SNE) is an unsupervised data vi-
sualization technique that attempts to capture local patterns in the data as well as
reveal the presence of clusters at larger scales. It was introduced in 2008 by van Der
Maaten and Hinton [116] and since then, it has been used in genomics to perform
unsupervised analysis of gene expression, especially in the context of single-cell RNA
sequencing (scRNA-seq) which can range from a few thousands up to millions of cells
(observations). t-SNE is also commonly applied in other tasks within biology since it
tends to yield good visualizations in datasets with a hierarchical organization among
the observations [117].
Consider a set of 𝑁 high-dimensional vectors 𝑋 = {x1, . . . x𝑁}. t-SNE aims to
construct a low-dimensional map 𝑌 = {y1, . . . , y𝑁} which usually is two or three-
dimensional. First, the similarity between the points in 𝑋 is computed as a joint
probability distribution 𝑃 . Each entry in the matrix 𝑃 is:
𝑝𝑖𝑗 =
exp(−‖x𝑖 − x𝑗‖2 /𝜎)∑︀
𝑘
∑︀
𝑙 ̸=𝑘 exp(−‖x𝑘 − x𝑙‖2 /𝜎)
,∀𝑖∀𝑗 : 𝑖 ̸= 𝑗 (2.8)
which is defined only only over pairs of non-identical points. Thus, 𝑝𝑖𝑖 = 0 since
only pairwise similarities between points are of interest. In the low-dimensional map
𝑌 , the similarity is measured with a joint distribution 𝑄, with pairwise distance 𝑞𝑖𝑗





𝑙 ̸=𝑘 exp(−‖y𝑘 − y𝑙‖2)
, ∀𝑖∀𝑗 : 𝑖 ̸= 𝑗 (2.9)
and also setting 𝑞𝑖𝑖 = 0, just as in the case of the pairwise similarities over 𝑋.
This formulation for 𝑞𝑖𝑗 was introduced in Stochastic Neighbor Embedding (SNE)
[118]. Then, the objective function of t-SNE seeks to minimize the Kullback-Leibler
divergence between 𝑃 and 𝑄:










However, when minimizing this objective using 𝑄 as defined by the pairwise sim-
ilarities in (2.9), the data points will suffer from a crowding problem related to the
volume differences between 𝑋 and 𝑌 : if 𝑋 is high-dimensional, pairs of points that
are slightly similar would be represented as far away in 𝑌 , and since this happens
for many pairs of points due to the high volume of 𝑋, the points will be squashed
and “crowded” together in 𝑌 [119]. The effects of dimensionality on volume have
already been discussed in Section 1.1.3. To alleviate this, 𝑞𝑖𝑗 is instead redefined to
be proportional to a Student-t distribution with one degree of freedom:
𝑞𝑖𝑗 =
(1 + ‖y𝑖 − y𝑗‖2)−1∑︀
𝑘
∑︀
𝑙 ̸=𝑘(1 + ‖y𝑘 − y𝑙‖2)−1
, ∀𝑖∀𝑗 : 𝑖 ̸= 𝑗 (2.11)
The distribution of 𝑄 has heavier tails and thus allows to represent larger distances in
the 𝑌 that correspond to only moderate distances in 𝑋. Minimization of the objective
function (2.10) is performed through gradient descent, with the gradient update given
by:
𝒴(𝑡) = 𝒴(𝑡−1) + 𝜂𝛿𝐶
𝛿𝒴
+ 𝛼(𝑡)(𝒴(𝑡−1) − 𝒴(𝑡−2)) (2.12)
with 𝒴(𝑡) being the solution at iteration 𝑡, 𝜂 is the learning rate, and 𝛼(𝑡) is the
momentum. Initialization of 𝒴(0) is done by random sampling from a Gaussian with







(𝑝𝑖𝑗 − 𝑞𝑖𝑗)(y𝑖 − y𝑗)(1 + ‖y𝑖 − y𝑗‖2)−1 (2.13)
In t-SNE, it is also necessary to fix a parameter called perplexity, which is used as
a proxy to choose values of 𝜎 in (2.8) and has the effect of balancing the objective
towards recovering local or global structure in the data. This value can be roughly
interpreted as the number of neighbors for each data point and may need to be tweaked
depending on the size of the data. We defer to [116] for its formal definition as well as
for the derivation of (2.13). Choosing a good value for perplexity is important when
using t-SNE since it tends to have a larger effect over the final map (see, for example,
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Class ● ● ●setosa versicolor virginica
Figure 2-3: Effect of perplexity in t-SNE. t-SNE performed over the classical
“iris” dataset with different values of perplexity.
descent (as long as the map is stable enough) [120].
Due to the nature of the joint distribution 𝑄, care must be exercised when in-
terpreting t-SNE maps. For example, the distances between the clusters might not
necessarily have a meaning: this can be seen, for example, in Fig. 2-3 where the dis-
tance between species clusters is conditioned on the attention given to the global/local
structure by the chosen perplexity value. A detailed exploration of the nuances of
t-SNE is presented in [120].
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2.1.3 Uniform Manifold Approximation and Projection
Recently, non-linear dimensionality reduction methods such as t-SNE have been used
to visualize the global structure of single-cell gene expression and reveal cell type
populations. These types of methods help avoid the overcrowding that happens when
clusters of data points are located in an overlapping areas [121], an issue that tends
to happen, for example, in PCA. Uniform Manifold Approximation and Projection
(UMAP) is a non-linear dimensionality reduction method that was recently intro-
duced and that is already being used to perform single-cell analyses due to its ability
to preserve both local and global structures in the data. Its derivation is based on
concepts from algebraic topology, manifold learning and Riemmanian geometry. Here,
we will present the main definitions of UMAP as described in the original work [122].
The summary of the mathematical idea of UMAP is to consider 𝑘-dimensional
simplices (convex hull of 𝑘+1 data points) to create simplicial complexes that describe
the underlying topological space of the data, given a sample. To do this, an open cover
(sets whose union represent the whole space) of the topological space is generated and
a Čech complex (a type of simplicial complex) is built from this. Since in practice
we work with finite samples, the open cover is generated through balls of a fixed
radius (through some distance, since the sample is assumed to be in a metric space)
around a point (see equation 2.15 for a clearer notion). UMAP then tries to generate
a low-dimensional embedding that that preserves the topology of the input space,
based mainly on 0- and 1-simplices.
From a computational perspective, this process is approximated with two steps:
constructing a graph of the data points (the proxy for the fuzzy simplicial sets)
and optimizing the graph layout in such a way that the topological structure of the
data is preserved. First, from a dataset 𝑋 = {x1, . . . , x𝑛} and a distance measure
𝑑 : 𝑋×𝑋 → R[0,∞), the 𝑘-nearest neighbors {x𝑖1 , . . . , x𝑖𝑘} are computed for each data
point x𝑖. For each point, the distance 𝜌𝑖 to the nearest neighbor is also computed:
𝜌𝑖 = min{𝑑(x𝑖, x𝑖𝑗 ) | 1 ≤ 𝑗 ≤ 𝑘, 𝑑(x𝑖, x𝑖𝑗 ) ≥ 0} (2.14)
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With these, we can generate a weighted graph ?̄? = (𝑉, 𝐸, 𝑤) with the vertices being
the data points, the edges being the sets of 𝑘-nearest neighbors for all data points
and the weights computed between each point and its neighbors:
𝑤𝑖(x𝑖, x𝑖𝑗 ) = exp
(︃




𝑤𝑖,𝑖𝑗 = 𝑤𝑖(x𝑖, x𝑖𝑗 ) + 𝑤𝑖𝑗 (x𝑖𝑗 , x𝑖) + 𝑤𝑖(x𝑖, x𝑖𝑗 )𝑤𝑖𝑗 (x𝑖𝑗 , x𝑖) (2.17)
Since 𝑤𝑖(x𝑖, x𝑖𝑗 ) is asymmetrical, the actual weights are just symmetrized in the
second line of the equation above. A weight matrix 𝑤′ is also computed for the data
points in the low-dimensional embedding 𝑌 , using an approximation for membership
strength based on two hyperparameters 𝑎 and 𝑏:
𝑤′𝑖𝑗 =
1
1 + 𝑎𝑑(y𝑖, y𝑗)𝑏
(2.18)
We now have everything to define UMAP’s cost function 𝐶, which is the cross-entropy
















With this objective, we find points {y𝑖, . . . , y𝑛} whose weighted graph 𝐻 (low-dimensional
representation) approximates the graph 𝐺 (input space). This can be thought of as a
non-convex optimization problem that is similar to optimizing a force-directed graph
layout, with the first term of (2.19) modeling the attraction between the points and
the second controlling the repulsion. It can be optimized through sampling-based
gradient descent (the derivatives are easy to compute), and initialized, for example,
with a spectral embedding. An example of UMAP is shown in Fig. 2-4, where the
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variability of the embedding is shown with respect to the number of neighbors 𝑘 which
balance local versus global structure, and the minimum distance between the points
in the embedding.
Figure 2-4: UMAP parameters. UMAP representations with varying minimal
distance and number of neighbors. The original input data is shown at the bottom.
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2.2 Statistical learning
The term statistical learning refers to computational methods and algorithms that aid
in understanding data [123] that can be either labeled or unlabelled. In the first case,
we speak of supervised learning since generally the goal is to learn a predictive function
to estimate an output based on a set on inputs; types of supervised learning tasks
include classification, regression and ranking. The second case is usually addressed
through unsupervised learning methods that aim to identify the relationships between
the observations in a dataset; for example, through clustering. These are two of the
main learning paradigms but others exist, such as semi-supervised learning where
data can be weakly-annotated or with labels existing only partially, and reinforcement
learning which is based on agents trying to maximize a reward by taking actions in a
controlled environment.
In a practical sense, the process of learning from data is streamlined through
machine learning, and this is one of the reasons why these methods have become
commonplace in the field of bioinformatics where the need exists to understand large
volumes of data and produce inferences from it. On the other hand, statistical learning
theory aims to formalize how that learning process occurs. In Section 1.1.3, a glimpse
was provided on how to measure learning when building a predictive function. When
learning from data, it is possible to build a function that will perfectly estimate that
data, however, this is not of interest: what we seek is for the predictive function to
pick up patterns in the training data that can generalize to unseen observations. The
ability to generalize is related to the complexity of the model, since ideally we would
want a model that is simple but that is also good at fitting the data.
Measuring the complexity of a model is not exactly straightforward: for example,
in parametric statistical modelling, complexity could be thought of as the number
of parameters in the model. In machine learning, we usually work with infinite-
dimensional hypothesis sets ℋ, but concepts from statistical learning theory such
as the Rademacher complexity or the Vapnik-Chervonenkis (VC) dimension provide
guarantees about the learning capabilities forℋ from finite samples, although through
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Figure 2-5: VC dimension of a classifier. The VC dimension for a model 𝑓 based
on a straight line is 3: at most three points can be perfectly separated in all possible
class arrangements in the data.
different conceptualizations of complexity [124]. To understand this intuitively, we
can illustrate what VC dimension is: consider a set of data points of cardinality 𝑆,
then, the VC dimension of a binary classifier model 𝑓 is the maximal cardinal 𝑆 for
which all the points can be shattered by 𝑓 : in other words, if a set of parameters 𝜃
exists such that 𝑓 can perfectly separate a set of at most 𝑆 points in any possible label
arrangement, then the VC dimension is 𝑆. In Fig. 2-5, we consider a model 𝑓 that is
simply a straight line and a set of 3 points with two classes. 23 possible arrangements
exist, and 𝑓 can perfectly separate all the cases. However, if we consider a set of 4 or
more, we can clearly see that this is not possible, since not all arrangements can be
separated. Thus, the VC dimension of 𝑓 is 3.
The fact that no unique way exists to measure complexity is related to the No
Free Lunch theorem [125], which, in short, states that there does not exist a single
model that will perform the best in all situations in the sense that if we take the
average performance of two different algorithms evaluated over a large set of different
problems, we will see that the performance is identical, and this happens because
each model makes a different set of assumptions about the data. We can, however,
control within-model complexity through the bias-variance tradeoff. If we assume



















Figure 2-6: Bias-variance tradeoff. Behavior of bias and variance with respect to
model complexity and prediction error.
the expected mean square error at a point 𝑥 in three terms: variance of 𝑓(𝑥), bias of
𝑓(𝑥) and the irreducible error Var(𝜖):
𝐸(𝑦 − 𝑓(𝑥))2 = Var(𝑓(𝑥)) + [Bias(𝑓(𝑥))]2 + Var(𝜖) (2.20)
which refers to the error we would expect if we evaluated 𝑥 when estimating 𝑓 repeat-
edly with many different sets of training data. Through the parameters of the model,
we can decide if we want to compromise variance, which refers to the variability in 𝑓
as a function of the training data, or favor bias, which refers to the errors that are
inherent to simplifying the problem. Finding a good tradeoff between both quantities
(see Fig. 2-6) is how we avoid underfitting and/or overfitting a model.
In this section we cover four methods that although not specific to computational
biology, can be used to understand biological datasets. Some of these, such as hi-
erarchical clustering, have been extensively used in the field, while others, such as
gradient boosting and model explanation frameworks based on Shapley values (the




Clustering is a type of unsupervised analysis performed when the goal is to identify
which observations of a dataset tend to be closely related to each other through
a quantification of their degree of (dis)similarity. Observations that belong to the
same cluster tend to share properties among themselves as opposed to observations
assigned to different clusters. How the observations are grouped strongly depends
on the dissimilarity measure used to compare the observations, as well as on the
clustering algorithm. Many clustering algorithms depend on a matrix of pairwise
dissimilarities D ∈ R𝑛×𝑛, with 𝑛 referring to the number of data points 𝑥𝑖 with
𝑝 variables in a dataset X ∈ R𝑛×𝑝. Through a function 𝑑𝑗(𝑥𝑖𝑗, 𝑥𝑖′𝑗) definining a
dissimilarity between attribute 𝑗 in both observations (for example, euclidean distance
for the case of continuous values), we can define a dissimilarity at the level of the





With this, we evaluate all pairwise combinations of objects to generate D, which is
assumed to be symmetrical for most algorithms:
D𝑖𝑖′ = D𝑖′𝑖 = 𝐷(𝑥𝑖, 𝑥𝑖′) = 𝐷(𝑥𝑖′ , 𝑥𝑖) (2.22)
Here, we introduce the generalities of hierarchical clustering, which is a type of clus-
tering analysis that bundles observations through a hierarchical arrangement. This
procedure does not require setting the number of clusters a priori, like in the case
of 𝑘-means. Instead, hierarchical clustering can be performed through two different
conceptualizations: agglomerative (bottom-up) and divisive (top-down) [47]. These
refer to the way that the clusters are defined: agglomerative starts by considering
each observation as a singleton cluster and then merges a pair of clusters according
to a specific criterion that seeks to minimize the distance between clusters, reducing
the number of clusters by 1 in each step until the root of the hierarchy is only one
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cluster (see Algorithm 1). For an example of agglomerative hierarchical clustering,
see Fig. C-8.
Algorithm 1: Agglomerative clustering
Data: D ∈ R𝑛×𝑛
Result: Dendrogram
1 Initialize: 𝐶 = {𝐶1 = {𝑥1}, . . . , 𝐶𝑛 = {𝑥𝑛}}
2 while |𝐶| ≠ 1 do
3 (𝐶𝑘, 𝐶𝑘′) = argmin𝐴,𝐵 𝑓SINGLE(𝐶𝐴, 𝐶𝐵), 𝐴, 𝐵 ∈ 𝐶
4 𝐶 = 𝐶 ∖ {𝐶𝑘, 𝐶𝑘′}
5 𝐶 = 𝐶 ∪ {{𝐶𝑘, 𝐶𝑘′}}
6 end
Examples of dissimilarity measures between two clusters 𝐶𝐴 and 𝐶𝐵 include single
linkage, which considers the distance between the two clusters to be the pair of
instances with the smallest distance:




and complete linkage, which takes the inter-cluster distance to be the most dissimilar
pair (maximal distances) of instances:




Measures such as average linkage or Ward’s criterion are also common. A divisive
strategy will start from the top of the hierarchy, with all data points grouped into
a single cluster, and creating subsequent partitions between pairs of clusters with
the largest distance according to a specific criterion. Both strategies are generally
monotonic, in the sense that dissimilarity between clusters will always increase with
respect to the cluster split level. Thus, cluster pairings can be represented through




Machine learning classification methods that are able to robustly deal with high di-
mensional spaces have allowed researchers to build models that use different types of
-omics datasets to distinguish between different groups of observations with respect
to phenotypic traits, or with disease [126]. One such method is gradient boosted trees,
which has been widely used in the last years due to its overall good performance in
different types of tasks [127] that rely on tabular data. Here, a common conceptu-
alization of gradient boosting trees called XGBoost will be described, following the
exposition by Chen and Guestrin [128].
Consider a dataset 𝒟 = {(x𝑖, 𝑦𝑖)} with number of examples |𝒟| = 𝑛 and data
dimensionality x𝑖 ∈ R𝑝, 𝑦𝑖 ∈ R. For any task such as regression, classification and
ranking, we seek to find an optimal set of parameters 𝜃 obtained by training a model
that minimizes an objective function that measures how well predictions 𝑦𝑖 = 𝑓(x𝑖)








with 𝑙 being a differentiable convex loss function and Ω being a regularization term
that penalizes the complexity of the model. In the context of tree boosting, the




𝑓𝑘(x𝑖), 𝑓𝑘 ∈ ℱ (2.26)
with ℱ = {𝑓(x) = 𝑤𝑞(x)} being the space of possible regression trees, and 𝑞 being a
tree structure which maps a data point to leaf in that tree: 𝑞 : R𝑝 → {1, . . . , 𝑇}, 𝑤 ∈
R𝑇 , where 𝑇 is the total number of leaves in a tree. Notice that here, each 𝑓𝑘 is
independent, meaning that it has its own set of leaf weights 𝑤 and tree structure 𝑞.
With this, from (2.26) we realize that the final prediction for a sample is given by the
sum of the corresponding leaf scores across all trees. With this context established,
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we can set the objective penalty as:
Ω(𝑓) = 𝛾𝑇 + 12𝜆‖𝑤‖
2 (2.27)
which aims to prevent overfitting by penalizing the leaf weights, and thus leading
to simpler models, which in the case of other tree learning methods was dealt with
by applying heuristics focused on improving impurity. It becomes evident that since
(2.25) contains functions as parameters, we cannot directly use stochastic gradient
descent to minimize this function, and thus, we rely on additive training (boosting) to
optimize the objective. At the 𝑡-th iteration, with prediction 𝑦(𝑡)𝑖 of the 𝑖-th instance,




𝑙(𝑦𝑖, 𝑦(𝑡−1)𝑖 + 𝑓𝑡(x𝑖)) + Ω(𝑓𝑡) (2.28)
The objective can be optimized using first and second order Taylor approximations
𝑔𝑖 = 𝜕𝑦(𝑡−1)𝑙(𝑦𝑖, 𝑦
(𝑡−1)


























Note that here, the objective depends on 𝑔𝑖 and ℎ𝑖. Therefore, custom loss functions
can be used as long as 𝑔𝑖 and ℎ𝑖 are known: this is how XGBoost can deal with other
types of problems besides classification: regression, ranking, etc. To measure how
good a tree structure 𝑞(x) is, we reformulate (2.30) by i) expressing the trees 𝑓𝑡(·)
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with 𝐼𝑗 = {𝑖|𝑞(x𝑖) = 𝑗} being the indices of the observations pushed into leaf 𝑗. We are
able to rewrite (2.31) in terms of the tree indices in (2.32) because the observations
that belong to the same leaf have the same score. Now, let’s assign terms to the
summations: 𝐺𝑗 =
∑︀
𝑖∈𝐼𝑗 𝑔𝑖 and 𝐻𝑗 =
∑︀


















By plugging this into (2.33), we finally obtain an equation that provides a measure







We defer to [128] for algorithmic details on how to iteratively add branches to the tree
in order to evaluate split candidates. In practice, it is important to perform parameter
tuning (for example, via grid search + cross-validation, or Bayesian optimization) to
find a good bias-variance tradeoff point. If a large number of estimators (trees) is
used, the decision boundary (in the case of classification) will overfit the data, not
being able to generalize (see, for example, Fig. 2-7 with 30 estimators).
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Figure 2-7: Decision boundaries in gradient boosted trees. Here we show the
effect of the number of estimators on the decision boundary for a toy classification
problem with two features and two classes. The granularity of the decision boundary
will increase as the number of estimators increases. A large number of trees without
proper regularization will lead to overfitting, as shown here with 30 estimators.
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2.2.3 Hyperparameter search with Bayesian optimization
Many machine learning methods depend on a set of hyperparameters 𝜆 to control
model complexity and make a tradeoff between bias and variance, as discussed earlier
in Section 2.2. These hyperparameters are different from those used as data weights
when fitting the predictive function, since the former are inherent to the algoritm used
for the learning task, where we ultimately seek to minimize a loss function ℒ(Xtest; 𝑓)
for a model 𝑓 over a test dataset. The model 𝑓 is fit based on an algorithm 𝒜 which
depends on the hyperparameters 𝜆 found to be optimal in a training dataset Xtrain:
𝑓 = 𝒜(Xtrain; 𝜆). Thus, hyperparameter search refers to the process of finding a set
𝜆* that produces an optimal model 𝑓 * [129]:
𝜆* = argmin
𝜆
ℒ(Xtest; 𝒜(Xtrain; 𝜆)) (2.36)
Sets of candidate hyperparameters can be derived, for example, through random
search in a space bounded between reasonable minimal and maximal values for each
hyperparameter, or also through grid search in which candidate values for each hyper-
parameter are proposed through a specific sampling criteria, for example, by selecting
a number of equidistantly spaced points between the lower and upper bounds for that
hyperparameter. It becomes evident that creating a granular grid (or even random
search) for many parameters can become prohibitive in terms of the number of eval-
uation needed to find 𝜆*, especially within the context of procedures that aim to
describe model robustness (through the inspection of the error criterion, for example)
such as bootstrapping or cross-validation.
Bayesian optimization provides a framework that can be used to make educated
guesses for 𝜆* candidates that tend to behave better than baseline models or ran-
dom search, and that, although requiring additional computations, can reduce overall
training time since less evaluations are needed to find an optimal point. Here, we very
briefly touch the practical considerations for this framework, as presented in [130],
and that are based on two main elements. The first is the choice of a prior distribution
(also called a surrogate model) over functions 𝑓 : 𝒳 → R that model the assumptions
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of the function we need to optimize: Gaussian processes (GP) allow this by inducing
a multivariate Gaussian distribution on a set of 𝑁 points {x𝑛 ∈ 𝒳}𝑁𝑛=1. We assume
then that 𝑓(x) is drawn from a GP, with each observation having a label {x𝑛, 𝑦𝑛}𝑁𝑛=1
that follows a normal distribution 𝑦𝑛 ∼ 𝒩 (𝑓(x𝑛, 𝜈)) with 𝜈 being the noise variance
of the observations. The second consideration is the derivation of an utility function
based on the posterior distribution from which we can decide where to sample next,
based on a criterion of expected loss: the acquisition function 𝑎 : 𝒳 → R+:
xt = argmax
x
𝑎(x|{{x1, 𝑦1}, . . . , {x𝑡−1, 𝑦𝑡−1}}) (2.37)
with x𝑡 being the next sampling point obtained by evaluating the acquisition func-
tion for the current data point conditioned over all previously drawn points. Once
the sampling point has been obtained, we estimate the response 𝑦𝑡 = 𝑓(x𝑡) + 𝜖𝑡,
add the pair {x𝑡, 𝑦𝑡} to the list of sampled points, and then repeat (acquire a new
sampling point). The expected improvement acquisition function has been shown to
perform better than other classical acquisition functions such as the probability of
improvement [130]. As its name suggests, it can be defined as the expectation of
the maximal difference between evaluating a sample x and the current best point
x+ = argmaxx𝑖∈{x1,...,x𝑡} 𝑓(x𝑖):
𝑎EI = E[max(𝑓(x)− 𝑓(x+), 0)] (2.38)
We refer to [131] for details on how to analytically evaluate the GP. In the case of
hyperparameter optimization, the sampling points correspond to candidate hyperpa-
rameters for 𝜆* and the objective function is defined by the machine learning problem
(for example, MSE in the case of regression, negative log-likelihood in classification,
etc.).
Fig. 2-8 shows an example of maximizing a known noise-free target function (in
red, and which is unknown in practice) through a GP. The left panel in the first
row shows two initial guesses that that generate an unhelpful posterior (dashed black
lines) but that will be the starting point for the optimization. We then start sampling
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candidate points in each step of the GP, and see the next candidate point to sample
according to the utility function (panels on the right). As we sample more points, the
uncertainty decreases. In Chapter 5 we perform Bayesian optimization for candidate
hyperparameter search while building classifier models.


























5 4 3 2 1 0 1 2 3
0
2




5 4 3 2 1 0 1 2 3
0
2








Objective Observations Prediction 95% CI
Figure 2-8: Bayesian optimization. First row is the initialization with two points,
and subsequent rows are the optimization steps. Left panels correspond to the GP
while the right panels show the utility function with the guess for the next point
indicated with black squares.
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2.2.4 Shapley values
Many research questions are now tackled through data-driven machine learning meth-
ods due to their capacity to handle high-dimensional spaces. Unlike classical statis-
tical methods that might generally be better suited for 𝑛 >> 𝑝 situations and whose
parameters can be interpreted, in most of machine learning methods it is often thought
that the price to pay for increased prediction accuracy is the reduced interpretability
due to the complexity of the models and their large number of parameters [132].
We can consider interpretability as the capability of describing the internal machin-
ery of a model in such a way that is comprehensible by humans, whereas explainability
refers to scrutinizing the reasons for which a model decides to make a specific pre-
diction [133], commonly through the creation of post-hoc models or calculations that
attempt to explain the first model. Although debate exists as to whether explainabil-
ity is the correct paradigm to understand what a model is doing and even to whether
the interpretability vs. accuracy tradeoff mentioned above is real (see, for example
[134]), methods for ML explainability have been successfully used in bioinformatics
applications. Examples include the characterization of gene expression in children in
response to air pollution [135] and recovering features that are relevant for splice site
prediction [136]. Here, we discuss a framework for ML model explainability based
on Shapley values, which is a cooperative game theory concept introduced by Lloyd
Shapley in 1951 (see [137] for a reprint of the original work).
Shapley values are a way to numerically summarize the value of playing a game
in terms of expected payout for each player in a coalitional game. To formalize
this, consider a subset of 𝑆 ⊆ 𝐹 of players, where 𝐹 is the set of all players, and a
characteristic function 𝑣 : 2𝑁 → R that maps a subset of 𝑁 players 𝑆 to a scalar value
that determines the worth of the coalition 𝑣(𝑆) as the expected payoff sum obtained
by the players in 𝑆. Shapley values are then the contribution 𝑣(𝑆 ∪ {𝑖})− 𝑣(𝑆) of a




|𝑆|!(|𝐹 | − |𝑆| − 1)
|𝐹 |! (𝑣(𝑆 ∪ {𝑖})− 𝑣(𝑆)) (2.39)
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Shapley values were used in [138] to the context of deriving variable usefulness
in multiple regression problems by comparing their contribution across all possible
models. By adapting (2.39), we can compute the attribution for a feature 𝑖 with a




|𝑆|!(|𝐹 | − |𝑆| − 1)
|𝐹 |! (𝑓𝑆∪{𝑖}(𝑥𝑆∪{𝑖})− 𝑓𝑠(𝑥𝑠)) (2.40)
with 𝑥𝑠 being an observation with a subset of features 𝑆. Shapley values are described
in [139] to be part of a class of methods for additive feature attribution: consider a
model 𝑓 for which explanations want to be derived, and 𝑔 a model to explain the
predictions of 𝑓 ; this class of methods then seeks to explain 𝑓(𝑥) on the basis of an
observation 𝑥, and rely on a mapping function ℎ𝑥 that is particular to that observation
to obtain a simplified version 𝑥′ of 𝑥: 𝑥 = ℎ𝑥(𝑥′). Then, 𝑔 is constructed in such a way
that 𝑔(𝑧′) ≈ 𝑓(ℎ𝑥(𝑧′)) for 𝑧′ ≈ 𝑥′. The explanation model is the sum of attributions
for informative features in this simplified input 𝑧′ ∈ {0, 1}𝑀 , with 𝜑𝑖 ∈ R as in (2.39),
with ℎ𝑥 mapping the indicator to the original input space:






Three desirable properties for additive feature attribution methods are covered in [139]
together with the presentation of the following theorem for an explanatory model 𝑔




|𝑧′|!(𝑀 − |𝑧′| − 1)!
𝑀 ! [𝑓𝑥(𝑧
′)− 𝑓𝑥(𝑧′ ∖ 𝑖)] (2.42)
This is the SHAP importance measure, which, in other words, corresponds to the
Shapley values of a conditional expectation of the model: 𝑓𝑥(𝑧′) = 𝑓(ℎ𝑥(𝑧′)) =
𝐸[𝑓(𝑧)|𝑧𝑠]. One can see from (2.42) that this is prohibitive in terms of computation
for large 𝑀 , since all possible subsets need to be evaluated. Sampling workarounds
have been proposed [140] (for Shapley values, although also applicable here), as well as
kernel approximations that reduce the number of evaluations. Model-specific approx-
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imations also have been derived, for example, for the case of trees [141]. The SHAP
framework has been used to generate explanations, for example, for the prevention of
hypoxaemia during surgery [142]. Here, we perform an experiment to illustrate how
SHAP values can be used in the context of phenotype prediction with gene expression
with the GTEx dataset. Two types of skin samples are collected: sun exposed (SE)
from the lower leg, and not sun exposed from the suprapubic part of the body. From
Fig. 1-13 it can be seen that skin samples (coded in two shades of blue) are clustered




















































































Figure 2-9: SHAP values in skin type classification. (a) SHAP values for the
top 20 genes with more impact on model output. SHAP values are computed for
every sample in every gene (each dot is a sample). Genes are sorted by the sum of
absolute SHAP magnitudes across samples. Positive SHAP values contribute towards
prediction of sun exposed skin, while negative values to the prediction of not sun
exposed skin. (b) log2(TPM+0.01) gene expression of the genes shown in (a), sorted
by difference in their medians. (c) t-SNE of skin samples based on the expression of
the 20 genes.
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Figure 2-10: Feature attributions for breast ductal carcinoma. On the left,
an histological image tile from a WSI of a TCGA breast sample affected by ductal
carcinoma. On the right, the feature attributions generated through GradientSHAP.
We fit a cross-validated gradient boosted tree model to discriminate the type
of skin sample (SE or NSE) based on the gene expression profile of each sample,
and calculate SHAP values for each gene (Fig. 2-9a). The expression of these top-
contributing genes is clearly different among skin types (Fig. 2-9b-c), demonstrating
that, although similar at the global level, both skin types contain transcriptional
signature subsets that allow to distinguish between types. In Chapter 5 we construct
models to predict sex based on gene expression and analyze the sets of contributing
genes based on SHAP values.
The SHAP framework can also be used to generate model explanations for non-
tabular inputs, such as images, as well as to intepret model layers and neurons in
neural networks. Here, we briefly illustrate such an usage: in Chapter 6 we fit a
convolutional neural network to predict the tissue of origin from histological image
patches derived from WSIs of cancer-affected tissues from The Cancer Genome Atlas
[143]. By using GradientSHAP (gradient expectations by random sampling from
a baseline), we can identify parts of the image that are highly predictive of the
class, as shown in Fig. 2-10 where an image tile from breast tissue (affected by
ductal carcinoma) appears on the left and its feature attributions appear on the
right, highlighting desmoplastic stroma that is characteristic of this type of cancer.
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2.3 Deep learning
The performance of statistical learning tools heavily depends on the set of features
used to encode descriptions about our data. Although human-guided feature creation
can certainly be of use in many cases, it becomes infeasible in tasks that deal with
very high-dimensional data, such as images, text and temporal sequences, for which
it is quite difficult to manually create meaningful features. For this reason, machine
learning methods have been used not only to make use of feature sets to solve a
particular problem, but also to learn an optimal data representation, process which
is termed representation learning.
Deep learning (DL) has quickly found applications in many different fields, both in
science and industry, due to its capabilities for representation learning, since it relies
on representations structured through layers with varying levels of abstraction: Fig.
2-11 shows an example of a fully-connected feedforward neural network 𝑓 (also called
a multilayer perceptron) mapping an input x ∈ R12 to an output 𝑦 ∈ R1, with an
input layer that corresponds to the number of features in the data, two intermediate
(hidden) layers and a final output with a single output node, that could be used, for
example, to model a regression problem.
Input layer ∈ ℝ12 Hidden layer ∈ ℝ8 Output layer ∈ ℝ1Hidden layer ∈ ℝ6
Figure 2-11: Neural networks. Fully-connected (FC) neural network with random
weights, denoted by the edge color (positive = red, negative = blue).
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This type of network is not considered DL, since it has a relatively shallow layout.
The increasing depth (number of layers) of performant DL models is what originated
the term deep learning, while the width of the network refers to the number of neurons
in each layer. Nevertheless, feedforward neural networks serve to introduce the general
concepts. As in all types of learning, they depend on a cost function as a proxy
to approximate the underlying true model 𝑓 *. These networks make predictions
based on composition of functions, for example, 𝑦 = 𝑓(x) = 𝑓 (3)(𝑓 (2)(𝑓 (1)(x))) with
one function for each layer in the network shown before, and with the functions
belonging to a class of transformations 𝜑(x, 𝜃) [144]. Here lies the main advantage of
deep learning when compared to several classical ML methods: the mapping function
𝜑 performs a non-linear transformation of the input x, allowing to learn complex
intermediate representations from the input features at the cost of making this a
non-convex optimization problem, with each layer having its own set of weights to
parametrize the representation. In other words, 𝜑 roughly defines the architecture of
the model, with each layer 𝑙 having a set of parameters W𝑙 and possibly biases c𝑙
coupled with a layer activation function 𝑔𝑙 that applies a non-linear transformation
to the data coming from the previous layer in the network. For example, in Fig. 2-11,
the transformations computed by the hidden layers for a single sample x could be:
h1 = 𝑔1(W1x + c1)
h2 = 𝑔2(W2h1 + c2) (2.43)
With W1 ∈ R8×12, x ∈ R12, c1 ∈ R8 and W2 ∈ R6×8, h1 ∈ R8, c1 ∈ R6. The
choice of an appropriate activation function 𝑔𝑙 depends on the problem domain [145]
which is in turn related to the loss function used to evaluate the problem, the network
architecture, and other design choices. Common activation functions are illustrated
in Fig. 2-12. Examples of loss functions used in regression problems are L1-loss (mean
absolute error), smooth L1-loss and mean squared error; in classification problems,
the negative log-likehood loss, cross-entropy loss and Kullback-Leibler divergence.


































tanh(x, ) = exp(x) exp( x)exp(x) + exp( x)








Hard-swish(x) =  [0, x, (x2 + 3x)/6]
 for [x 3, x 3, otherwise]












Figure 2-12: Activation functions. Common activation functions in deep learning
applications. Φ is the CDF of the normal distribution. For a given input vector, these
(particular) functions are applied elementwise.
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Model training is performed in two stages: the forward pass in which the acti-
vations and pre-activations are computed for each layer, and backpropagation, which
refers to the computation of the gradient of the layer weights and their optimiza-
tion with a specific algorithm. Backpropagation was introduced in [146] and is the
backbone of modern deep learning. Here, we illustrate the process following the ex-
position in [147], considering a quadratic loss function for a sample and target (x, 𝑦),
with weights W𝑙 for layer 𝑙 and the same activation function 𝑔 for all layers:
ℒ(x; 𝜃) =
⃦⃦⃦
𝑦 −W𝑙𝑔(W𝑙−1 . . . W2𝑔(W1x))
⃦⃦⃦2
(2.44)
In the forward pass, the layer activations h𝑙 are computed by applying 𝑔 on the pre-
activations z𝑙 which are simply the linear combination of the layer weights and the
activations from the previous layer, all the way until layer 𝐿:
h𝑜 = x, z1 = W1h0 (2.45)
h1 = 𝑔(z1), z2 = W2h1
..., ...
h𝐿−1 = 𝑔(z𝐿−1), z𝐿 = W𝐿h𝐿−1
In the backward pass, the gradient of the loss over the layer weights is computed. This
depends a diagonal matrix D𝐿 of derivatives of 𝑔 evaluated at every pre-activation
for each layer, as well as the derivative of the loss with respect to z𝐿:




With this, the gradients with respect to the weight layers are:
𝜕ℒ
𝜕W𝑙
= (W𝐿D𝐿−1 . . . W𝑙+2D𝑙+1W𝑙+1D𝑙)𝑇 𝑒(h𝑙−1)𝑇 , 𝑙 = {1, . . . , 𝐿} (2.48)
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If we consider the following formulation for error backpropagation:
𝑒𝐿 = 𝑒 (2.49)
𝑒𝐿−1 = (D𝐿−1W𝐿)𝑇 𝑒𝐿
. . .
𝑒1 = (D1W2)𝑇 𝑒2
then (2.48) can be simplified:
𝜕ℒ
𝜕W𝑙
= 𝑒𝑙(ℎ𝑙−1)𝑇 , 𝑙 = {1, . . . , 𝐿} (2.50)
Updates for each W𝑙 are performed in the backward pass with stochastic gradient
descent or related optimizers such as AdaGrad, Adam, and RMSProp. A lack of
proper initialization of the model weights before starting the optimization can result
in failure to reach convergence and training the network overall, and thus, several
weight initialization schemes have been developed to prevent this [148]. In practical
applications, data is usually large enough that is not possible to compute these for all
the samples at the same time in a single pass. Thus, they are split in mini-batches,
which refers to blocks of samples used to perform the forward and backward passes.
The mini-batch size can be chosen, for example, with respect to hardware capabilities
or aspects related to the optimizer, such as the learning rate [149]. The flexibility
in formulating a model architecture is one of the reasons for the adoption of DL in
many different types of computational biology problems, including: health record pro-
cessing, gene expression signature extraction, sample cluster characterization, sample
classification, inferring tissue-specific splicing mechanisms, TF-DNA motif recogni-
tion, promoter and enhancer identification, prediction of miRNA targets, secondary
protein structure prediction, identification of protein-protein interaction networks,
and lastly, bioimage analysis for the determination of morphological phenotypes [150],
which is the primary subject of interest for this thesis. Since this strongly depends
on the principles of CNNs, these will be briefly introduced in the next section.
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2.3.1 Convolutional neural networks
CNNs, as opposed to vanilla feedforward networks, are meant to work with multi-
way array inputs such as images, text, and video, among others, and are based on
four properties of natural signals: local connections, shared weights, multiple layer
usage, and pooling [151]. The pioneering concepts for Convolutional Neural Networks
(CNNs) were introduced in the 80’s, when LeCun et al. [152] explored the use of back-
propagation in a network architecture to the problem of recognizing hand-written
zip code digits, although some of the key components of CNNs like convolutional
and downsampling layers were introduced earlier and are biologically inspired on the
hierarchy model of the visual nervous system [153]. Later on, it was shown that
an improved version of the original model, known as LeNet [154] (see Fig. 2-13)
outperformed other models at that time, which kickstarted the field of deep learning.
Convolution Max-pooling Convolution Max-pooling FC FC FC
32x32 6@28x28
6@14x14 16@10x10 16@5x5 1x120 1x84 1x10
Figure 2-13: Convolutional Neural Networks. Example of a classical CNN: the
LeNet architecture for handwritten character recognition. Input data is in the form
of 32 × 32 (pixels) grayscale images. Through a combination of convolutions and
max-pooling (subsampling), the network generates a final feature vector of size 10.
Convolutional layers are based on feature maps, which allow to learn specific char-
acteristics of the input image (for example, in Fig. 2-13, after the first convolution,
there are 6 feature maps of size 28x28), with all the neurons in a given feature map
sharing the same parameters when scanning the input from the previous layer, but
with each filter having a different set of weights, which makes each filter capture dif-
ferent information from the input. Pooling layers perform a smoothing of the input
by calculating a summary statistic (such as the maximum value of a group of pixels),
which can be thought of as a kind of downsampling.
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Since LeNet, many major CNN models have been developed for classification,
object detection, segmentation, among other applications, each one with a differ-
ent architecture and hardware requirements. Examples of these architectures are:
AlexNet, GoogleNet, VGGNet, ResNet and DenseNet [155]. Several techniques exist
to improve the stability of the learning process. Examples are batch normalization,
which refers to the normalization of feature maps in the network to have a mean of
zero and unit variance; and dropout which is a type of regularization consisting in
randomly removing network edges or neurons with a specific probability with the aim
of reducing overfitting [156].
One might think that the applicability of deep learning is limited in situations
when data is scarce to train a model. However, through the use of techniques like
transfer learning, we can exploit the fact that the early layers of a model learn generic
features (in the case of image data) such as edges and blobs [157], and thus, the weights
of an existing trained network (for example, trained over ImageNet) can be transferred
and adapted to suit a different problem or image types. This effectively reduces the
sample size needed to train a model. Coupled with other techniques such as data
augmentation which can be used to make transformations on a set of images (for
example, random rotations, perspective warping, cropping, flipping, resizing, etc.),
training a model to solve a domain-specific task does not necessarily have to depend
on prohibitive amounts of data.
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2.3.2 Integrating histopathology with molecular features
In Section 1.1.6, the different types of tasks that could be addressed with histolog-
ical image data and deep learning models were introduced. Here, we will focus on
describing recent advances that aim to produce general models of histology as well as
the integration of histological image features with molecular features.
It is well known that histological features enable pathology characterization and
classification into subtypes, although mixed evidence exists about how these features
can be prognostic or predictive with respect to clinical outcomes in disease, for exam-
ple, in non-small cell lung cancer [158] or melanoma [159]. However, recent work has
used DL models trained on tile-based histological features to predict genetic features
associated with disease. An example of this is in Kather et al. [160], where DL mod-
els trained on H&E histology are used to predict microstatellite instability (MSI).
The latter is commonly identified through genetic analyses or immunohistochemistry,
and aids in determining the response to immunotherapy in patients with gastroin-
testinal cancer. They find that the models can distinguish MSI-associated features,
validating the findings in an external H&E set, and that the fraction of MSI-predicted
tiles correlates both with gene expression and immunohistochemical data, suggesting
that histology could play a role in inferring molecular features. Direct prediction
of genomic alterations from histopathological patterns has also been addressed, for
example, for whole-genome duplications and point mutations in driver genes [161].
Other works have focused in predicting gene expression patterns directly from WSIs
and their spatialization in the context of cancer [162].
In the context of normal human tissues, existing work on an early version (v6) of
the GTEx dataset has used convolutional autoencoders and sparse canonical corre-
lation analysis to find image features relating to population variation and associated
with genetic variants in stomach and colon tissues [163], suggesting that histologi-
cal image features can be encoded and related with molecular traits, potentially to
the level of spatially resolving gene expression as we present in early explorations in
Chapter 6.
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Besides inferring single traits from WSIs, these have also been used in conjunc-
tion with paired data types to improve predictions. For example, Chen et al. [164]
developed a framework that integrates histopathology with genomic features such as
mutations, copy-number variation and RNA-Seq for survival outcome prediction in
cancer. To do this, they train models over each different data modality (CNNs and
graph convolutional neural networks over WSIs, FCNs over genomic profiles) and com-
bine the feature vectors through gating-based attention meachnisms and Kronecker
products.
Existing models of histology in human are mostly focused on diseased tissues and
identification of malignancies, but efforts have also been done to build models of
normal tissue histology: Sing et al. [165] benchmarked the performance of different
CNN architectures to recognize 46 different tissues from WSIs derived from rat tissue
samples, finding that the generated feature vectors cluster together with respect to
individual tissues and that morphologically similar tissues tend to have overlapping
clusters. They suggest that these representations can be used to perform histological
outlier identification, as well as discussing how these models, although not imme-
diately applicable in their current state, could be used as a basis for cross-species
histology predictions.
Most, if not all of these analyses, are built upon a set of common building blocks:
WSIs are divided into a grid of smaller sized-tiles; models that are based purely on
WSIs are trained used transfer learning (i.e. pre-trained architectures over existing
datasets) or using (convolutional) autoencoders; feature vectors that encode the image
patterns are generated as the output of the network and used for specific tasks.
Although model design choices are variable in the literature (chosen WSI resolution,
network architectures, regularization techniques, model training frameworks, source
model for transfer learning, optimization, etc.), the biggest conceptual variation, at
least in the case of linking histological features with molecular traits, lies in how the
final feature vectors are used to perform the link. Some works decide to aggregate
feature vectors from tiles corresponding to a single WSI into a single representation
by calculating summary statistics for each component and then directly computing
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sample correlations with other data pairs (but this complicates the traceability of the
contribution of individual tiles), while others perform more complex meta-learning
steps to directly model the link with the molecular features.
Although these types of tools have the potential to aid in disease screening with
reduced costs, their application in clinical settings is not immediate and has challenges
both from the ethical and legal perspectives. Gerke et al. [166] comment that there
are several issues that need to be addressed to apply artificial intelligence models to
healthcare: from the ethical standpoint, data consent, model safety and transparency,
algorithmic fairness and biases; and from the legal side, concerns exist about safety
and effectiveness, liability, among other issues.
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Chapter 3
The effects of death and
post-mortem cold ischemia on
human tissue transcriptomes
Characterizing gene expression in tissues of living organisms is currently not possible
due to the difficulties involved in obtaining these samples. For this reason, tissue sam-
ples obtained from post-mortem organisms are a proxy to study the behavior of gene
expression, with the caveat that post-mortem RNA patterns cannot be considered ex-
actly analogous to normal RNA levels in the living, since death and the post-mortem
interval (PMI, which is the time elapsed since death) causes a cascade of events that
alters these levels, and this degradation occurs in a tissue-specific manner. Here,
we describe how post-mortem interval impacts gene expression levels and how these
change across PMI intervals in 36 different tissues from 540 human donors. Our re-
sults suggest that transcriptional regulation continues after human death. Since the
transcriptome responds to death in a tissue-specific manner, we used this variation to
build models for estimating PMI for human individuals. We find that a few accessible
tissues can be used to derive these estimates, and propose an usage protocol for an
hypothetical real life scenario. Although larger sample sizes are needed to fully de-
scribe the predictive accuracy, these models suggest that gene expression signatures
can carry information about the elapsed time since death.
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Summary of my key contributions
• Built gradient boosted tree models to predict sample post-mortem interval from
gene expression:
1. Fit repeated cross-validated models to estimate PMI at the sample level,
separately for each of 36 human tissues.
2. Combined the tissue predictions to derive a prediction of the post-mortem
interval at the level of the individual.
3. Built separate models for blood samples to assess the possibility of over-
fitting, since these were sourced from ante- and post-mortem individuals,
and reasoned that if there was a large amount of overfitting it would be
possible to predict time to death. Found that ante-mortem predictions
were essentially random.
4. Performed a model stability analysis by evaluating sample prediction per-
formance at the tissue level independently, through repeated cross valida-
tion to generate the distribution of model statistics.
5. Found that a few readily-accessible tissues are enough to predict PMI, and
proposed an example of a procotocol to follow to predict individual PMI
in a real case scenario.
6. Repeated the PMI prediction experiment using Transcript Integrity Num-
bers (TIN) and found similar prediction accuracy, although the sets of
genes contributing to the predictions intersect only moderately, suggest-
ing that effects of PMI on the transcriptome can result both from RNA
degradation and regulation of gene expression.
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The effects of death and post-mortem cold
ischemia on human tissue transcriptomes
Pedro G. Ferreira et al.#
Post-mortem tissues samples are a key resource for investigating patterns of gene expres-
sion. However, the processes triggered by death and the post-mortem interval (PMI) can
significantly alter physiologically normal RNA levels. We investigate the impact of PMI on
gene expression using data from multiple tissues of post-mortem donors obtained from the
GTEx project. We find that many genes change expression over relatively short PMIs in a
tissue-specific manner, but this potentially confounding effect in a biological analysis can be
minimized by taking into account appropriate covariates. By comparing ante- and post-
mortem blood samples, we identify the cascade of transcriptional events triggered by death
of the organism. These events do not appear to simply reflect stochastic variation resulting
from mRNA degradation, but active and ongoing regulation of transcription. Finally, we
develop a model to predict the time since death from the analysis of the transcriptome of a
few readily accessible tissues.
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Post-mortem human tissue samples are a valuable resourcefor biological research. Specifically, use of post-mortemmaterial is crucial for studying the patterns of normal gene
expression underlying tissue specificity within individuals, as
sampling such tissues from living individuals would be impos-
sible. However, the death of an organism triggers a cascade of
events that ultimately, in a relatively short time frame, lead to cell
death and autolysis. Although DNA is known to be relatively
stable over long post-mortem periods, RNA is much more labile
in nature, and sensitive to degradation in a tissue-specific man-
ner1. There are conflicting reports on how the post-mortem
interval affects RNA integrity2–10 but several studies, in different
mammals, have shown that RNA can remain largely intact even
for considerable time periods, when samples remain properly
stored. In addition, a variety of pre-mortem factors, including
environmental parameters and the circumstances of death, may
also influence the quality of the collected tissues and their
RNA8,11. RNA quality impacts measures of gene expression.
Recent studies12–15 have shown that sequencing lower RNA
quality samples, as measured by the RNA integrity index (RIN)16,
leads to a decrease in the quality of the data obtained by high
throughput RNA sequencing (RNA-seq), and the use of RIN, and
other related variables, as covariates in differential expression
analysis, has been recommended12,13,17.
On the other hand, transcriptional changes are expected to
occur as a response to the death of an organism. However, little is
currently known about how death and the length of the post-
mortem cold ischemia interval specifically affect gene expression
since most existing reports are based on very few genes, tissues or
individuals5–7,10,11,17,18. Therefore, RNA levels measured in post-
mortem tissue samples will be affected both by biological
responses to organism death, as well as to RNA degradation
occurring as a consequence of cell death. Understanding how
these effects are dependent on the post-mortem interval is
essential for the proper use of post-mortem gene expression
measures as a proxy for ante-mortem physiological gene
expression levels5,10,18–20.
Here we analyze the GTEx21–25 RNA-sequencing data to
investigate the impact of death and the post-mortem cold
ischemic interval on the transcriptomes of human tissues. We
find that different tissues have a different response over the time
elapsed since death, but that when appropriate covariates are
identified and taken into account, the impact of death on tissue
transcriptomes can largely be controlled. We identify the cascade
of molecular events triggered by death specifically in the Blood
transcriptome. Finally, we develop a model to predict the time
since death from the analysis of the transcriptome of a few readily
accessible tissues.
Results
Study overview. We used mRNA sequencing data from the GTEx
project (V6, Supplementary Table 1 and 2), and the derived gene
and transcript quantifications obtained on Gencode26 V19. We
restricted our analyses to 36 tissues with >20 samples, including
whole blood and two brain sub-regions (cortex and cerebellum)
for a total of 7105 samples, corresponding to 540 donors (Sup-
plementary Fig. 1, 2, 3, Methods). All samples were collected and
preserved with the PAXgene Tissue preservation system21.
The GTEx metadata contains an extensive annotation of
samples and donors, including the postmortem interval (PMI).
For GTEx individuals, PMI is defined as the time since death to
the start of the GTEx collection procedure. For tissue samples,
this is defined as the time in minutes spanning the window from
the moment of death, or the cessation of blood flow, until tissue
stabilization and/or preservation takes place, with values ranging
from 17 to 1739 min (Fig. 1a, Supplementary Note 1). Correlation
analysis shows that there is a strong association of PMI with
variables describing tissue recovery and death circumstances, as
these variables are correlated and reflect the same intrinsic
features of the collection procedures (Supplementary Fig. 4,
Supplementary Table 3). The relationship between PMI and RNA
stability is very tissue-dependent (Fig. 1b, Supplementary Fig. 5,
Supplementary Table 4), in agreement with previous
observations5,17,27.
Impact of PMI on gene expression. To identify genes that
changed expression depending on PMI, we used the five PMI
intervals also used by the GTEx Biospecimen Methodological
Study (BMS)21, and asked which genes had a significant and
noticeable change between two consecutive time intervals (>2-
fold change and Wilcoxon test p< 0.05, see Methods and Sup-
plementary Note 2). The number of genes with a significant






























































































































































































































































































































































































































































































































































































































Fig. 1 Characteristics of the samples and tissues used in this study. a Distribution of PMI values (in minutes) with tissues ordered by the median value.
Whole blood contains samples with negative time corresponding to samples obtained pre-mortem. b Distribution of Pearson correlation between PMI and
RIN values. Esophagus, Liver, Colon, Ovary, Uterus, Vagina, and Heart are the tissues in which RIN is more affected by PMI (r< −0.5), while Skin, Pituitary,
Spleen and Nerve are the ones in which is less affected (r> −0.1)
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tissues, ranging from none in brain cerebellum and spleen, to
>600 in muscle and colon transverse (Fig. 2a). Although most
tissues are characterized by a sharp shift in gene expression at
around 6 h after death, there are remarkable differences between
tissues regarding the transcriptional response to PMI (Fig. 2b).
Some tissues (e.g., muscle) exhibit an early response, with most
genes that change expression doing so right after death (Sup-
plementary Fig. 6). Another set of tissues show a more sustained
response, with gene expression changes of similar magnitude
occurring through all PMI intervals (Fig. 2c). Finally, another set
of tissues show a peaked response, with most changes occurring
between the intervals of 4–6 h and 6–15 h (Supplementary Fig. 7).
There is little overlap of affected genes across the tissues. We
identified 187 genes (94 are protein-coding) with post-mortem
gene expression changes in at least three tissues (Supplementary
Fig. 8). The gene that showed consistent changes across the
largest number of tissues was RNASE2, a gene from the family of
ribonucleases, enzymes involved in the degradation of RNA.
RNASE2 shows a consistent decrease in expression across 13
tissues (Fig. 2d). Two alpha globin genes, HBA1 and HBA2,
involved in the transport of oxygen from the lung to the
peripheral tissues, show an increased expression in several tissues
but not in blood, where they are the most expressed genes
(Fig. 2d). Several histone genes show increased patterns of
expression in line with previous results28,29 (Supplementary
Fig. 8, Supplementary Data 1). Growth factors, such as EGR3 also
have an increased expression from 4hr to later on (Fig. 2d,
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Fig. 2 Effect of PMI on gene expression. a Distribution of the number of genes with significant temporal changes per tissue between at least two time
intervals. Brain and pituitary have longer PMIs, only within last two time intervals, thus less interval ranges to detect significant changes. b Heatmap with
the number of genes with significant changes detected between two consecutive time intervals. c Heatmap with normalized expression values for genes
with changes in liver. The top bar is the color code for the PMI interval of each sample, the right bar list genes involved in the various functions and
pathways. On the side we highlight sub-clusters with different patterns of temporal expression. d Example of four genes with different temporal patterns.
RNASE2 is a non-secretory ribonuclease involved in several functions; HBA1 is alpha hemoglobin involved in oxygen transport; EGR3 is a transcriptional
regulator involved in early growth response; CXCL2 is a chemokine gene that encodes secreted proteins involved in immune and inflammatory processes
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CXCL2 show a more dynamic behavior with expression changes
in opposite directions at subsequent intervals (Fig. 2d). Gene
ontology analysis of the genes affected across several tissues
(Supplementary Fig. 8) shows enrichment for genes in the
extracellular region and genes involved in nucleosome and
chromatin assembly and in protein–DNA complexes. There is
also enrichment for inflammatory and immune response
processes.
While there are noticeable changes in gene expression
associated with PMI, we nonetheless found that the characteristic
transcriptional signature of tissues remains largely intact through
the PMI intervals considered here. We clustered the GTEx
samples at these intervals and measured, using modularity (see
Methods), how well the clustering recapitulates tissue type. Here,
we compute modularity on the network constructed from gene
expression correlations between samples when the data are
grouped by tissues. Modularity remained stable through the PMI
intervals at any threshold of the correlation defining the network
edges (see Supplementary Fig. 9).
Because PMI dependent expression changes are largely tissue-
specific, they could confound tissue differential gene expression
since the observed effects could be caused by differential response
to PMI rather than by differences in tissue biology. To investigate
to what extent these effects can be controlled for, we used a linear
regression model that allows incorporating additional covariates.
We specifically selected fourteen variables, predominantly demo-
graphic, medical history and sample QC metrics that are
orthogonal to the sample collection procedure, to include as
expression covariates in the model21 (see Supplementary Fig. 4,
Supplementary Table 5 and 2). These are essentially the covariates
employed in the GTEx eQTL analyses24. Residuals were then used
as the expression phenotype and the Pearson correlation (r) as a
measure of linear relationship with PMI (Methods, Supplemen-
tary Notes 2). On average we found only 54 genes per tissue
(0.2%), which showed significant correlation of gene expression
with PMI (FDR< 1%) (Fig. 3a, Supplementary Table 6),
compared to 6919 genes per tissue (39.3%), if using the same
model without covariates. In most of these cases, however, the
effect is small (only 189 (1.1%) with r< |0.2| (Supplementary
Fig. 10). Moreover, clustering of tissues based on the ranking of
correlations gene expression-PMI generally recapitulates tissue
type (Fig. 3b). These results suggest that the effect of PMI on
measured gene expression is relatively modest and can be further
minimized by using appropriate covariate correction in analyses.
The effect is weakly mediated by the number of exons, the length
of the gene and of the coding region and GC content
(Supplementary Table 7). PMI has also little effect on the
proportion of intergenic RNA-seq reads, as well as on 3’ mapping
bias, commonly observed in RNA degraded samples12,14,30–32
(Supplementary Figs. 11–15, Methods).
To specifically analyze the impact of PMI in energy
metabolism, we investigated its relationship with mitochondrial
RNA (mtRNA) levels. We observed no significant changes in
mtRNA concentration across different RIN values, and donor
ages (Supplementary Figs. 16 and 17). Across most tissues,
samples exhibit a significantly lower proportion of mitochondrial
reads in late PMIs (Fig. 4a, Methods), except blood, salivary
gland, heart-left ventricle and, particularly, liver that exhibits a
substantial higher proportion of mitochondrial RNAs for late
PMIs (Fig. 4b, Supplementary Fig. 17). Decreasing mtRNA
abundance across all PMI intervals is observed specifically in
female tissues (ovary, vagina, and uterus, see Fig. 4c).
Finally, we investigated the effect of PMI on splicing. We
calculated the inclusion levels33 of internal exons (Supplementary
Fig. 18a, Methods). We then performed linear regression analysis
of PMI and PSI values and found 1,399 exons (612 unique)
significantly correlated with PMI (|r| > 0.5 and FDR ≤1%;
Fig. 5a–c), of which 160 were observed in three or more tissues
(Fig. 5a). In contrast to gene expression, there is a substantial
sharing of exons among the top affected tissues (those with
≥ 20 significant exons), with the tissue pairwise overlap ranging
from 43% to 82%, representing 22 to 76 shared exons. Functional
analysis of genes with recurrent exons (i.e., with association with
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Fig. 3 PMI and gene expression correlation patterns. a Distribution of Pearson correlation between gene expression and PMI, across the different tissues
(sorted by sample size, in parenthesis). Only for a few genes, this correlation exceeds an absolute r-value of 0.2. b Clustering based on the ranking
(Spearman) correlation of the values in (a) show that sub-tissues of a given tissue or closely related organs have the similar patterns of correlation
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on RNA binding and RNA splicing genes (Supplementary
Fig. 18b, c). We also investigated if, as a consequence of death,
we could observe a generic alteration of splicing. As a proxy for
splicing alteration, we computed the Shannon’s entropy on the
relative abundance of a gene’s alternative splicing isoforms
(Methods)—higher values corresponding to more stochastic
production of alternative isoforms. We did observe an increase
of splicing entropy in many cases (Fig. 5d, e), although not a
systematic trend across all tissues (Supplementary Fig. 19).
Changes induced by death in the whole blood transcriptome.
Among the samples collected for GTEx, the blood samples are
unique in having been collected pre-mortem for some donors and
post-mortem for others. This provides an opportunity to assess
the impact of death on the gene expression of a specific tissue.
Dimensionality reduction (MDS) and hierarchical clustering of
gene expression profiles clearly distinguishes pre- and post-
mortem states of blood samples (Fig. 6a and Supplementary
Fig. 20). The “cause of death” (assessed by the 4-point Hardy scale
classification, Supplementary Notes 1) is quite different for
individuals from whom Blood was obtained pre-mortem com-
pared to post-mortem, but this does not appear to have a major
impact on the clustering, which is independent of Hardy classi-
fication (see Methods, Fig. 6a).
To characterize changes in gene expression that are triggered
by death, we identified genes that were differentially expressed
between pre-mortem and post-mortem blood samples, the latter
being collected at several different PMI intervals (Fig. 6b,
Supplementary Table 8 and Supplementary Data 2). Immediately
following death (and up to seven consecutive hours) we observe
an increase in the expression of many genes, and a decrease in the
expression of a few. The majority of the changes in gene
expression, however, occur between 7 and 14 h post-death, with
thousands of genes showing differential expression (equally in
both directions) relative to pre-mortem samples. Then, between
14 and 24 h, the transcriptome seems to stabilize, with
comparatively few genes showing differential expression relative
to pre-mortem samples (among those that do, there are more
over-expressed than under-expressed). Categorizing the nature of
these changes in gene expression in blood samples following
death, we observed five main functional activities34 (Fig. 6c,
Supplementary Table 9, Supplementary Notes 3): 1) changes in
DNA synthesis and fibrinolysis; 2) deactivation of the immune
response; 3) an increase in activity of processes related to cell
necrosis; 4) an abrupt inactivation of carbohydrate metabolism,
synthesis of lipids (e.g., cholesterol) and ion transport; and 5) an
activation of processes related to Blood coagulation and Response
to stress (Supplementary Fig. 21a). Specifically, the way in which
carbohydrate metabolism is affected, with severe deactivation of
the tricarboxylic acid cycle, while glycolysis is activated (FDR<
10−27; Fig. 6d, Supplementary Table 9), suggests that hypoxia is
likely playing a major role in the initial pre- to post-mortem
transition (FDR 7.2 × 10−67). More gradually, the immune system
is also deactivated (several immunity-related functions with FDR
< 10−30, Supplementary Table 9, Supplementary Fig. 21b). In
addition, a response to stress, along with the detection of DNA
damage and the activation of the corresponding repair machinery
is observed (FDR< 10−14; Supplementary Table 9). Finally, a
general arrest of cell proliferative processes occurs. Processes like
growth arrest are activated and others, like Initiation factor, the
starting process of protein production, are dramatically
deactivated.
The transcriptional changes detected above may partially be
related to changes in the cellular composition of blood triggered
by death. Indeed, blood is a complex tissue composed of multiple
cell types. We investigated differences in cell composition
between blood samples collected pre- and post-mortem. We
used CIBERSORT35, to deconvolute bulk gene expression into
expression levels for 18 different cell types. We found significant
differences in overall cellular composition between pre- and post-
mortem blood samples (p< 0.001), the most notable changes
induced by death being an increase in resting NK cells and CD8
T-cells, and a substantial reduction in neutrophils (Fig. 7a). These
results are consistent with the observed deactivation of the
immune system (Supplementary Fig. 21b), since similar trends
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Fig. 4 Effect of PMI on mitochondrial transcription and splicing. a Proportion of RNA-seq reads originating from mitochondrial genes (mtRNA
concentration) in early (≤680) and late (>680) PMI intervals. b, c mtRNA concentration depending on PMI in Liver (b) and Ovary (c)
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system with age. Neutrophils, in particular, are the first cells to
migrate to pathogenic infected sites, and a decrease in their levels
implies impaired ability to traffic into and out sites of infection.
Death also has an observable impact on splicing in the blood
transcriptome. We identified 497 exons (from 381 genes) that
were differentially included between the pre- and post-mortem
samples (p< 0.01, |ΔPSI| > 0.1, Supplementary Fig. 22, Supple-
mentary Table 10). This represents 14% of all exons (3441) that
were found to be variable across samples (Methods). Most of
these 497 exons (75%) tended to be “included” in the pre-mortem
samples (and not in the post-mortem samples), suggesting that
splicing deregulation is occurring. Indeed we found that post-
mortem samples have a higher entropy than pre-mortem samples
(Fig. 7b), reflecting tighter, more controlled, usage of splicing
isoforms in the pre-mortem samples. In general, we found there
was an increased usage of the major (dominant) isoform in the
pre-mortem samples relative to the post-mortem samples
(Supplementary Fig. 23).
Prediction of the post-mortem interval from gene expression.
The precise estimation of PMI is a problem of central importance
in forensic pathology. Traditional methods for this task rely on
physical modifications observed on the body, including algor,
livor, and rigor mortis36. However, these approaches may be
unreliable or inaccurate18. The use of RNA assays as an addition











































































































































































































































































































































































































































































Fig. 5 Effect of PMI on splicing. a Distribution of the number of exons with significant differential inclusion across the different tissues; inset: number of
exons with differential inclusion occurring in multiple tissues. b, c Examples of two exons with PMI-correlated inclusion levels. SRSF3 and SF1 encode pre-
mRNA splicing factors that form part of the spliceosome. d Splicing Entropy for the APBB1IP gene depending PMI in the lung tissue. e APBB1IP gene has
three isoforms. The heatmap shows the proportion of each isoform in the Lung samples sorted by PMI (1 indicates that only one isoform contributes to the
expression of the gene and 0 that the isoform is not expressed) PMI of the samples range from 49 to 1558minand are represented in the green to red
gradient scale bar. Exon structure (not to scale) for the three isoforms is represented below. This figure depicts how the expression of the longer transcript
in this gene becomes less dominant as PMI increases, and, as a consequence, the abundance of the different isoforms tends to converge
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for a correlation between RNA degradation and PMI1,10. The use
of mRNA markers in PMI prediction also holds great promise,
but so far only a few genes from a handful of human tissues have
been tested18. Herein, our analyses suggest that the patterns of
gene expression change with time after death in a tissue specific
manner, and might thus be collectively used to predict the PMI
for a given individual. We use the GTEx RNA-seq data to
develop and to test such an approach. We first use gradient
boosted trees37 to infer models that use expression of protein
coding genes to predict the PMI of each tissue separately. We
used data from 399 individuals (about 75% of the 528 available
individuals) for training the models and 129 (~25%) for testing
(Supplementary Fig. 24 and 25). In the test set we obtained R2
values between predicted and real tissue PMI ranging from 0.78
to 0.16 (Supplementary Fig. 26 and 27), similarly to what was
obtained in the training set (Supplementary Fig. 25). We also
calculated for each sample, the difference between real and pre-
dicted tissue PMI, and found little deviation on average, although
the models tend to overestimate PMI (Fig. 8a). To assess the
possibility of overfitting due to the complexity of the data we
performed a model stability analysis via resampling (Supple-
mentary Fig. 28). In addition, we used the blood samples and we
repeated the training and testing procedures (×100) separately in
post-mortem and in pre-mortem samples. We reasoned that if
predictions resulted from overfitting, we should be able to predict
the time to death in pre-mortem samples equally well as the time
since death in the post-mortem samples. Reassuringly, predic-
tions of time to death were essentially random (median R2 0.02
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2 - Immune response deactivation
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Fig. 6 Transcriptional changes in blood after death. a Multi-Dimensional Scaling of blood samples shows separation between pre and post-mortem
samples. Samples are colored by the Hardy scale of the cause of death. b Number of genes differentially expressed between the pre-mortem samples and
the post-mortem samples stratified at different PMI intervals. Darker filling corresponds to genes that are found as differentially expressed in the previous
interval. c The five main temporal patterns of change in functional activities upon organismic death. d Hypoxia seems to play a major role in the pre-to
post-mortem transcription as reflected in the way in which the carbohydrate metabolism is affected (activations in red, deactivations in blue). Response to
hipoxia is activated from pathways “Platelet activation pathway” and “cGMP-PKG signaling pathway” through the activation of the corresponding circuits
that end in the effector gene ITPR1, annotated as Response to hypoxia, and from pathways “HIF-1 signaling pathway” and “cGMP-PKG signaling pathway”
through the activation of the effector gene VEGFA. The “HIF-1 signaling pathway” also activates Glycolysis through the activation of different circuits that
trigger effector proteins (PDK1, PFKL, ALDOA, etc.) with annotations such as glycolytic process, canonical glycolysis, glucose metabolic process, etc. The
“HIF-1 signaling pathway” also inhibits Tricarboxylic acid cycle through the inhibition of circuits that trigger the effector protein PDHA1 with diverse GO
annotations such as tricarboxylic acid cycle, acetyl-CoA biosynthetic process from pyruvate or carbohydrate metabolic process
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To infer the PMI of each individual, we subtracted from each
tissue predicted PMI the time elapsed since the beginning of the
GTEx procedure to the processing of that tissue, and averaged the
resulting values (Fig. 8c, d). On average, the PMI prediction error
(signed difference between real and predicted) is 9.45 min and the
median of −63.75 min (Supplementary Fig. 30). The R2 of the
predicted and real PMI is 0.77 when all tissues are considered,
and 0.8 when using only the top 20 tissues (R2 > 0.5 in the
training set, Fig. 8b). As a measure of stability of the PMI
prediction on a given individual, we assess the consistency of the
tissue PMIs for the individuals. We reason that if all tissues
predict consistently very similar PMIs, the prediction of the PMI
for the individual is more reliable than if the tissue PMI
predictions are very variable across tissues. To assess the
consistency of the tissue PMI prediction for a given individual
we compute the coefficient of variation (cv), lower values thus
indicating more reliable predictions. Supplementary Figure 31
shows the cv distribution on the individuals from the test set.
Since the availability of so many tissues is unrealistic in a
forensics scenario, we identified the smallest combination of
tissues that can be used to determine an individual’s PMI
accurately. For each individual in the initial test set, we identified
the subset of tissues of a fixed size that can predict the individual
PMI with the highest precision. We find that for subsets of sizes
2–6, the tissues that appear more frequently are Adipose—
Subcutaneous, Lung, Thyroid, and Skin (Sun Exposed) (Supple-
mentary Fig. 32). We prioritized this approach over simply
identifying the combination of tissues with highest R2. Predic-
tions using these four tissues are even superior to those using all
top 20 tissues (R2 = 0.86) (Supplementary Fig. 33), and actually
only marginally superior to those obtained using some combina-
tions of only two tissues among the four above (Supplementary
Fig. 33 and 34).
We investigated to what extent the PMI predictions are robust
to the causes of death since this could also have an impact on the
transcriptome. To have sample sizes large enough, we grouped
the causes of death reported by GTEx (Supplementary Fig. 35a) in
three major death classes: cerebrovascular disease, heart disease,
and other causes of death. We did not observe an impact of the
class of death in the accuracy of the predictions, as measured by
R2 (Supplementary Fig. 35b).
The results above suggest that gene expression values
(estimated, for instance, through RNA-Seq) can be used to
effectively predict time since death. Figure 9 summarizes the main
steps to follow in a putative real case scenario.
We also investigated whether estimates of RNA degradation
can be used to predict PMI. We have employed exactly the same
methodology, but using the transcript integrity number15 (TIN)
data instead of gene expression. TINs have been proposed to
measure RNA integrity based on the uniformity of the read
distribution across transcript length15. TIN-based predictions of
individual PMI have similar accuracy to those based on gene
expression (Supplementary Figure 36a and 36b). However, there
is only moderate intersection between the two methods on the
genes contributing the most to the predictions (Supplementary
Figure 36c). This is consistent with our finding that the post-
mortem transcriptomic changes are both the result of RNA
degradation and of regulated gene expression.
Discussion
Here we report on the largest systematic study of the impact of
death and post-mortem cold ischemia on gene expression across
multiple human tissues. Samples obtained post-mortem are a
valuable source of material for studies requiring organs and tis-
sues difficult to obtain, or those where it is impossible to study
and manipulate them in living organisms. Hence, understanding
the impact of death in tissues is essential for the proper inter-
pretation of post-mortem gene expression levels as a proxy for
in vivo, living physiological levels.
The death of an organism clearly has an immediate impact on
tissue transcriptomes, as illustrated by our analysis of ante- and
post-mortem samples. Changes in gene expression as a response
to death, and during subsequent post-mortem ischemia, might be


































































































































































































































Fig. 7 Differential cellular composition and splicing entropy in blood. a Cellular composition analysis for 18 cell types shows an increase in NK-cells-resting
and T-cells-CD8 and decrease in Neutrophils composition from pre- to post-mortem blood samples. b Splicing entropy in pre- and post-mortem samples
for genes of different number of isoforms
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enzymatic processes underlying mRNA degradation. However,
our results suggest instead that there is ongoing regulation of
transcription, at least during the hours immediately following
death. We observed that in the majority of tissues there are many
genes that display expression profiles that are more complex than
simple monotonic changes with PMI. This is in agreement with a
recent study by Pozhitkov et al.29, in which gene expression
profiles produced by cDNA microarrays were analyzed in zeb-
rafish and mouse samples with post-mortem intervals up to 48
and 96 h. That study showed a non-monotonic increase in the
abundance of certain transcripts and suggested that previously
silenced genes were actively transcribed at later post-mortem time
points.
Similarly, analysis of splicing changes with PMI did not show
conclusive evidence of systematic splicing deregulation (as mea-
sured by the splicing entropy) across tissues. Death, in contrast,
did apparently lead to some splicing deregulation in blood. In
particular, we found that the usage of the major isoform (the most
abundant isoform compared to the rest) was attenuated in post-
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Fig. 8 Prediction of the PMI from gene expression in post-mortem samples. a Distribution of the PMI prediction error per tissue. b Regression of the real
PMI versus the predicted individual PMI on the test set of 129 individuals. Plots in panels (c) and (d) illustrate two examples (GTEX-145MN and GTEX-
145ME) of the prediction of the PMI for an individual based on the prediction of PMI from each tissue from the individual. For a given tissue, each yellow
dot represents a prediction from each one of 13 different models. The black dot is the mean prediction of these 13 models. The green line represents the
real PMI value for the individual. The individual PMI prediction is calculated as the average of the final tissue PMI predictions, and is represented by the red
line
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across tissues and biological conditions has been reported as a
general characteristic of genes38,39, and has lead to extensive
debate on the physiological relevance of regulated alternative
splicing39. Since most data to date has been collected from post-
mortem samples, the preferential usage of a single major isoform
in living cells may be even more prevalent than previously
reported.
While the effects of death per se on gene expression are distinct
from those of increasing PMI, we found a number of genes
involved in the assembly of DNA, nucleosome and chromatin
that were affected by both. Expression changes of these genes
suggest a possible form of gene regulation through the alteration
of the chromatin structure. Pozhitkov et al.29 described an
increased expression of epigenetic regulatory genes, hypothesizing
that the activation of these genes reveals the nucleosomes and
allows for the later transcription of developmental genes that have
no early expression. We consistently detected the upregulation of
genes involved in DNA organization, but we could not detect
changes in expression among genes related to development. This
could be due to the lack of reference expression levels from very
early post-mortem samples.
Based on the tissue specific response of the transcriptome to
PMI, we built machine-learning models to predict the time of
death of a recently deceased individual. We show that RNA-seq
performed on a few key tissues could become a powerful tool to
aid in forensic pathology. It could carry the footprint not only of
the time since death, but also of the cause of death—even though
we could not properly carry out these analyses because of the
small sample sizes available. Interestingly, the most informative
tissues to predict time of death included readily accessible ones,
such as skin and subcutaneous adipose. While these results show
promise, larger datasets more balanced across a wider post-
mortem time interval will be required to assess the full potential
of the approach.
In line with previous studies12,13,15,17,20 our analyses show that
the investigation of the impact of post-mortem ischemia in tissue
transcriptomes is essential to properly interpret gene expression
estimates obtained from post-mortem tissue samples. Further-
more, understanding the transcriptional changes occurring with
time after death could have multiple applications. Here, we illu-
strated an application specific to forensic pathology, but other
applications could include improving biospecimen procurement
and organ preservation protocols. These could, in turn, have an
impact on the procedures employed for organ transplantation.
Post-mortem tissues are irreplaceable sources for researching
and understanding human biology, but as our study demon-
strates, death does introduce a bias in the cellular transcriptomes,
even over relatively short timeframes. Ideally cellular transcript
levels should be measured “in vivo” in unperturbed cells to pro-
vide an unbiased characterization of true physiological cellular
transcriptomes, and this should in turn be performed individually
in each of the millions of cells that constitute a living tissue.
However, current technologies for the genome-wide character-
ization of the transcriptome still require the dissociation and
destruction of cells, even when obtained from living donors, and
the impact of this cellular destruction on the transcriptome is also
largely unknown. Despite this, our results indicate that overall,
relatively few genes show significant changes over the post
mortem intervals studied, and the genes that do change do not
change systematically, but vary by cell and tissue type. To mini-
mize and limit the impact of these changes, adhering to strict
protocols and standards for the collection of high quality tissue
and RNA, combined with careful documentation of all key
sample procurement covariates (as was done for GTEx21), can
allow the effects of post-mortem ischemia to be largely identified
and corrected for in analyses. Post-mortem samples can therefore
be of tremendous value for studies of both normal and disease
biology.
Methods
Data and filters. We used mRNA sequencing data (Illumina paired-end, 76 bp)
from the GTEx project Analysis Freeze V6 release (phs000424.v6.p1). RNA-seq
libraries are non-strand specific, with Poly-A selection and generated with Illumina
TruSeq protocol. Further details on sample collection, processing and quality
control of the RNA-seq samples from version V6 can be found in the supple-
mentary material of24 and in21,23,40. As described in Carithers et al.21 the GTEx
project made an effort to collect tissues within 8 h of PMI and RIN values ≥6. All
samples under analysis in this study were collected and preserved with the PAX-
gene Tissue preservation system developed by Qiagen21.
From the 55 available tissues in the V6, we started by selecting those with at
least 20 samples. Brain samples are preserved either with PAXgene Preserved or
Fresh Frozen methods. The latter does not have ischemic time available. We have
included 161 samples from Cerebellum and 147 from Cortex preserved with
PAXgene method and with ischemic time available. We further removed cell lines
from the set of tissues. The final dataset comprises 36 tissues, with 36–1049 samples
with a mean of 253 samples, see Supplementary Fig. 1.
Gene expression. RNA-seq reads were aligned to the human genome
(hg19/GRCh37) using TopHat41 (v1.4) and Gencode annotation v1926 was used for
gene quantification. We considered genes with at least 5 reads mapping in exons
and from all biotypes in the annotation. The raw read counts were used for dif-
ferential expression analysis and the RPKM42 values, which were log2 transformed
with an added pseudo-count used in the remaining analysis. For the regression
analyses, the matrix of expression values was obtained for the samples of each
tissue and then normalized with the normalize.quantiles function from the pre-
processCore library43.
In order to investigate the global patterns of gene expression we have
considered the gene expression values of all the tissues and all the genes from the
annotation26. We have then performed multi-dimensional scaling (MDS) using the
isoMDS function from the package MASS in R. We defined the distance for two
samples A and B as:
Protocol for post-mortem interval prediction of an individual
1. Annotate the start time of the forensic procedure, START_TIME.
2. Annotate the stabilization time of the tissues, among the following ones, that are available:
Skin sun exposed (lower leg) sample, SKNS_STAB.
Adipose Subcutaneous sample, ADPSC_STAB.
Thyroid sample, THYROID_STAB.
Lung sample, LUNG_STAB.
3. Prepare sample, extract RNA and perform RNA sequencing (RNA-seq) analysis, possibly with a portable
and real-time equipment of the available tissues.
4. Process the RNA-seq  data to obtain gene expression quantifications for each available tissue sample. 
5. Provide to the PMI prediction software the gene expression values in each available tissue together with
the stabilization time of the tissue, and the time of the initiation of the forensic procedure.   
6. The prediction software provides tissue and individual PMIs, as well as the coefficient of variation of the
tissue PMIs as a measure of the stability of the predictions 
Fig. 9 Protocol for post-mortem interval prediction. Steps to be performed to predict the PMI of an individual
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dist(A, B) = 1–PearsonCorrel(A, B). As shown in Supplementary Fig. 3 there is a
clear transcriptional signature characterizing each tissue. Further discussion on
detectable and tissue specificity expression and gene expression patterns across
tissues can be found here25.
Post-mortem interval (PMI) information. GTEx annotation provides informa-
tion on three types of ischemic time: Total Ischemic time for a sample, Total
Ischemic time for a donor and Ischemic Time (time for the start of the GTEx
procedure). All these variables are quantified in minutes. Throughout the text we
have used the term Post-Mortem Interval (PMI) to refer to ischemic time and
except if explicitly stated it refers to the sample ischemic time. Negative PMI values
(observed in blood samples) correspond to samples extracted pre-mortem. GTEx
annotation contains a total of 249 sample and subject variables, which are divided
in six groups: Sample attributes (prefix SM), Death circumstance (DTH), Demo-
graphic (no specific prefix), Medical History (MH), Tissue Recovery (TR), Serology
results (LB). We selected those variables with> = 2 and< = 15 values, removing
cases of unknown values. We then computed a linear regression with PMI,
obtaining the adjusted R2 and the Pearson correlation with PMI (cor.test in R with
use = “na.or.complete”). Categorical variables were converted to numeric. Supple-
mentary Fig. 4 shows the respective correlation values for all the variables, where
we observe that TR, LB and DTH variables are highly correlated with ischemic
time. This basically reflects different aspects of the tissue collection procedure that
are highly associated with PMI.
Covariate selection. In order to assess the impact of PMI on gene expression we
need to account for the possible effect of other pre-mortem variables on the var-
iation of gene expression. For the selection of the variables of interest we excluded
TR, LB and DTH variables due to their strong association with PMI, which may
result from the fact that all these variables capture the underlying characteristics of
death circumstances and tissue extirpation procedure. We then focused on sample,
demographic and medical history variables (correlation values with ischemic time
ignoring missing values), summing 166 variables. We further filter for those cov-
ariates that are qualitative and describe a phenotype such as age or gender and that
exclude those that are simply metrics from the sequencing (SM). Finally, we kept
those variables with |r| > 0.1 with PMI. Non-numerical variables are converted to
numeric format. The final set of covariates used for regression analysis of PMI and
gene expression is presented in Supplementary Table 5.
Gene expression and PMI regression model. In order to assess the impact of
PMI on gene expression we took into account a set of fourteen covariates (Sup-
plementary Table 5). Then, for each gene (with average expression across the tissue
samples greater than 0.5 RPKM) we implemented a linear regression model where
the gene expression profile is modeled with relation to the covariates: reg = lm
(gene_expression ~ matrix.selectedCovariates). The residuals of the model are then
used as the expression phenotype: gene_expression.resid = residuals(reg). Finally,
the correlation between the residuals and the PMI is calculated, r = correlation
(gene_expression.resid, pmi.vals). The corresponding correlation and p-values
(adjusted with BH method44) are then stored for all genes. This procedure is
repeated for all tissues (Supplementary Fig. 37). To compute the correlation values
of gene expression and PMI without the covariates, a procedure similar to the
above was used where Pearson correlation is obtained between gene expression and
PMI values (Supplementary Fig. 38). Supplementary Note 2 provides the algo-
rithmic details of the methodology.
Non-linear temporal differential expression. In order to find non-linear differ-
ential expression we developed a method to identify significant changes between
different post-mortem intervals. For each tissue we grouped the samples as in21 and
in five different PMI intervals I1:< 1 h, I2: ≥ 1 h and< 4 h, I3: ≥ 4 h and< 6 h, I4: ≥
6 h and< 15 h and I5: ≥ 15 h. We then normalized the gene expression of each gene
computing a Z-score = ((X-mean)/stdev) and calculated the median expression in
each of these intervals. Every two consecutive intervals, with a minimum number
of five samples are then compared. We consider an event of temporal differential
expression between Ti and Ti+1, where Ti and Ti+1 correspond to the expression
values of the gene in the interval i and i + 1 if we meet the two following conditions:
pvalði; iþ 1Þ ¼ wilcox:test Ti; Tiþ1ð Þ;with pval<0:05 ð1Þ
fold changeði; iþ 1Þ ¼ log2 median Tið Þ=medianðTiþ1Þð Þ; jfold changeði; iþ 1Þj>2
ð2Þ
Supplementary Fig. 39 provides the algorithmic details of the methodology.
Tissue similarity for PMI correlated expression. In order to build a tissue
similarity matrix of the correlation profiles (gene expression and PMI) we per-
formed a pairwise comparison of all tissues. For every pair of tissues we obtain the
common genes by intersecting genes that in both tissues have correlation value of
gene expression with PMI. For every pair of tissues we then obtain a Spearman
ranking correlation based on the correlation values of the common genes. We then
used the heatmap.2 function from gplots to calculate the heatmap with dendro-
gram in Fig. 2f.
Functional enrichment analysis. For functional enrichment analysis we used the
R libraries: DOSE45, ClusterProfiler46, Kegg.db47 following the tutorial of
ClusterProfiler46.
Differential expression in blood samples. For differential expression analysis we
used the statistical methods implemented in the edgeR package48. We started by
building a matrix with gene read counts in premortem (n = 169) and postmortem
(n = 223) Blood samples. Genes were filtered to have at least 5 reads per million
mapped reads in at least 10% of the samples on one of the tested groups (cpm
function). We created a design matrix taking into account 2 groups (pre- and
postmortem samples) and several covariates:
design<model:matrix ð SMRINþ AGEþ ETHNCTY þMHCANCERNMþ
SMCENTER þ SMTSTPTREFþ SMNABTCHT þ GENDER þ group; covars:matrixÞ
Covariates SMRIN and AGE were discretized according to the following
intervals: SMRIN =< 7*/7−8/8−9/9–10 and AGE = 20−30/30−40/40−50/50−60/60
−70. Covariates were converted as factors. See Supplementary Table 5 for the
description of the covariates, where group variable corresponds to the pre and post-
mortem samples. We then followed the protocol at48 performing the normalization
with the TMM method49 Generalized Linear Model (GLM) based functions to
estimate common dispersion and differential tests. For the differential expression
analysis across different post-mortem blood intervals, we first divided the post-
mortem samples in four groups, which provided an equal number of samples in
each group: G1 (n = 56): 0< pmi< = 406 min; G2 (n = 56): pmi> 406 and
pmi < = 635; G3 (n = 56): pmi > 635 and pmi< = 867; G4 (n = 55): pmi> 867 and
pmi < = 1401. A similar approach as the one described above was then applied to
compare all the pre-mortem samples with each of the G1, G2, G3, and G4 groups.
Figure 4b and Supplementary Table 8 shows the number of differentially expressed
genes for the different intervals.
Transcriptional patterns of pre and post-mortem blood. In order to explore the
transcriptional differences in pre and post mortem blood samples we have built the
respective expression matrix based on RPKM values that were then log2 converted
and normalized with normalize.quantiles function as previously described. We
then performed hierarchical clustering (HC) and multidimensional scaling (MDS).
We defined the distance between samples a and b as, dist(a,b) = 1 – cor(a,b), where
cor is the Pearson correlation of a and b vector. Hierarchical clustering solution was
then computed with hclust function using the average method. Visualization was
performed using the heatmap.2 function with the input of the distance matrix and
the previously calculated HC solution as the dendrogram parameter. Postmortem
samples (n = 20) with a PMI smaller than the respective individual PMI were
excluded. Heatmap with PMI interval colors is shown in Supplementary Fig. 20,
and samples in MDS plot were colored according to Hardy Scale (Fig. 4a).
Signaling pathway models. The hiPathia34 tool was used for the interpretation of
the consequences of the combined changes of gene expression levels and/or
genomic mutations in the context of signaling pathways (see Supplementary Fig. 40
and 41). Significant circuits associated to PMI were obtained by fitting a linear
model and were summarized by the median value across samples per circuit and
time points. Supplementary Note 3 and Hidalgo et al.34 provide the algorithmic
details of the methodology.
Gene structural features. Features were derived from the Gencode annotation
v1926, including the number of projected (non-redundant exonic regions) exons,
length of the coding regions, overall length of the gene, biotype. We obtained
projected exons first by sorting by genomic coordinates and then by merging
exons. We used bedtools50 for this step. GC content was obtained from the
Ensembl Biomart (www.ensembl.org/biomart). For each tissue we have calculated
the Pearson correlation between the vector of gene features and the respective
correlation value between gene expression and PMI. Supplementary Table 7 con-
tains the correlation values per tissue for each feature.
Mitochondrial transcription. For estimating the mitochondrial RNA concentra-
tions (MT%), we divided all reads in annotated mitochondrial (mt) genes by the
total number of reads in annotated (nuclear and mitochondrial) genes. To account
for the substantial different mitochondrial activity across tissues, we divided each
sample by the median MT% found in the corresponding tissue (nMT%). We then
regressed a linear model nMT% ~ PMI and compared the slopes obtained at each
time point between the different tissues (Supplementary Fig. 17). Correcting for the
influence of age in the linear model changed the distribution of relative MT% only
marginally (shifted values< = 0.05) (Supplementary Fig. 16).
RNA-seq metrics across tissues. We have explored if the different tissues show
differences in RNA-seq quality control metrics obtained with the RNA-SeQC40
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pipeline. Supplementary Table 11 lists the variables used for this analysis. The
mapping proportions along the different gene features are shown in Supplementary
Fig. 11 and 12. Degradation of the RNA may result in different mapping bias
effects, in particular in a higher read coverage at the 3′ end of the genes. We have
calculated for each sample a read coverage ratio between the 5′ and the 3′ 50bp-
based normalization. Distribution of these values for the different tissues is shown
in Supplementary Fig. 13 and the relation with RIN and PMI are shown in Sup-
plementary Fig. 14 and 15.
Clustering modularity. To assess if gene expression signatures of tissues are
preserved across the PMI bins, as defined above (section “Non-linear Temporal
Differential Expression”), we selected only the tissues that had at least 10 samples
within each bin of PMI. Because differences in the number of samples per tissues
can introduce variation in the network structure, we randomly selected the same
number of samples per tissue in each PMI bin, corresponding to the minimum
number of samples per tissue across all the PMI bins. Thus, we have 4 combina-
tions of 422 samples, one for each PMI bin, with the same tissues, and the same
number of samples per tissue. For each combination of samples, we compute
pairwise Pearson’s correlation coefficient on the log2-transformed RPKM expres-
sion values after adding a pseudo-count of 1. From each matrix of correlation
coefficients we built 7 networks, where nodes are the samples and edges are con-
nections between samples that are correlated with a coefficient higher than a given
threshold (out of 7 thresholds, from 0.86 to 0.92). These thresholds gave com-
parable network densities, defined as the proportion of connected nodes over the
total number of possible edges, across all the networks. We used the modularity
formula (R package igraph51, modularity function) to measure how well the
samples in each network are aggregated by tissue type. Supplementary Fig. 9 shows
the distribution of modularity with relation to network density.
Exon inclusion analysis. GTEx samples were processed through the Integrative
Pipeline for Splicing Analyses (IPSA) pipeline with default settings52. Namely,
short reads were mapped to human genome (hg19/GRCh37) using TopHat41
(v1.4). The alignments were filtered to have an overhang of at least 8 nt and
entropy of the offset distribution of at least 1.5 bits. Novel short exons (shorter than
the read length) were predicted using reads with more than one split with canonical
GT/AG splicing nucleotides and minimum entropy of at least 1.5 bits for each
splice junction. The percent-spliced-in (PSI) metric was computed as in Wang
et al.33 by using inclusion and exclusion reads with the minimum total count of 5
reads; that is, exons for which the combined number of inclusion and exclusion
reads was less than 5 were excluded.
From the PSI values calculated by the IPSA pipeline52 we have performed
further filtering on a tissue basis based on the three following criteria: Select exons
with NAs in less than 10% of the cases; Select exons they have a standard deviation
greater than 0; Select exons if the difference between the max and min PSI values is
larger than 0.1;
From this subset of selected exons we have then performed correlation analysis
of the PSI value with the PMI value for each tissue. Supplementary Fig. 18a shows
the number of tested exons according to the above filtering and Fig. 3d the number
of significant exons at 1% FDR and |r| > 0.5.
Differential exon inclusion in blood. Exons with PSI values following the three
criteria defined in the previous section in Blood samples were selected for differ-
ential expression analysis. This yielded a set of 3441 exons. Next, differential exon
inclusion was tested with Wilcoxon Sum Rank test, with multiple testing adjust-
ments by Benjamini-Hochberg method44, and the median of the PSI values in each
group calculated. Exons were deemed significant included if they pass the following
criteria: FDR< 1%; and |ΔPSI| > 0.1;
Cellular composition. In order to perform gene expression signal deconvolution
we applied CIBERSORT35 v1.04 and the LM22 gene signature to all blood samples,
using gene RPKMs, with default parameters, deconvoluting the signal into 22
different cell types. We discarded four cell types with average fraction below 0.01 in
both conditions, keeping 18 cell types. We compared the cell-fractions of pre- and
post-mortem samples globally using the Anderson–Darling test53 and by cell-type
obtaining a p-value using the two-sided Wilcoxon Rank-Sum test54, adjusted to
multiple-testing by Benjamini–Hochberg method44.
Splicing entropy analysis and PMI association. To investigate changes in pat-
terns of isoform usage and how these correlate with the PMI we have calculated the
splicing entropy based on the relative abundance of an isoform/transcript within a
gene. The following selection criteria and calculation was performed on a tissue-by-
tissue basis: start by selecting genes with two or more isoforms; next, select genes
with a non-zero expression in 90% of the samples of the tissue. Calculate isoform
ratios for each gene: For a gene G, with k isoforms I, the splicing ratio is defined as:
P Iið Þ ¼ IiPk
i¼1 Ii
, where Ii corresponds to the RPKM value for the isoform i of G.




i¼1 p Iið Þ´ log p Iið Þ
The splicing entropy of gene G is maximal if all its isoforms have the same ratio
and minimal if one of the isoforms dominates all the expression of G.
Then, for each gene, we correlate the splicing entropy with the respective PMI
of the sample. From this test, we obtain the r-value and p-value. Perform p-value
adjustment for multiple testing by Benjamini–Hochberg method44. We repeat this
analysis for all the selected tissues. In Supplementary Table 10 we provide the total
number of genes tested per tissues and the genes with a |r| > 0.5 and FDR< 5%.
Figures 3g, h present an example of a gene with a significant change in lung.
Supplementary Fig. 19 presents the distribution of the correlation values for
Splicing Entropy and PMI across the different tissues.
Machine learning models for PMI prediction. The predictive model for PMI
based on gene expression was constructed with a two-step approach using an
ensemble of gradient boosted trees (Supplementary Fig. 24) in order to provide a
robust estimate of PMI and avoid overfitting. 528 available individuals are initially
partitioned into training and testing datasets, using 75% and 25% of the data,
respectively. This partition is performed in such a way that we try to keep a similar
underlying distribution of the number of available tissues per individual both for
the training and testing datasets.
In order to build these tissue models (with the R implementation of the xgboost
package37), we first create a fixed split of individuals into training and test sets. For
a given tissue, we perform 3-repeat-5-fold cross validation with the samples
corresponding to the individuals of the training block in order to select the best
model, and we generate the predictions over the unseen test set using this model.
This process is repeated 13 times using different seeds to take into account the
variation in the hyperparameter optimization process. The output is a matrix of n
samples×13 columns, where each column represents the tissue PMI prediction of
all test samples for each iteration. The final tissue PMI predictions will be taken as
the row average of this matrix. Only protein coding genes with a correlation > = 0.4
with the tissue ischemic time were used in order to reduce the computational
burden of model fitting. No other covariate was considered. Hyperparameter
search was performed during this cross-validation loop using standard grid search
for tree depth ranging from 4 to 6, η ranging from 0.001 to 0.1, γ ranging from 0 to
0.15 and up to 1000 rounds, using RMSE as optimization criteria. For each tissue
we repeat the previous process 13 times using different seeds to determine the
training set fold partitions in order to have a measure of the variability of the final
prediction while applying the models on the test set (Supplementary Fig. 24b). On
Supplementary Fig. 25a, we show the variability of the number of genes selected by
the each 13 models, per tissue.
Once we have obtained the 13 models per tissue, we use each one of them to
generate PMI predictions for each tissue sample in the test set. Therefore, 13
predictions are generated per tissue for a given test individual. We take the average
of these predictions as our final PMI prediction for that particular tissue. On
Supplementary Fig. 27 we can see examples of the tissue performance on the test
set.
In the second step of our procedure, for each individual we will correct the final
tissue PMI predictions by subtracting the elapsed time of the GTEx procedure.
Since we know how much time has passed since the beginning of the GTEx
procedure until a specific sample has been processed, this time difference has to be
subtracted from the tissue PMI predictions in order to normalize them to a
reference level, which is the start of the GTEx procedure. Finally, to predict the
individual PMI (which is considered to be the time from death until the beginning
of the procedure), we compute the average of these corrected tissue PMI
predictions.
One important remark is that the final quality of the individual PMI prediction
for the test individuals will highly depend on how accurate the individual tissue
models are. For this reason, while performing the second step of the prediction
procedure, we decided to use only the top 20 tissues with the best R2 performance
in the training data (Supplementary Fig. 25b). The R2 for each of these tissues while
applying the models on the test set is shown on Supplementary Fig. 26. The density
of the individual PMI prediction error, which is defined as the signed difference of
the real and predicted individual PMI is shown on Supplementary Fig. 30.
To investigate whether we are recovering a real predictive signal from gene
expression instead of just an artifact, we used whole Blood samples, where there is
information available for pre-mortem individuals as well. We reasoned if we were
able to predict accurately the time to death for pre-mortem individuals this would
reflect overfitting. To this end, for each cohort (pre-mortem and postmortem), we
partitioned the data into training and testing datasets, fitted the model on the
training data with 3-repeat-5-fold cross validation, performed the predictions on
the test set and then obtained the regression statistics of real vs. predicted Blood
PMI. We repeated this process a hundred times with different seeds, generating a
different training/testing partition each time, in order to study the variability of the
regression statistics. There is a significant difference of the regression statistics
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-02772-x
12 NATURE COMMUNICATIONS |  (2018) 9:490 |DOI: 10.1038/s41467-017-02772-x |www.nature.com/naturecommunications
96
between pre-mortem and postmortem samples, with a very poor fit for pre-mortem
samples (Supplementary Fig. 29).
To study the stability of the tissue PMI predictive models we decided to evaluate
the tissue performance irrespective of the training/testing partition used so far. For
each tissue we partition all the available samples into 75% for training and 25% for
testing. Once each tissue model is fitted on the training set with 3-repeat-5-fold
cross validation, we calculate the p-value of the F-test (Supplementary Fig. 28), R2
and slope (not shown) for the regression of the predicted tissue PMI in the test set
versus the real tissue PMI. This process is then repeated 50 times by varying the
training/testing partition in order to measure the variability of the regression
statistics.
In order to find the optimal subsets of tissues for predicting an individual’s PMI,
we computed the individual PMI with all the possible combinations of sizes 2–6 of
the available tissues for each individual in the test set. Then for each set size we
keep the tissue combination that performed the best for each individual, in terms of
individual PMI prediction error. With this, we can calculate the proportion of
times a given tissue appeared in the optimal subset of a fixed size (Supplementary
Fig. 32). We see that Adipose—Subcutaneous, Lung, Thyroid and Skin—Sun
Exposed (Lower leg) are the tissues that consistently appeared on more optimal
subsets of all sizes; and these tissues are also the ones that appear among the top
most stable ones on the previously mentioned stability analysis. We then compute
the individual PMI using all the possible combinations from size 2 to 4 using these
four tissues (Supplementary Fig. 33 and 34).
As an additional description of stability of the individual PMI predictions, we
have computed the standard deviation (SD) and coefficient of variation (CV) of the
corrected tissue PMI predictions for each individual in our original test set, and
generated the density curves of these statistics, shown on Supplementary Fig. 31,
both for the top 20 tissues and the top 4 tissues of the best subset analysis.
Supplementary Fig. 35 shows the distribution of the death classes in the test set
individuals of our PMI prediction methodology. In order to inspect if there is any
immediate effect of the cause of death on the individual predictions, we have
grouped the death classes in three larger categories: cerebrovascular disease, heart
disease (which groups “Ischemic heart disease” and “Other forms of heart disease”)
and others (which groups the remaining classes). We observe that the performance
of the predictions in terms of R2 is very similar among the death classes.
To perform the prediction using TIN15 data, we have employed the same
methodology as with gene expression data, using the same initial partition of
training and testing individuals. Since it is a proof of concept, we have only
performed 3 repetitions of the process instead of 13 like in the gene expression
method in order to reduce the computational burden. Supplementary Fig. 36a
shows the performance of the model based on the TIN measure at the tissue level,
while Supplementary Fig. 36b compares the predictions based on TIN with the
predictions based on gene expression at the individual level. On Supplementary
Fig. 36c, we show the number of most informative genes (defined as the union of
genes with importance> = 0.1 across all the 13 models in the case of the gene
expression model, and the union of the genes with importance > = 0.1 across the 3
models in the case of TIN, with “importance” being a measure computed by
xgboost) with respect to each tissue and data type.
Data Availability. All data are available from dbGaP (accession phs000424.v6.p1)
with multiple publicly available data views available from the GTEx Portal
(www.gtexportal.org). The code can be obtained at https://public_docs.crg.es/
rguigo/Papers/human_PMI_transcriptome/.
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Chapter 4
A limited set of transcriptional
programs define major cell types
Through bulk RNA-seq gene expression, it has been previously shown that tissues
and organs have characteristic transcriptional profiles [106]. These profiles, however,
are the result of an heterogeneous cell type mixture, with each cell type contributing
differently to the expression of each gene. In this work, we produced 53 human pri-
mary cells from 10 anatomical sites and together with GTEx data, found that cells in
the human body cluster into five major cell types: epithelial, endothelial, mesenchy-
mal, blood and neural. These have a close correspondence with the basic histological
types that are used to classify tissues. We observe that these major cell types are
independently replicated in mouse single-cell gene expression, and hypothesize that
the underlying transcriptional programs could generalize to mammals. To bridge hu-
man bulk tissues transcriptomes with transcriptional identity at the cell type level,
we derive gene signatures for these five major cell types and computationally infer
their enrichments on human tissues samples. We find that tissue identity based on the
abundance of the five major cell type replicates the tissue identity at the gene expres-
sion level. By integrating transcriptomics, free-text processing of pathology reports
and image analysis, we validate the estimations of celullar enrichments and demon-
strate how departures from normality in these enrichments correlate with histological
phenotypes associated with disease.
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Summary of my key contributions
• Analyzed single-cell RNA-seq data from the Tabula Muris project for 20 mouse
organs and tissues, and found that most individual cells (and cell types) also
cluster together into the five major cell types discussed in this work, suggest-
ing the possibility of the existence of a limited number of core transcriptional
programs in mammals in general and not only in humans.
• Identified histological phenotypes from nearly 8000 free-text pathology reports
associated with GTEx histological images using part-of-speech tagging, fuzzy
string search and parse trees. These histological phenotypes are now integrated
(including all samples in the final GTEx release) in the GTEx histological image
database.
• Benchmarked cellular deconvolution (constrained least squares, support vector
machine-based proportion estimation, CIBERSORT, reference free deconvolu-
tion) and enrichment (xCell) methods to estimate cellular abundances from bulk
RNA-seq data.
• Generated cellular enrichments in 8,527 GTEx samples for the five major cell
types (endothelial, epithelial, mesenchymal, neural and blood) using cell type
signatures derived from 54 primary cells from the ENCODE project and from
the GTEx project. Compared these enrichments with the proportions estimated
by deconvolution methods. Even if deconvolution and enrichment are based on
different assumptions and modelization of the problem, the estimated cell type
abundance trends were mostly replicable among methods.
• Using xCell cellular enrichments, we found that:
1. Cellular composition constitutes a characteristic signature of tissues and
reflects their histological features.
2. Departures from normal cellular composition correlate with histological
phenotypes associated with disease.
102
• Performed dimensionality reduction (t-SNE and UMAP) of 8,527 GTEx sam-
ples using the estimated cellular enrichments for the five major cell types, and
verified that these enrichments recapitulate tissue type as strongly as the clus-
tering based solely on transcriptional profiles.
• Trained a support vector machine classifier using histological images on stom-
ach tissue to identify the presence of mucosa and muscularis layers, and applied
it over images of colon tissue which has similar histology to that of stomach,
observing that the layer predictions match the differences observed at the tran-
scriptional level with respect to cellular composition of epithelial and mesenchy-
mal major cell types.
• Performed histological image analysis to estimate the proportion of adipocytes
with respect to the total area of the tissue in WSIs of adipose tissue, observing
the proportion (∼ 84%) is likely to explain the endothelial cell type enrichment
observed for this tissue.
• Analyzed the pathology reports of skeletal muscle tissue to derive a numerical
estimation of the proportion of fat in atrophic samples.
• Generated cellular enrichment estimations for the five major cell types for sam-
ples from 19 cancer types using gene expression from the Cancer Genome Atlas
Pan-Cancer Analysis of Whole Genomes Project (PCAWG). We used these to
find alterations in cellular composition in cancer when compared to normal
samples.
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A limited set of transcriptional programs define major
cell types
Alessandra Breschi,1,2,3,9 Manuel Muñoz-Aguirre,1,4,9 Valentin Wucher,1,9
Carrie A. Davis,5 Diego Garrido-Martín,1,2 Sarah Djebali,1,2,6 Jesse Gillis,3
Dmitri D. Pervouchine,1,7 Anna Vlasova,8 Alexander Dobin,5 Chris Zaleski,5
Jorg Drenkow,5 Cassidy Danyko,5 Alexandra Scavelli,5 Ferran Reverter,1,2
Michael P. Snyder,3 Thomas R. Gingeras,5 and Roderic Guigó1,2
1Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, E-08003 Barcelona, Catalonia, Spain;
2Universitat Pompeu Fabra (UPF), E-08003 Barcelona, Catalonia, Spain; 3Department of Genetics, Stanford University, Stanford,
California 94305, USA; 4Universitat Politècnica de Catalunya. Departament d’Estadística i Investigació Operativa, 08034 Barcelona,
Catalonia, Spain; 5Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11742, USA; 6Institut National de Recherche en
Santé Digestive (IRSD), Université de Toulouse, Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National
de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), École Nationale Vétérinaire de Toulouse (ENVT),
Université Paul Sabatier (UPS), 31024 Toulouse, France; 7Skolkovo Institute for Science and Technology, Moscow, Russia 143025;
8Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), 1030 Vienna, Austria
We have produced RNA sequencing data for 53 primary cells from different locations in the human body. The clustering of
these primary cells reveals that most cells in the human body share a few broad transcriptional programs, which define five
major cell types: epithelial, endothelial, mesenchymal, neural, and blood cells. These act as basic components of many tis-
sues and organs. Based on gene expression, these cell types redefine the basic histological types by which tissues have been
traditionally classified. We identified genes whose expression is specific to these cell types, and from these genes, we estimat-
ed the contribution of the major cell types to the composition of human tissues. We found this cellular composition to be a
characteristic signature of tissues and to reflect tissue morphological heterogeneity and histology. We identified changes in
cellular composition in different tissues associated with age and sex, and found that departures from the normal cellular
composition correlate with histological phenotypes associated with disease.
[Supplemental material is available for this article.]
Transcriptional profiles reflect cell type, condition, and function.
In tissues and organs, they are monitored in RNA extracted from
millions to billions of cells (116–109) (Haque et al. 2017), likely in-
cluding multiple cell types. As a consequence, the transcriptional
profiles obtained from tissue samples represent the average expres-
sion of genes across heterogeneous cellular collections, and gene
expression differences measured in bulk tissue transcriptomes
may thus reflect changes in cellular composition rather than
changes in the expression of genes in individual cells. Single-cell
RNA sequencing (scRNA-seq) has indeed revealed large cellular
heterogeneity in many tissues and organs (Trapnell 2015), and
the Human Cell Atlas (HCA) project (Regev et al. 2017) has been
recently initiated to define all human cell types and to infer the
cellular taxonomy of the human body. As a step in that direction
and to bridge the transcriptomes of tissueswith the transcriptomes
of the constituent primary cells, and to understand how these im-
pact tissue phenotypes, we have generated bulk expression profiles
of 53 primary cell lines isolated from 10 different anatomical sites
in the human body. These profiles include long- and short-strand-
specific RNA-seq and RAMPAGE data (Fig. 1A; Supplemental
Tables S1–S4).
Results
Major cell types in the human body
Clustering of the primary cells based on gene expression profiles
revealed a number of well-defined clusters (Fig. 1B,C; Supple-
mental Figs. S1, S2A,B; Supplemental Methods 1). One cluster
was composed of endothelial cells; a second large cluster included
a mixture of cell types: fibroblasts, stem cells, and muscle cells,
among others, which we collectively termed as mesenchymal.
Two smaller clusters, which clustered together, were composed
of epithelial cells; finally, the melanocytes clustered separately.
Almost all of the individual primary cells are assigned to the proper
major cell type. The exceptions are renal mesangial cells, which
have contractile properties but are classified as epithelial, and
lung epithelial cells, that are classified as mesenchymal. These
two cell types, however, are of embryonic origin—in contrast to
the vast majority of primary cells in our study, which are adult
9These authors contributed equally to this work.
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(Supplemental Table S1)—and their transcriptomes may not re-
flect the transcriptomes of fully differentiated cells.
The clustering of primary cells does not appear to be dominat-
ed by body location or embryological origin. Body location con-
tributes very little to the expression profile of primary cells,
explaining only ∼4% of the variance in gene expression
(Supplemental Fig. S2C). Variation of gene expression among or-
gans is similar for the different clusters (Supplemental Fig. S2D).
The transcriptional diversity among cells within a given organ
can be as high as that across the entire humanbody (Supplemental
Fig. S2E). A similar clustering is obtained using FANTOM CAGE-






Figure 1. Basic transcriptional programs of human primary cells. (A) Overview of primary cells analyzed in this study and the body location they are ex-
tracted from. (B) Hierarchical clustering of human primary cells based on the correlation of gene expression. The clustering in four major clusters is sup-
ported by the silhouette analysis and the elbow method (Supplemental Fig. S2A,B). t-SNE of human primary cells based on gene expression measured
here (C), on gene expression measured by CAGE by the FANTOM Consortium (D), and on candidate regulatory elements (cREs) by the ENCODE
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Supplemental Fig. S3A,B; Supplemental Table S5; Supplemental
Methods 2; The FANTOM Consortium and the RIKEN PMI and
CLST (DGT) 2014), which reveals, in addition, two clusters corre-
sponding to blood and neural cells, which were not represented
in our set of primary cells. The analysis of a different set of primary
cells from the ENCODE Encyclopedia Registry of candidate regula-
tory elements (cREs) (Supplemental Table S6; The ENCODE Project
Consortium 2020), based on DNase I hypersensitive sites (DHSs),
also recapitulates the clustering (Fig. 1E; Supplemental Fig. S3C;
Supplemental Methods 3). The clustering remains in the set of
146 nonredundant primary cells that results from merging the
RNA-seq, the CAGE, and the DHS data. The clustering is thus con-
served despite the heterogeneity of the underlying assays and ex-
perimental protocols used to generate these different data sets
(Supplemental Fig. S4). In the clustering, neural cells (mostly astro-
cytes from different brain regions and neurons) cluster together
with a few neuroepithelial primary cells (we labeled them epithe-
lial, but they are mostly ciliated cells from different sites in the
eye). Although the neural cells profiled by CAGE seem to have a
distinct transcriptional signature (Supplemental Fig. S3A), neural
cells profiled by DNase-seq show a gene expression pattern similar
to mesenchymal cells (Supplemental Fig. S3C). However, the neu-
ral cells profiled byDNase-seq are, in contrast tomost primary cells
investigated here, of embryonic origin; thus, they are unlikely to
express the transcriptional program characteristic of adult neural
cells. The analysis of publicly available transcriptomics data from
nervous tissues, including single-cell and bulk RNA-seq, strongly
support that the neural cell type is a proper major type differenti-
ated from the other types (Supplemental Figs. S5–S7; Supplemen-
tal Methods 1).
Comparable multitissue RNA-seq data have become recently
available at the single-cell level for 20 mouse organs and tissues
through the Tabula Muris project (The Tabula Muris Consortium
2018). Principal component analysis (PCA) of the individual cells
and hierarchical clustering of the primary cell types show that
most individual cells, andmost cell types, clustered into the afore-
mentioned five major cell types, irrespective of the organ of origin
(Supplemental Figs. S8, S9; Supplemental Methods 4). As in the
case of melanocytes, we also found a few specialized cell types
which do not properly belong to these types. Hepatocytes are a no-
table example (Supplemental Figs. S8A, S9A). Although closer to
the epithelial cells than to cells of other types, they seem to have
a quite specialized transcriptional program.
Altogether, these results suggest the existence of a limited
number of core transcriptional programs encoded in the human
genome, and likely inmammalian genomes, in general. These pro-
grams underlie the morphology and function common to a few
major cellular types, which are at the root of the hierarchy of the
many cell types that exist in the human body (Table 1). They all
show similar transcriptional heterogeneity, with blood and epithe-
lial within the solid tissues being themost transcriptionally diverse
(Supplemental Fig. S10). These transcriptionally definedmajor cell
types correspond broadly, but not exactly, the basic histological
types in which tissues are usually classified (e.g., Eroschenko
2013;Mescher 2013; Young et al. 2013): epithelial, of which endo-
thelial is often considered a subtype; muscular; connective, which
includes blood; and neural. However, from the transcriptional
standpoint, endothelial constitutes a separate type, closer, if any,
to themesenchymal than to the epithelial type. Blood is also a sep-
arate major cell type, and the connective (but not blood) and the
muscular histological types cluster together into a single mesen-
chymal transcriptional type (Fig. 1F).
Within each of themajor types, further hierarchical organiza-
tion of cell typesmay exist. Althoughwe have not profiled enough
diversity of primary cells to resolve the taxonomic substructure
within each major cell type, hints of this substructure can be
seen in the epithelial type. Within the epithelial cluster, two
well-defined subclusters can be identified (Fig. 1B–E; Supplemental
Fig. S2A). One of the clusters is mademostly by renal cells, indicat-
ing that body location may play a role in subtype specialization.
The epithelial cluster includes primary cells of all embryonic ori-
gins (ectoderm, endoderm, and mesoderm), suggesting that the
transcriptional programs of cells may not be fully inherited
through development, but partially adopted through function.
The more heterogeneous composition of the epithelial type is
also apparent in the mouse scRNA-seq (Supplemental Figs. S8, S9).
Our results also suggest that althoughmany cells are likely to
adhere to these basic transcriptional programs, many other prima-
ry cells are likely highly specialized and very tissue-specific. Aswith
melanocytes and hepatocytes in our analyses, these specialized
cells are likely to have their unique transcriptional program.
Cell-type-specific genes
We identified a total of 2871 genes (including 2463 protein-coding
genes, 283 long noncoding RNAs, and 125 pseudogenes), the ex-
pression of which is specific to epithelial, endothelial, mesenchy-
mal or melanocyte cell types (Fig. 2A; Supplemental Fig. S11;
Supplemental Table S7). These cell-type-specific genes include
nearly all genes that we identified as the major drivers of the clus-
tering (Supplemental Fig. S12; Supplemental Methods 1).
Examples of these genes include collagen (COL1A2, COL3A1,
COL6A1/A2/A3), expressed in mesenchymal cells; epithelial tran-
scription factors genes OVOL1/2; VWF gene encoding for the en-
dothelial marker von Willebrand Factor; and TYR gene encoding
for the melanocyte-specific enzyme tyrosinase (for a list of manu-
ally curated driver genes, see Supplemental Table S8). Figure 2B
shows the expression pattern of LINC01235, an endothelial-specif-
ic long noncoding RNA (lncRNA) of unknown function. The gene
is expressed in nearly all endothelial cells analyzed here, but not in
cells from other types, and its expression is correlated to protein-
coding genes with endothelial-related functions (Supplemental
Table 1. Cell types in the human body
Cell type Sets of cells with similar phenotype (morphology
and functions). The similarity threshold
induces a taxonomic hierarchy of cell types, by
means of which similar cell types are
recursively aggregated into higher order types.
Primary cell type Cell types at the bottom of the taxonomic
hierarchy. They denote specialized cells
phenotypically identical (to some resolution);
they cannot further be segregated into
biologically meaningful subtypes; for example,
pancreatic beta cells. In our work, we do not
include cell lines here, which are primary cells
that have been transformed to proliferate
indefinitely.
Major cell type Cell types at the root of the taxonomic hierarchy.
They cannot be further aggregated in




Cell type topologically restricted to a specific
anatomical region (tissue, organ, body
location); for example, hepatocytes.
Transcriptional
program
The pattern of gene expression characteristic of a
given cell type.
Transcriptional programs define major cell types
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Figure 2. Cell-cluster-specific genes. (A) Expression of 2871 genes specific to major cell types. (B) Expression of the endothelial-specific lncRNA
LINC01235. Separate strand-specific signal tracks are shown for endothelial cells, and the other tracks contain overlaid signal for each cell type. The
lncRNA has highly correlated (correlation coefficient >0.9) expression with 72 protein-coding genes across our set of primary cells. Nearly all these genes
are endothelial specific, and they are functionally enriched for vessel development and angiogenesis (Supplemental Fig. S13A). The gene appears to be
under relatively strong regulation, because it has almost 1500 eQTLs across multiple tissues in GTEx (v7), well above the average eQTLs for lncRNAs (about
450). (C) Network of themost strongly coexpressed (Pearson’s r>0.85) cell-type-specific transcription factors (TFs). Nodes are colored according to the cell
type specificity of the TF, and they shaped based on the availability of sequence motif: (square) available; (circle) not available. (D) Proportion of cell-type-
specific genes with predicted TF binding over cell-type-specific genes that harbor a DHS around their TSS (−10 kb/+5 kb), individually for each cell-type-
specific TF (with binding motif available) and cell line for which DNase-seq data was available. In general, we found that genes specific to a given type are
enriched for binding motifs for TFs specific to that type. For example, the proportion of endothelial-specific genes with DHS sites that harbor motifs for the
endothelial-specific TF ERG in dermal blood endothelial cells (HDBEC) is larger than the proportion of genes with DHS sites specific of othermajor cell types.
Primary cells highlighted in red, although included within the epithelial major cell type, they have been labeled as neural/epithelial in Figure 1D, and they
are therefore not proper epithelial; consistently, they do not show the enrichment in binding motifs for epithelial-specific transcription factors. Refer to
Supplemental Table S6 for a complete description of the acronyms. Enrichment adjusted P-values: (∗) <0.05; (∗∗) <0.01; (∗∗∗) <0.001.
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Fig. S13A). The gene, however, is expressed in multiple tissues;
therefore, it is not tissue specific.
The functions of annotated tissue-specific genes closely
match the expected biology of the primary cells in each type (Sup-
plemental Fig. S13B). Cell-type-specific
genes show consistent restricted expres-
sion in the FANTOMCAGE data (Supple-
mental Fig. S14), and they are enriched
for encyclopedia cREs (Sheffield et al.
2013) specifically in the primary cells of
that type (Supplemental Fig. S15). Using
ChIP-seq histone modification data ob-
tained in a number of primary cells (Sup-
plemental Table S9; Supplemental
Methods5; TheENCODEProjectConsor-
tium 2012), we found the promoters of
genes specific to a given type to be en-
riched for activating chromatin marks in
primary cells of that type compared
with primary cells of different type (Sup-
plemental Fig. S16A). However, overall,
except for H3K4me1,we found low levels
of most activating marks in the promot-
ers of cell-type-specific genes compared
with all genes, even after controlling for
differences in gene expression. In con-
trast, the promoters of cell-type-specific
genes show similar or higher levels of re-
pressive histonemodifications compared
to all genes (Supplemental Fig. S16B).
This is consistent with previous reports
showing that genes under tighter regula-
tion show lower levels of activating his-
tone modifications than broadly
expressed genes (e.g., Rach et al. 2011;
Pervouchine et al. 2015).
Among cell-type-specific genes, we
identified 167 transcription factors (TFs)
from a total of 1544 TFs annotated in
the human genome (Zhang et al. 2012).
We focused on 56 that showed the stron-
gest coexpression patterns (Pearson’s r≥
0.8) (Fig. 2C; Supplemental Fig. S17).
They include previously annotated cell-
type-specific transcriptional regulators,
such as ERG, which has been shown to
regulate endothelial cell differentiation
(McLaughlin et al. 2001), and TP63,
which is an established regulator of epi-
thelial cell fate and is often altered in tu-
mor cells (Yoh and Prywes 2015).
Consistent with the hypothesis that the
cell-type-specific TFs might regulate cell
type specificity, we found that genes spe-
cific to a given type are enriched for bind-
ing motifs for TFs specific to that type in
most cell lines (Fig. 2D). The enrichment
arises specifically when the motifs occur
in open chromatin domains in primary
cells of that type (e.g., in epithelial pri-
mary cells, epithelial-specific genes are
enriched, compared to genes specific to
other types, in epithelial-specific TFmotifs occurring in open chro-
matin domains) (Fig. 2; Supplemental Fig. S18).
We found that transcriptional regulation appears to play a




(Barbosa-Morais et al. 2012)
(Barbosa-Morais et al. 2012)
Figure 3. Transcriptional complexity of human primary cells and evolutionary conservation of cell-
type-specific genes. (A) Distribution of the relative contribution of gene expression to the variation in iso-
form abundance between major cell types (blue) and between all primary cells. Large values of the con-
tribution of gene expression indicate that changes in isoform abundance from one condition (primary
cell, cell type) to another can be simply explained by changes in gene expression. Small values, in con-
trast, indicate that changes of isoform abundance aremostly independent of changes in gene expression
and can obey changes in the relative abundance of the isoform. (B) Number of differentially expressed
genes (DE, y-axis) versus the number of genes with differentially spliced exons (DS, x-axis), between pairs
of samples of the same cell type (within, blue), or different cell types (between, red). DS genes have been
obtained using IPSA (https://github.com/pervouchine/ipsa-full). See also Supplemental Figure S19.
(C) Fraction of 1 to 1 orthologs between each species and human for major cell-type-specific genes
and for protein-coding genes overall. Species are sorted by increasing evolutionary distance fromhuman.
The black line is given as a reference, and it indicates the proportion of six-way orthologs (chimpanzee,
rhesus, mouse, opossum, platypus, and chicken) that are present in each species. The proportion is not
100% in these species because different versions of the GENCODE gene set reference were used. The
genes in this set of six-way orthologs are used for the comparison of gene expression in Supplemental
Figure S22A. See also Supplemental Figure S22C. (D) Pearson’s r between gene expression in each hu-
man organ and the corresponding one in every other species. The correlation is computed across all
the genes in each major cell type separately. See also Supplemental Figure S23.
Transcriptional programs define major cell types
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both in defining the major cell types as well as the individual
primary cells within the types. We estimated the fraction of
the variation in isoform abundance explained by variation in
gene expression (Gonzalez-Porta et al. 2012) to be on average
67% across transcriptional types and 55% across primary cells
(Fig. 3A). The lower proportion of variance explained across pri-
mary cells suggests that splicing plays a comparatively more im-
portant role in defining the transcriptomes of primary cells
within a given type than in setting the transcriptional programs
of the major cell types. In additional support of this conclusion,
we found that although the number of differentially expressed
genes in pairwise comparisons of primary cells is much larger be-
tween than within cell types, the number of differentially spliced
genes is similar (Fig. 3B; Supplemental Fig. S19; Supplemental
Methods 6).
Although bulk gene expression is the main contributor to
define cell-type specificity, other transcriptional events are also
cell-type specific. First, using the RNA-seq data, we identified cell-
type-specific splicing events, independent of the tissue of origin
(Supplemental Fig. S20; Supplemental Table S10; Supplemental
Methods 6). Second, using the RAMPAGE data, we identified cell-
type-specific TSSs (Supplemental Fig. S21; Supplemental Table
S11; Supplemental Methods 7).
The basic human transcriptional programs seem to have been
established early in vertebrate evolution: genes orthologous of cell-
type-specific genes are underrepresented compared to orthologs of
all genes in invertebrate genomes (Supplemental Fig. S22A,B), but
they are overrepresented in vertebrates, as early as in tetrapoda.
One exception is epithelial genes, which are overrepresented
only in mammals (Fig. 3C; Supplemental Fig. S22C). Within the
set of orthologous genes across tetrapoda (Barbosa-Morais et al.
2012), the expression of cell-type-specific genes is less conserved
than that of protein-coding genes overall, especially at larger evo-
lutionary distances (Fig. 3D; Supplemental Figs. S22D, S23;
Supplemental Methods 1). This suggests an important role in the
evolution of gene expression regulation in shaping the basic tran-
scriptional programs in the human genome. Epithelial-specific
genes also show the lowest conservation of expression levels.
The transcriptional program characteristic of the epithelium ap-
pears to be, therefore, the most dynamic evolutionarily—possibly
reflecting a greater need for adaptation of the epithelial layer in
constant interaction with the environment—and it is also consis-
tent with the greater transcriptional heterogeneity of this major
cell type.
Estimation of the cellular composition of complex organs from
the expression of cell-type-specific genes
Weused the patterns of expression of cell-type-specific genes to es-
timate the cellular composition of human tissues and organs from
GTEx bulk tissue transcriptome data (version 6, 8555 samples, 31
tissues, 544 individuals) (The GTEx Consortium 2017). We used
xCell (Aran et al. 2017), using the sets of genes specific to epithelial,
endothelial, and mesenchymal major cell types derived from EN-
CODE, and specific to brain (neural) and blood derived from
GTEx (Yang et al. 2018) as signatures, and computed the enrich-
ments of these cell types in eachGTEx tissue sample (Supplemental
Methods 8).
The xCell enrichments (Fig. 4A; Supplemental Table S12) are
largely consistent with the histology of the tissues. For example,
esophagus mucosa is enriched for epithelial cells, whereas esopha-
gus muscularis is enriched for mesenchymal cells. Skin (both ex-
posed and unexposed) is enriched in epithelial cells and
fibroblasts in mesenchymal cells. Blood and brain are only en-
riched in blood and neural cells, respectively. Most other tissues
are not enriched in these two major cell types, with the expected
exceptions of spleen enriched in blood cells and pituitary enriched
in neural cells. Testis, which has widespread transcription
(Soumillon et al. 2013), is also enriched in neural cells, a reflection
of the similarity of the expression programs of these two organs
(Guo et al. 2005). Consistent with previous observations
(Frontini et al. 2012), we found enrichment of cells of endothelial
type in adipose tissue. The analysis of the pathology reports of the
subcutaneous adipose tissue shows that it is often contaminated
with other tissues, in particular blood vessels, which would ex-
plain the enrichment in cells of the endothelial type.We have fur-
ther processed and analyzed the histopathology images available
from the GTEx adipose samples (Supplemental Methods 8) and es-
timated that, on average, ∼84% of the adipose tissue corresponds
to adipocytes (Supplemental Fig. S24), which would explain the
endothelial enrichment. In skeletal muscle, we do not observe a
particularly large enrichment in cells of the mesenchymal type,
in apparent contradiction with our initial classification (Fig. 1B,
F). The samples in GTEx, however, are all from differentiated skel-
etal muscle, whereas the ENCODE primary cells that we used to
identify the mesenchymal-specific genes are undifferentiated sat-
ellite cells (SkMC) and smooth muscle cells (Supplemental Table
S1).We analyzed single-cell RNA-seq data produced during skeletal
myoblast differentiation (Trapnell et al. 2014) and found that dif-
ferentiating skeletal muscle cells retain the mesenchymal signa-
ture through most of the differentiation pathway, acquiring only
the GTEx muscle specific signature when fully differentiated
(Supplemental Fig. S25A–C). Further supporting that muscle is in-
deed of mesenchymal type, potentially forming a well-defined
subtype, gene expression profiles cluster together myoblast differ-
entiating single cells with ENCODE mesenchymal cells, rather
thanwith epithelial or endothelial cells, or forming a separate clus-
ter (Supplemental Fig. S25D).
To independently assess the xCell enrichments, we analyzed
the histological images of the few tissues in which samples were
obtained from different subregions. These are most notable in the
case of transverse colon and stomach. The GTEx stomach sam-
ples are all from the gastric body, whose walls consist of two
broad layers: the mucosa, which is mostly epithelial, and the
muscularis, which is smooth muscle (Fig. 4B). We processed the
histological images and identified a subset of samples that pre-
sented mostly the muscularis or the mucosa layer (Supplemental
Methods 8). The enrichment of epithelial cells in the samples
from the muscularis layer is much lower than in the samples
from the mucosa layer; conversely, the enrichment of mesenchy-
mal cells is much higher in the muscularis than in the mucosa
layer. The two sets of samples are almost perfectly separated by
our cellular enrichments (Fig. 4C), explaining the bimodality in
the distribution of cell type enrichments observed specifically
in the stomach samples (Fig. 4A). Consistently, we found that
epithelial-specific genes were exclusively expressed in the mucosa
layer, and mesenchymal-specific genes were exclusively ex-
pressed in the muscularis layer (Fig. 4D). Next, we used the
classification of stomach images to train an SVM model (Supple-
mental Fig. S26A,B) and used this model to predict the presence
of the two layers in 196 transverse colon samples, with histology
similar to that of stomach (Supplemental Methods 8). The
SVM-predicted classification closely matches the differences ob-









Figure 4. Expression of cell-type-cluster-specific genes in GTEx organs. (A) Enrichment of eachmajor cell type in GTEx tissues, estimated from bulk tissue
RNA-seq using the xCell method. As a control, we also include, at the bottom of the plot, the enrichments of the endothelial, epithelial, and mesenchymal
primary cells monitored here (Fig. 1B). As expected, since the gene signatures have been derived from these very same cells, endothelial primary cells are
heavily enriched in the endothelial type, but not in the other types, epithelial cells in the epithelial type andmesenchymal cells in themesenchymal type. (B)
Example of stomach histological slides, which represent the twomain tissue layers and the procedure for themanual annotation of the images based on the
presence of those layers. Each GTEx histological image displays up to six tissue slices. For the stomach samples, we scored each slice for the presence (1) or
absence (0) of the muscularis and mucosa layers, summed up the values for each layer separately and divided by the number of slices. If the proportion of
slices with mucosa layer, or muscularis layer, is more than 50%we classify the entire slide as mc1, or ms1, respectively. If the proportion is lower, we classify
the slide asmc0 orms0. A combined class, for examplemc0ms1, is assigned to the slides. Thus, samples labeledmc0ms1 aremostlymuscularis, and samples
labeledmc1ms0 aremostlymucosa. (C) Enrichment of cells of epithelial andmesenchymal types in stomach samples containingmostly themucosa (green)
or mostly the muscularis (purple) layer. (D) Expression of the cell-type-specific genes that drive the separation of stomach samples in mostly muscularis or
mostly mucosa samples. Among discriminant cell-type-specific genes, mucosa-only samples express almost exclusively epithelial-specific genes, whereas
muscularis-only samples express exclusively mesenchymal-specific genes.
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bimodality of cellular composition (Fig. 4A) is again related to the
unbalanced presence of the two tissue layers across samples (Sup-
plemental Fig. S26C). Considering that stomach and colon were
not represented in our primary cell collection, this constitutes a
strong validation of our estimates of the cellular enrichments
in tissues.
Alterations of cellular composition in pathological states
We projected the solid non-neural GTEx tissue samples on a three-
dimensional space according to the enrichments of epithelial, en-
dothelial, and mesenchymal cell types in each sample (Fig. 5A;
Supplemental Fig. S27). The spatial arrangement of the samples re-
capitulates tissue type as strongly as the clustering based on gene
expression (Supplemental Fig. S28). This suggests that the basic
cell type composition is a characteristic signature of tissues and
that departures from this composition may reflect pathological
or diseased states. To assess this hypothesis, we analyzed the histo-
logical reports associated with the GTEx images (7911 reports).We
used fuzzy string search and parse trees to convert the natural lan-
guage annotations produced by the pathologists to annotations in
a controlled vocabulary that can be analyzed automatically
(Supplemental Methods 8; Supplemental Table S13). In this way,
we identified 19 histological phenotypes affecting one or more tis-
sues for which there were at least 30 affected samples. From these,
we identified six conditions with significant (FDR<0.01) altered
contributions of major cell types when comparing the composi-
tion of affected and normal tissue (Fig. 5B–E). Atherosclerosis in
the tibial artery, which is more prevalent in older donors
(Supplemental Fig. S29A), is associated with an increase in endo-
thelial cells (Fig. 5B); this might be attributed to endothelial prolif-
eration stimulated in peripheral artery occlusion (Ziegler et al.
2010). Atrophic skeletalmuscle, a phenotype that is also correlated
with age (Supplemental Fig. S29B), is associatedwith an increase in
mesenchymal cells, which is consistent with the reported increase
of connective tissue (Appell 1990) and intermuscular fat (Manini
et al. 2007; Addison et al. 2014) in atrophy (Fig. 5C). Indeed, anal-
ysis of the pathology reports of GTEx muscle histological images
reveals that the proportion of fat is almost twice as high in atrophic
than in non-atrophic muscle (24% vs. 13%) (Supplemental
Methods 8). Elevated enrichments of mesenchymal cells are also
observed in liver congestion (Supplemental Fig. S30A), a condition
that often precedes fibrosis, which is characterized by an activation
of matrix-producing cells, including fibroblasts, fibrocytes, and
myofibroblasts (Elpek 2014). Despite the low presence of cells of
the major cell types in the testis, we found a further reduction of
enrichment of endothelial cells in testis undergoing spermatogen-
esis (Supplemental Fig. S30B). In lung pneumonia, we also observe
alteration of all cell types (Supplemental Fig. S30C). The sixth con-
dition is gynecomastia, a pathology that is characterized by ductal
epithelial hyperplasia (Cuhaci et al. 2014). We investigated differ-
ences in cellular composition between males and females and
found them significant only in mammary tissue, where female
breasts show much higher enrichment in epithelial cells than
male breasts, possibly owing to the presence of epithelial ducts
and lobules (Fig. 5D). Males diagnosed with gynecomastia show
a cellular composition similar to that of females, mirroring tissue
morphology.
We also observed specific age-related changes in cellular com-
position in lung and ovarian tissues. In lung samples we observe
changes of all cell types, in particular, a significant reduction of ep-
ithelial cells in older donors (Fig. 5E), which is consistent with the
impaired recellularization of lung epithelium that has been ob-
served in decellularized lungs of aged mice (Sokocevic et al.
2013). Consistently, a similar pattern can be observed in the lungs
of the individuals that died of respiratory-related causes
(Supplemental Fig. S30D,E). In ovarian samples of women older
than 48, a lower bound for menopause occurrence, we observe a
decrease in endothelial cells (Supplemental Fig. S30F), potentially
related to an age-dependent decline in ovarian follicle vascularity
(Tatone et al. 2008).
Altered cellular composition is likely to be particularly rele-
vant in cancer. Therefore, we analyzed transcriptome data from
The Cancer Genome Atlas Pan-Cancer Analysis of Whole
Genomes Project (PCAWG) (The Cancer Genome Atlas Research
Network et al. 2013) for 19 cancers affecting tissues also profiled
in the GTEx collection and estimated the cellular enrichments of
the major cell types (Supplemental Fig. S31; Supplemental
Methods 9). In some cases, there is also transcriptome data for nor-
mal samples from the same cancer project, which serves as a con-
trol for the highly different methodologies used in GTEx and the
cancer projects. Thus, in lung cancer, there is an increase in epithe-
lial cells (Fig. 6A,B), likely reflecting the epithelial origin of most
lung cancers. In kidney primary tumors, in contrast, there is an
overall increase of endothelial cells across most cancer subtypes,
consistent with the increased vascularity associated with the can-
cer (Fig. 6C,D). The exceptions are renal papillary cell carcinomas,
which instead present reduced vascularity (Aziz et al. 2013). In
both cases, the cellular composition of GTEx samples and normal
samples from the cancer projects are similar, supporting the ro-
bustness of our cellular characterization. Alterations in cellular
composition can also reflect cancer progression. For ovary, even
though we lack a comparable set of normal samples from the can-
cer projects, there are data on different stages of the disease, which
serve as an internal control (Fig. 6E,F). Compared to GTEx normal
data, there is an increase in epithelial cells in cancer, which ismore
evident as the severity of the cancer progresses, from primary to
recurrent.
Discussion
The ultimate aim of human genetics is to understand how varia-
tions in the sequence of DNA impact organismal traits. However,
the path connecting the DNA sequence of the genome to the phe-
notypic traits of the organism remains mostly unknown, involv-
ing a hierarchy of levels of increasing organizational complexity.
This path, which unfolds during development, initiates with the
transcription of DNA into RNA and its subsequent processing to
functionalmature RNAs. These,mostly through translation to pro-
teins, determine cell morphology and function. Cells with similar
functions aggregate to form tissues, and tissues organize into or-
gans. Systems aremade of different types of organs thatwork coop-
eratively to perform a particular function. Owing mostly to
genome-wide association studies (GWASs), thousands of genetic
variants have been connected to human traits and diseases.
GWASs, however, uncover only statistical association. Fully under-
standing the causes and themechanisms throughwhich DNA var-
iation impacts organismal phenotypes requires understanding
how this variation impacts through each of the intermediate levels
of organizational complexity. The advent of high throughput
technologies to monitor transcription—microarrays first, then
RNA sequencing—made possible the identification of genetic var-
iants affecting gene expression. However, how DNA variants and
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Figure 5. Alterations of the contributions of the major cell types to tissues in histological phenotypes. (A) GTEx samples represented in a 3D space in
which the axes are the enrichments of endothelial, epithelial, and mesenchymal cells. (B,C) Differences in xCell enrichments of major cell types (Mann–
Whitney U test, adjusted P-values as FDR) between affected and normal states. Histological images of affected and normal tissues are displayed (see
text for details): (Athr) atherosclerosis (n=31); (Atrp) atrophy (n=34); (Nrml) normal (n=285 and n=388, respectively). (D) Major cell type xCell enrich-
ments in female breast samples (Feml, n=85), and male breast samples with (MlGy, n =36) or without gynecomastia (Male, n=85). Only significant FDR
(≤0.05) are shown, all of them being between female and male without gynecomastia (left, FDR) and between male without gynecomastia and male with
gynecomastia (right, FDR). (E) Changes inmajor cell type xCell enrichments in lung samples with age. Pearson’s r and adjusted P-values as FDR: endothelial r
=0.17 and FDR=3.2 × 10−3; epithelial r=−0.23 and FDR=6×10−5; mesenchymal r=0.25 and FDR=2.4 × 10−5.
Transcriptional programs define major cell types
Genome Research 1055
www.genome.org
 Cold Spring Harbor Laboratory Press on August 21, 2020 - Published by genome.cshlp.orgDownloaded from 
112
intermediate levels of biological organization, namely, cells and
tissues (or organs), is largely unknown. The reason has been the
lack of phenotypic data on cells and tissues with associated geno-
mic, epigenomic, and transcriptomic data.
Very recently, however,mostly through advances both in sin-
gle-cell sequencing and in digital imaging technologies, data have
started to become available, which can be used to connect themo-




Figure 6. Alterations of the contributions of the major cell types to tissues in cancer. (A) xCell enrichments in epithelial cells in lung cancers andmatched
normal controls from the PCAWG project separated by cancer project: (LUAD-US) lung adenocarcinoma, TCGA, USA; (LUSC-US) lung squamous cell car-
cinoma, TCGA, USA. (B) Enrichment in matched normal and cancer lung samples by donor, pooled across the cancer projects. The P-value for the Mann–
WhitneyU test for the differences in epithelial contribution between normal and cancer samples in the LUAD-US project is: 8.1 × 10−6. (C) xCell enrichment
in endothelial cells in kidney cancers and matched normal controls from the PCAWG project separated by cancer project. (RECA-EU) renal cell cancer,
France, EU; (KIRP-US) kidney renal papillary cell carcinoma, TCGA, USA; (KIRC-US) kidney renal clear cell carcinoma, TCGA, USA; (KICH-US) kidney chro-
mophobe, TCGA, USA. (D) xCell enrichments in matched normal and cancer kidney samples by donor. The adjusted P-values for theMann–WhitneyU test
for the differences in endothelial contribution between normal and cancer samples in the RECA-EU, KIRC-US, KICH-US projects are respectively 3.8 × 10−12,
0.0024, and 0.65. (E,F) xCell enrichments in epithelial cells in ovarian cancers from the PCAWG project separated by cancer project (E) or by donor for
matched primary and recurrent samples (F): (OV-AU) ovarian cancer, Austria; (OV-US) ovarian serous cystadenocarcinoma, TCGA, USA. The P-value for
the Mann–Whitney U test for the differences in endothelial contribution between primary and recurrent samples in the OV-AU project is 3.6 × 10−27.
The donors in B, D, and F are sorted based on the difference between the enrichments. The dashed lines in D and F separate the matched samples in which
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this regard, the data collected here on the transcriptomics of hu-
man primary cells, and the links that we have established between
these data and the phenotypic traits of organs constitute a unique
resource, serving as an intermediate resolution of complexity be-
tween single-cell and whole-organ transcriptomics. This resource
will contribute to the understanding of how the interplay between
transcription and cellular composition shapes tissue histology and
ultimately impacts human phenotypes. Our analyses suggest that
a large fraction of human cells and cell types in tissues belong to a
fewmajor cell types, providing a high-level transcriptionally based
hierarchical classification of human cells. Extending the variety of
profiled cell types, achieving single-cell resolution, and integrating
expression datawith epigenetics data, as proposed in the HCA pro-
ject (Regev et al. 2017), will enrich our understanding of the con-
stitutive cell types in the human body and their functional
relationship.
Methods
RNA isolation, library construction, and sequencing
For each cell type to bemade into a library, we obtained cell pellets
that were stored in RNAlater (Thermo Fisher Scientific) as catalog
items from PromoCell (https://www.promocell.com) and Scien-
Cell (https://www.sciencellonline.com/) (for a list of primary cells,
see Supplemental Table S1). In short, the RNA was isolated from
sorted cells based on cell morphology and cell surface markers.
Each cell type was passaged to expand the cell numbers for 24–
48 h (1-2 doublings) before total RNA extraction and shipping.
Thus, this protocol represents a minimum of exposure to non-na-
tive conditions. The cell morphologies are checked at this time. Al-
though it is clear that the molecular context (influence of external
cytokins and neighboring cells) of these cells has changed, they
cluster in a very similar fashion to profiles shown by single-cell
isolates of the corresponding types. Thus, the limited passage
has an unlikely effect on the gene expression program. We rely
on the providers’ standards for quality assurance. Quality sheets




award.rfa=ENCODE3). We ordered three vials per cell type per
donor for a total of 3 million cells. The three vials were combined,
and we isolated total RNA from them using the Ambion mirVana
miRNA Isolation kit (AM1561). The rRNA was removed using the
RiboZero Gold Protocol (RZG1224). The libraries are made using
a homebrew “dUTP” protocol (Parkhomchuk et al. 2009), which
generates stranded libraries. They were sequenced on the Illumina
platform inmate-pair fashion and processed through the data pro-
cessing pipeline at the ENCODE DCC. Additional information
about each of these steps, metadata, and files can be found at
https://www.encodeproject.org/.
RAMPAGE sample preparation
Isolation of RNA is described in the preceding section. The RAM-
PAGE protocol (Batut and Gingeras 2013) was used to make librar-
ies. Each library was sequenced in mate-pair fashion on the
Illumina platform. Detailed protocol and quality-control images
and metrics on a per library basis can be found in the “Production
Documents” appended to each RAMPAGE assay at the ENCODE
Data Coordination Center (https://www.encodeproject.org/).
Small RNA isolation, library construction, and sequencing
Isolation of RNA is described in the preceding section. The
Illumina TruSeq protocol was used to make libraries. Each library
was sequenced in single end fashion on the Illumina platform.
Detailed protocol and quality-control images and metrics on a
per library basis can be found in the “Production Documents”
appended to each Small RNA assay at the ENCODE Data
Coordination Center (https://www.encodeproject.org/).
RNA-seq processing pipeline
Raw reads from the 106 RNA-seq libraries (for a list of ENCODE li-
brary IDs, see Supplemental Table S1; for submitted FASTQ files,
see https://www.encodeproject.org/) were aligned with STAR
v2.3.1z (Dobin et al. 2013) to the human genome assembly
hg19. Readsmapping tomore than 20multiple positions were dis-
carded. Read counts for all long genes annotated inGENCODEv19
(Harrow et al. 2012) were computed with RSEM 1.2.19 (expected
read counts) (Li andDewey 2011). Statistics on the number of reads
and mapping are available on Supplemental Table S14.
Furthermore, we verified using liftOver that the cell-type-specific
genes are consistent between GRCh37/hg19 and GRCh38/hg38,
with a successful conversion of 2855 of the 2871 genes.
For most of the analyses, we average expression values for a
given pair of replicates and sometimes the two biological replicates
are fromdonors of the opposite sex; therefore, we remove genes on
Chromosome Y. The lack of an enrichment step for polyadeny-
lated transcripts preserves the presence of some short biotype
genes, which are still longer than 200 bp. Thus, we remove genes
with at least one transcript annotated as short RNA in
GENCODE. These genes are often of repetitive nature, which
makes the quantification of their expression problematic; this is
why we decided to remove them.
Read counts which are not reproducible between two repli-
cates (npIDR>0.1) (Djebali et al. 2012) are set to 0. The matrix of
read counts after npIDR is provided as Supplemental Table S2. Af-
ter filtering for reproducibility, read counts are normalized to a
slightly modified version of RPKM (reads per kilobase of exon
model per million mapped reads) (Mortazavi et al. 2008). Specifi-
cally, read counts were first normalized to counts per million
(cpm), in which the library sizes are the trimmedmean ofM values
(TMM) (Robinson and Oshlack 2010) scaled sums of exonic reads,
and then normalized by gene length. Finally, RPKM values from
the two replicates were averaged, and genes with RPKM<1 in all
samples were discarded, resulting in 16,265 genes, including
13,990 protein coding, 1380 long noncoding RNAs, and 895 pseu-
dogenes. Statistical analyses were performed with R version 3.6.1
(R Core Team 2019).
As the samples were prepared and sequenced in three known
distinct batches (Supplemental Table S1), we used the
removeBatchEffect() function from R limma package (Ritchie et al.
2015) to build a linear model with the batch information and
the cell types on log10-transformed RPKM (with a pseudocount
of 0.01), and we regressed out the batch variable.
Data access
All experimental protocols for the samples described here, and all
data generated for this study, are publicly available on the
ENCODE portal (https://www.encodeproject.org/). GTEx gene ex-
pression is available in the GTEx portal (https://www.gtexportal
.org).
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Chapter 5
The impact of sex on gene
expression and its genetic
regulation across human tissues
Mechanisms that have a role in the biology of human sex can translate to complex
phenotypes and diseases, for which some can exhibit different behaviors in males and
females. Although factors such as the sex chromosomes and hormones are typically
attributed as sources of these effects, less is known about sex differences at the molec-
ular level. To this end, in this work we aim to document sex differences in the human
transcriptome and its regulation. We survey sex differences (defining males and fe-
males solely on the basis of their XY and XX sex chromosomes) in the transcriptome
of 44 human tissues, and find that differential gene expression with respect to sex is
ubiquitous across tissues but with small effect sizes, and tends to be largely tissue
specific. Using computationally-inferred cell type enrichments from bulk RNA-seq
gene expression (with different gene signatures than those used in Chapter 4), we
characterize differences in cell type composition between males and females and how
these can be linked to phenotypes associated to disease. We find that the sex differ-
ences in genetic regulation (sex-biased eQTLs) are much less common when compared
to gene expression differences. Nevertheless, we find associations for gene-trait pairs
that are driven by a single sex.
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Summary of my key contributions
• Estimated surrogate variables from gene expression data in order to capture
variation from unknown technical sources. Demonstrated that these surrogate
variables are correlated with computationally-inferred cell type abundances, as
well with other technical covariates although to a lesser degree.
• Performed differential gene expression between males and females (948 human
individuals) separately in 44 tissues totalling 16,245 RNA-seq samples across
35,431 genes. With these results, we found that:
1. Sex effects on gene expression exist across all tissues. A total of 13,294
genes (37 % of the transcriptome) exhibit differential expression in at least
one tissue.
2. Sex-differential expression effect sizes are small, especially for autosomal
genes.
3. Sex-biased genes are, in general, tissue-specific and tend to be expressed
at most in small subsets of tissues. Only 30 genes have a consistent sex
bias across all tissues, and most of these are known XCI escapees.
• Assessed the replicability of differentially expressed genes identified with GTEx
RNA-seq by performing differential expression on independent datasets in four
different tissues, observing moderate to strong replication. Containerized all
the differential expression analyses in a reproducible Docker image.
• Illustrated tissue similarities with hierarchical clustering (with uncertainty as-
sessment via multiscale bootstrap resampling) based on gene expression profiles
and differential expression (meta-analysis) effect sizes. Identified driver genes
for each cluster, both in the clustering based on gene expression and on sex-
differential expression effect sizes. With these, we observed that:
– Hierarchical clustering between both data types is highly concordant.
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– Tissue specificity of sex-differentiated effects is not driven by tissue-specific
gene expression (i.e. the clusters, although similar, are not primarily
weighted by the same genes).
• Developed cross-validated gradient boosted tree classifier models to predict sex
in for each of the 44 tissues, performing parameter search with bayesian opti-
mization and Gaussian processes. Computed Shapley values for each model as
a proxy to explain class predictions at the sample level. With these, we found
that:
1. Prediction with X-linked genes is accurate, with high sensitivity and speci-
ficity in all tissues. The most predictive X-linked genes are known X-
Chromosome Inactivation (XCI) escapees.
2. 40 X-linked genes that are predictive of sex have not been previously de-
scribed as X-Chromosome Inactivation (XCI) escapees, suggesting their
potential escapism, which needs to be validated experimentally.
3. Sex prediction with autosomal-only genes is less accurate, less specific and
required more genes. The exceptions are breast and muscle tissues, where
autosomal genes predicted sex with specificity and sensitivity ≥ 90%.
4. Genes among the top predictive autosomal ones have been shown to have
roles in hormone regulation and sex-differentiated traits.
• Identified sets of transcription factor (TF) binding sites with large enrichment
differences between female- and male- biased genes. Although some of these
TFs have known roles in sex differences, for example, in body growth rates and
liver gene expression, the rest are mostly uncharacterized.
• Analyzed sex differences in computationally-inferred enrichments for seven cell
types. Found that significant differences exist in a few tissues.
• Found six pathological phenotypes with altered cell type enrichments in males
and females, using the histological phenotypes derived from free-text pathology
reports in Chapter 4.
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• Performed PCA of gene expression in breast tissue using the set of autosomal
predictive genes derived from the classifer model mentioned above. Found that
this set of genes, besides allowing to discriminate between males and females,
also identifies a separation between male individuals affected by gynecomastia,
and non-affected males. By examining the loadings, we characterize a set of
genes that show association with gynecomastic males, an example is the TRH,
which is known to play a role in the mediation of protein levels which are altered
in gynecomastia.
Note:
Due to licensing restrictions, here follows the accepted version of the manuscript.
Please refer to https://doi.org/10.1126/science.aba3066 for the copyedited (pub-
lished) version of the manuscript.
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Abstract: Many complex human phenotypes exhibit sex-differentiated characteristics. However, 
the underlying molecular mechanisms of these differences remain largely unknown. We generated 
a catalog of sex differences in gene expression and in the genetic regulation of gene expression 
across 44 human tissue sources surveyed by GTEx (v8 release). We demonstrate that sex 
influences gene expression levels and cellular composition of tissue samples across the human 
body. A total of 37% of all genes exhibit sex-biased expression in at least one tissue. We identify 
cis-eQTLs with sex-differentiated effects and characterize their cellular origin. By integrating sex-
biased eQTLs with genome-wide association study data, we identify 58 gene-trait associations that 
are driven by genetic regulation of gene expression in a single sex. Together we provide an 
extensive characterization of sex differences in the human transcriptome and its genetic regulation. 
 
One Sentence Summary: Sex differences in the human transcriptome are widespread, highly 
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Many complex human phenotypes, such as anthropometric traits like waist-to-hip ratio, exhibit 
sex-differentiated distributions; disease features, such as prevalence, progression, age of onset, and 
response to treatment, often differ by sex (1–5). These sex differences have been previously 
attributed to hormones, sex chromosomes, differences in behavior and environmental exposures, 
as well as various genetic models (6), but the mechanisms and underlying biology of the sex 
differences remain largely unknown. The Genotype-Tissue Expression (GTEx) project (7) 
provides an opportunity to investigate the prevalence and genetic mechanisms of sex differences 
in transcriptomes and to identify how sex and genetics interact to influence complex traits and 
disease. The analyses presented here characterize sex differences in a relatively large population 
sample, including many tissues that generally lack characterization. As the causative tissue is 
unknown for many diseases and disorders, analysis of this diverse tissue set can serve as a powerful 
resource for investigations into the basis of sex-differentiated phenotypes. 
We present an extensive characterization of sex differences in the human transcriptome across 44 
tissue sources of the GTEx project (v8 data release, (8)) from 838 individuals (557 males, 281 
females), comprising a large collection of multi-tissue bulk gene expression and genotype data 
(Fig. 1, (9)). Here we quantify and characterize sex differences in gene expression levels (sex-
biased gene expression) and cis sex‐biased expression quantitative trait loci (sb-eQTLs). By 
incorporating the results of these sex-aware analyses of GTEx data with gene features and 
transcription factor binding annotation, we describe tissue-specific and tissue-non-specific drivers 
and mechanisms contributing to sex differences in the human transcriptome and eQTLs. By 
integrating data from genome-wide association studies (GWAS), we report multiple sex-
differentiated genetic effects on the transcriptome that colocalize with complex trait associations, 
highlighting the power of characterizing sex bias in GTEx samples for the mechanistic 
interpretation of GWAS signals.  
Sex effects on gene expression are ubiquitous but small 
Using GTEx v8 data (Table S1), we quantified sex-biased gene expression in each of the 44 tissue 
sources for all genes expressed in at least one tissue. We consider a total of 35,431 X-linked and 
autosomal genes, including protein-coding, lincRNA, and other less characterized gene types such 
as transcribed pseudogenes (9). For each tissue, we first fit a linear model that accounts for known 
sample and donor characteristics, as well as surrogate variables that capture hidden technical or 
biological factors of expression variability, including tissue cell-type composition (Fig. S1, A, B 
and C). Consequently, we are able to identify sex-biased gene expression that does not derive from 
sex differences in cell-type abundances. We next modeled sex-bias effects across tissues. We 
discovered a total of 13,294 differentially expressed genes (sex-biased genes; local false sign rate 
(LFSR) ≤ 0.05), with 473 to 4,558 genes discovered per tissue, representing 1.3% to 12.9% of all 
tested genes, respectively (Figs. 2A, S1, D to F, Table S2). Previous studies have reported 
widespread sex-biased gene expression (10–12), and described breast as the most sex-
differentiated tissue (10, 11, 13). However, we did not observe this in the present study after 
controlling for sex differences in tissue cell-type composition (Fig. S1A). We next assessed 
replication of sex-biased genes in independent gene expression datasets for four tissues (brain 
cerebellum, brain cortex, heart left ventricle and lymphocytes, Table S2). We observed moderate 
to strong replication (average π1=0.62, average effect size Spearman’s rho = 0.78). In total, 37.5% 
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(13,294/35,431) of the human transcriptome was differentially expressed in at least one tissue. Of 
these, 531 genes (4%) were X-linked and 12,763 genes (96%) were autosomal, representing 47% 
and 37% of all tested X-linked and autosomal genes, respectively. Although abundant, sex effects 
are mostly small (Fig. S2A), particularly for autosomal genes ((9), Fig. S2B). X-linked genes with 
higher expression in females (female-biased genes) exhibited larger sex effects (median fold 
change (FC) = 1.13) than either X-linked genes with higher expression in males (male-biased 
genes; median FC = 1.08), or autosomal sex-biased genes (median FCM and FCF = 1.04; Fig. S2B), 
potentially due to escape from X-chromosome inactivation (XCI) (14). The number of sex-biased 
genes and the effect sizes were not dominated by either sex (Fig. S2C). 
Sex-biased gene expression is largely tissue-specific 
Sex-biased genes exhibited a skewed pattern of tissue sharing - they were likely to be differentially 
expressed in only a small subset of tissues (Fig. 2B), as previously reported (10–13). Of 13,294 
total sex-biased genes, 2,416 were (18.2%) differentially expressed in only a single tissue (Fig. 
2B), suggesting tissue-dependent regulation.  Only 30 genes (0.23%; 22 of which are known 
constitutive XCI escapees, Table S3) exhibited consistent sex bias across all 44 tissue sources (Fig. 
2B). This tissue-specificity did not simply reflect patterns of gene expression across tissues; sex-
biased genes tended to be ubiquitously expressed across tissues, while sex-biased expression was 
limited to one or a few tissues ((9), Figs. 2C, S2D). The majority (8,241/10,878 genes, 76%) of 
genes with sex bias in ≥2 tissues exhibit consistent effect direction across tissues, especially for 
X-linked genes (Fig. S2E). Notably, whole blood and cell lines, the most widely studied 
biospecimen types, were not representative of sex-biased expression across tissues; sex-biased 
genes in whole blood comprised only 12.9% (1,710/13,294) of all sex-biased genes. Although 
hierarchical clustering of tissues based on gene expression and sex-biased expression are highly 
concordant (Cophenetic correlation = 0.75; (9), Fig. 2C, Fig. S3, A, B and C), the intersection 
between the cluster-defining gene sets (Table S4) is less than expected by chance (P < 2.2e-16, 
Hypergeometric test). For example, both expression and sex-biased expression supported a cluster 
of brain subregions that is clearly differentiated from other tissues (Figs. 2C, S3, B and D). 
However, the cluster based on sex-biased expression was driven by 194 genes, while the 
transcriptome-based brain cluster was driven by 982 genes, from which only six were common 
with those defining the sex-based brain cluster. Among drivers of the sex-based liver cluster, we 
identified CYP450 genes - CYP1A2, CYP3A7, CYP3A4 - as previously reported (15); but we also 
found genes less well-characterized for sex bias, such as PZP, H19 and VWCE which were 
previously shown to be sex-differentially expressed due to liver-specific sex differences in DNA 
methylation (16). These results suggest that the tissue-specificity of sex-biased expression is not 
driven primarily by tissue-specific gene expression.  
X-linked female-biased genes accurately predict sex and suggest tissue-specific candidates 
for escape from X-chromosome inactivation 
We accurately predicted sex from gene expression, as previously explored (17), using X-linked 
genes ((9), Fig. S4, A to D) with gradient boosted trees. Although the most predictive X-linked 
genes (Fig. S4E) are those known to escape XCI, we identified 40 X-linked female-biased genes 
predictive of sex (within the top tertile with respect to their Shapley values) not previously 
described as XCI escapees (Table S3). While these results suggest further evaluation of these genes 
as potential XCI escapees, we did not directly test escape from XCI, and female-biased expression 
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of X-linked genes may originate from other mechanisms. Sex prediction from autosomal genes 
was less accurate (mean accuracy = 84%), less specific (mean specificity = 56% and sensitivity = 
96%; Fig. S4D), and required more genes (Fig. S4F) than prediction based on X-linked genes. 
However, in two tissues - breast and muscle - autosomal genes predicted sex with specificity ≥ 
90% and sensitivity ≥ 98% (Fig. S4G). 
Sex-biased genes exhibit non-random and tissue-specific genomic distribution  
Except for the enrichment of female-biased genes on the X chromosome, little is known about the 
genome-wide distribution of sex-biased genes. We applied a positional gene enrichment analysis 
method (PGE) (18) separately for male- and female-biased genes (LFSR ≤ 0.05) from each tissue 
((9), Fig. S5A). We discovered clustering of a total of 1,559 sex-biased genes in 134 autosomal 
and five X-linked regions (hypergeometric test P ≤ 0.001; Fig. 3A, left; Table S5). On the X 
chromosome, pseudoautosomal (PAR) region PAR1 and the remainder of the X chromosome short 
arm p were enriched for male-biased and female-biased genes, respectively (Fig. 3A, right), as 
previously reported (14). Female-biased gene enrichment was stronger (Spearman’s rho=0.51, P 
= 1.63e-15) in the younger strata of arm p (Fig. S5B), likely driven by escape from XCI (14, 19). 
Although enriched X chromosome regions spanned ~126Mb, only 25% of subregions were 
enriched in at least two thirds of the tissues. Among autosomal sex-biased genes, we observed a 
cluster of male-biased genes on chromosome 20 that was identified in 70% (30/44) of tissues (Fig. 
S5C), but the majority of the 134 autosomal enriched regions were tissue-specific, identified on 
average in ~7% (3/44) of tissues (Fig. S5D, Table S5). These results are compatible with tissue-
variable escape from XCI (14, 20) and with tissue-specific topologically associating domains, 
possibly mediated by hormones (21). Further investigation is warranted to corroborate these and 
other hypotheses, as observed patterns may originate from a variety of mechanisms.  
Promoters of sex-biased genes are enriched for hormone-related and other transcription 
factor binding sites 
We hypothesized that transcription factor (TF) activity might drive observed patterns of 
differential expression, as sex-biased gene regulation by TFs has been recently reported (13), and 
TFs contribute to evolutionary changes in sex bias (12). We tested for enrichment of TF binding 
sites (TFBS) of 231 TFs previously identified through ChIP-seq (22) in promoter regions (i.e., 2kb 
upstream of the transcription start site) of male- and female-biased genes ((9), Fig. S5E). We 
discovered enrichment for TFBS of a total of 92 TFs (Fig. S5F), two of which were X-linked (AR, 
ELK1). TFBS for 54 TFs were enriched among female-biased genes, and 60 TFs among male-
biased genes, with 22 TFs enriched among both sets of genes (Table S6). The 92 TFs include i) 
known hormone-related TFs estrogen (ESR1), androgen (AR) and glucocorticoid (NR3C1) 
receptors, ii) ten TFs that colocalize with steroid receptors, and iii) TFs with a non-reported or 
less-characterized hormone association, including SP1, E2F6, NRF1, KLF9, and SP2, the top five 
TFs with consistent TFBS enrichment across tissues (9).  
The strongest difference between male- versus female-biased enrichment profiles was observed 
for TFBS of SP2, SP4, NFYB, TWIST1, STAT5B (female-biased) and HNF4G, NFKB1, E2F6, 
HNF4A, ETS1 (male-biased), respectively, which were detected across most tissues (Fig. 3B, 
Table S6). In contrast, we observed tissue-specificity for enrichment of TFBSs of several TFs, e.g., 
RFX2, ETV4 for brain and breast tissues, respectively (Fig. 3B, Fig. S5F). While STAT5B and 
HNF4A play known roles in sex differences in body growth rates and liver gene expression (15), 
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less is known about their roles and sex biases across all tissues. The effect of sex on most of the 
remaining TFs is uncharacterized. Together, these results suggest that hormone-related TFs 
regulate sex-biased expression as expected, but also indicate that additional TFs play a role in sex-
biased gene expression, in some cases in a tissue-specific manner (Table S6). Notably, TFBS 
enrichment is not driven by sex-biased expression of the TFs themselves (9), consistent with the 
observation that sex-biased TF targeting of genes is independent of sex-biased gene expression 
(13). However, this scenario cannot be discarded if such differences occur at an earlier 
developmental time point and translate into a more constitutive sex-biased TF binding profile (23). 
Alternatively, other mechanisms involving TFs could be causal drivers, e.g., post-translational 
modifications as reported in mice (24). 
Sex-biased genes are involved in a highly diverse set of biological functions and suggest sex-
specific deposition of epigenetic marks  
To gain insight into cellular functions affected by sex-biased genes, we performed gene set 
enrichment analysis (GSEA) in each tissue, considering the direction of the sex effect ((9), Fig. 
S6A, Table S7 and S8). To identify gene sets that are enriched across multiple tissues, we 
performed a meta-analysis using Fisher's combined probability test and identified 2,134 enriched 
gene sets (FDR ≤ 0.05; Table S9). We applied a community detection approach to identify 
common features across enriched gene sets and defined 36 clusters (Table S9). Among the top 
scoring clusters ((9)), we identified enrichment of genes in pathways involved in drug and hormone 
response, epigenetic marks, embryonic development and tissue morphogenesis, fertilization, 
sexual reproduction and spermatogenesis, fat metabolism, cancer, immune response, and other 
functions (Fig. 3C, Table S9). The top scoring cluster corresponds to targets of PRC2 and 
trimethylation of histone H3 at lysine 27 (H3K27me3), which is predominantly driven by female-
biased genes; a pattern also reported for other epigenetic modifications (13). This complex induces 
gene silencing and is involved in XCI (25). Sex-specific deposition of H3K27me3 marks have 
been previously reported, resulting in sex-biased gene expression in mammalian placenta (26) and 
adult liver (27). These differences have been hypothesized to be regulated by sex differences in 
secretion of placental glycosyltransferase OGT and pituitary growth hormone. The observed 
association of H3K27me3 with sex biased expression in the tissues of this study (Table S9) has 
not been previously reported. We also identified clusters related to drug metabolism that include 
CYP450 genes. While sex-biased expression of CYP450 has been reported in liver (15) and linked 
to sex-differentiated growth hormone profiles, we observed sex-biased expression in additional 
tissues (Fig. S6B). Sex-biased expression was also identified for clusters related to gonad tissue 
functions, e.g., meiotic synapsis, which comprise genes expressed largely in testis (Fig. S6B). It is 
possible that part of the cross-tissue sex-biased expression patterns observed in adult tissues are 
derived from gamete formation and embryogenesis (28). Together, these results indicate that sex-
biased genes are involved in a wide range of biological functions and pathways, many of which 
have not been previously associated with sex differences. 
Sex and disease influence tissue cellular composition 
The GTEx tissue samples are mixtures of heterogeneous cell types, with variation among 
individuals and tissues (29). In whole blood, cell-type composition differs between sexes (30, 31), 
but little is known about sex differences in composition of other tissues. Using a t-test we examined 
each GTEx tissue for sex differences in cellular composition using estimated abundances of seven 
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cell types (29) (9). We discovered significant (FDR ≤ 0.05) differences for four cell types - 
keratinocytes, neutrophils, adipocytes and epithelial cells - in three tissues (Fig. S7A, Table S10). 
We hypothesize that additional cell types uncharacterized in this study may influence cell-type 
composition of GTEx tissues, particularly of immune cells, as marked sex differences in immune 
cell abundances have been reported (30, 32). To investigate cellular abundances in disease, we 
utilized histological annotations from pathology review of GTEx tissue samples (9). We 
discovered six pathological phenotypes with altered cell-type composition (Fig. S7 B-E, Table 
S10). Together these results suggest that sex is correlated with tissue cellular composition, and that 
disease may alter cellular abundances in a sex-differentiated manner or in sex-specific pathologies. 
Sex differences in the genetic regulation of gene expression are highly tissue-specific and 
less common than sex effects on gene expression 
Sex-differentiated human phenotypes and disease characteristics may derive, in part, from sex-
differentiated genetic effects (6, 33–36), some of which may impact gene expression. For each of 
491,694 conditionally independent cis-eQTLs identified in the sex-combined cis-eQTL analysis 
of the GTEx v8 project (8), we performed sex-biased cis-eQTL (sb-eQTL) analysis in each of 44 
tissues present in both sexes (Fig. 1). We used a linear regression model including genotype, sex, 
and covariates, and tested for significance of a genotype-by-sex (G×Sex) interaction on expression 
(9). Notably, this approach captures both G×Sex interactions that derive from sex and from sex-
correlated factors, including cell-type abundances or environmental factors. While the contribution 
of cell-type heterogeneity to sb-eQTLs is currently unknown, we observed sex differences in tissue 
cell-type composition (Fig S7A), which may impact sb-eQTL discovery. Hence, we characterized 
the impact of cell-type-specific eQTLs on sb-eQTLs (see below). We discovered a total of 369 sb-
eQTLs, corresponding to 366 genes (sb-eGenes) (FDR ≤ 0.25, Table S11). The majority of sb-
eQTLs were identified in breast (261 sb-eQTLs), but also in muscle (36 sb-eQTLs), skin (18 sb-
eQTLs), and adipose tissues (14 sb-eQTLs; Fig. 4A, Fig. S8, A and B). Overall, sb-eQTLs showed 
strong evidence for tissue specificity (9); only one sb-eQTL was significant in two tissues (Table 
S11), and only 21% displayed patterns suggestive of tissue-sharing even at a lenient significance 
threshold (PG×Sex  ≤  0.01). Only 36 (14%) sb-eGenes exhibited sex-biased expression in the 
discovery tissue (MASH LFSR ≤ 0.05; Table S12), similarly to recent observations (37). (37) 
different functional mechanisms contributing to each sex bias type.  
 
To provide additional support for the sb-eQTLs, we used two approaches to assess differential 
allele-specific expression (ASE) between sexes: allelic fold-change (ASE aFC) (38) and 
Environment-ASE through Generalized LinEar modeling (EAGLE) (39) (9). Allele-specific 
expression can arise due to cis-regulatory genetic effects in heterozygous individuals. Differential 
ASE, therefore, indicates condition-specific cis effects (39) including sex-specificity. We observed 
that, despite limited power when restricted to heterozygous individuals and differences in 
methodology, both approaches support that a portion of the detected sb-eQTLs correspond to sex 
differences in ASE (Fig. S8C): sb-eQTLs were enriched for sex-biased ASE aFC (All tissues: π1 
= 0.36, breast: π1 = 0.41, Fig. S8, D and E) and for EAGLE associations (π1 = 0.13, empirical test, 
P ≤ 0.001). Of the 243 and 163 sb-eQTLs tested by ASE aFC and EAGLE methods, respectively, 
65 (26.7%) were supported by ASE aFC (Wilcoxon P ≤ 0.05) (Fig. S7, F and G), 29 (17.8%) were 
supported by significant EAGLE associations, and 16 sb-eQTLs (10.4% of the 154 sb-eQTLs 
tested by both methods) were supported by both methods (Table S11). 
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We were limited in our ability to replicate sb-eQTLs because the majority of sb-eQTLs were 
discovered in breast, and matching, well-powered datasets do not exist. We performed internal 
validation, splitting GTEx breast samples into discovery and validation cohorts, and observed 
moderate replication (mean π1 = 0.28; (9), Fig. S8H). We next assessed sb-eQTL replication 
(considering sb-eQTLs from breast, whole blood, and all tissues) in independent larger (~900 
subjects) whole blood eQTL datasets, including DGN (40) and GAIT2 (41) cohorts ((9), Table 
S13). We observed weak replication (π1 = 0 - 0.12, depending on sb-eQTL set and replication 
cohort). Poor replication of sb-eQTLs has been previously reported (40, 42, 43) and has been, in 
part, attributed to low power (44), but also to methodological and study design differences.  
 
For each sb-eGene, we also performed sex-stratified cis-eQTL analysis for each tissue, 
downsampling males to match the female sample size (9). We observed strong correlation 
(Spearman's rank correlation rho = 0.78, P ≤ 2.2e-16) between male and female cis-eQTL effect 
sizes. For 58% of sb-eQTLs, sex-stratified cis-eQTL analysis revealed associations in both sexes 
with concordant allelic effect, but different effect sizes. For example, rs117380715-ADRA1A in 
adipose subcutaneous tissue showed a stronger effect in females than in males (βF = -0.78, PF = 
4.64e-18, βM = -0.47, PM = 3.98e-10) (Fig. 4B, Fig. S8I). For the remainder of the sb-eQTLs, a cis-
eQTL was detected exclusively in either females (70, 19%) or males (84, 23%). For example, we 
identified a female-specific cis-eQTL for rs8942-C4BPB in breast (βF = 0.40, PF = 2.68e-07, βM = 
-0.02, PM = 8.90e-01) (Fig. 4B, Fig. S8I). C4BPB encodes the beta unit of the C4b-binding protein, 
and controls activation of the complement cascade (45). We also identified a male-specific cis-
eQTL for rs2273535-AURKA in skeletal muscle (βM = 0.47, βF = 0.01), described in (8). AURKA, 
Aurora kinase A, is a member of the serine/threonine kinase family involved in mitotic 
chromosomal segregation, muscle differentiation (46), and a known risk factor for several cancers 
(47). These results demonstrate that sex-biased genetic effects on gene expression exist for a small 
proportion of previously identified cis-eQTLs, and some sb-eQTLs affect genes implicated in 
human phenotypes. 
Sex differences in genetic regulation of gene expression are partially mediated by cell-type-
specific eQTLs  
Given that the G×Sex interaction term of our eQTL model captures interactions that derive from 
sex as well as interactions with sex-correlated factors, we next characterized the fraction of sex-
biased eQTLs that are driven by cell-type-specific eQTLs (Fig. S9A). We focused on breast, the 
tissue with the most sb-eQTLs and the largest sex differences in cellular composition (Figs. S7A, 
S8B). We tested 261 breast sb-eQTLs for enrichment of cell-type interacting cis-eQTLs (ieQTL) 
(29) (9). These ieQTLs correspond to cis-eQTLs where the effect varies depending on estimated 
cell-type abundances (29). Breast sb-eQTLs were strongly enriched (π1 = 0.66 and 0.89) for ieQTL 
signal corresponding to adipocytes and epithelial cells (Fig. S9B). After including an interaction 
term for genotype-by-epithelial cell abundance estimates in the sb-eQTL model, 58% of breast sb-
eQTLs (152/261) remained significant, while for 42% of sb-eQTLs (109/261), the genotype-by-
sex effect was strongly attenuated (Fig. S9C, Table S14). For example, the strongest breast sb-
eQTL, rs2289149-LINC00920 (P = 4.83E-11) was not significant after incorporating the genotype-
by-epithelial cell abundance estimates in the model (βG×Sex = 0.187, CI(95%) = [ -0.004 , 0.378 ], 
Fig. S9C, Table S14).  
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To formally test the impact of cell-type composition on sb-eQTL detection, we performed a 
mediation analysis, utilizing genotype interactions with estimated epithelial cell abundance as a 
potential mediator ((9), Fig. S9D). We discovered that 60 (23%) sb-eQTLs were mediated by cell-
type abundances (Average Causal Mediation Effects P ≤ 0.001, Fig. 4C) (Table S14). Mediation 
by other cell types cannot be excluded, particularly by immune cells: we observe that breast sb-
eGenes are enriched for immunoglobulin variable chain genes (Fisher's Exact Test, OR = 12, P = 
9.2e-08. In all cases, the eQTL effect size is larger in females (Table S11). Since immunoglobulin 
genes are mainly expressed in B cells and are among the most sex-discriminative genes in breast 
(Fig. S7D), we hypothesize that immunoglobulin sb-eQTLs may be driven by greater abundances 
of this cell type in female breasts. Collectively, these results indicate that a large proportion of sb-
eQTLs in breast are driven by cell-type-specific genetic effects on gene expression that become 
apparent when cell types differ between sexes, although our analysis cannot distinguish whether 
the tested cell types or others correlated with them (Fig. S9E) are the true mediators of the signal.  
Sex-aware eQTL-GWAS colocalization provides insights into the genetic basis of complex 
traits 
To assess the utility of sb-eQTLs to dissect the molecular basis of complex trait associations, we 
performed colocalization (48) between sex-stratified cis-eQTLs and 87 GWASes, representing 74 
distinct complex traits, for 1,089 sb-eGenes at a more relaxed FDR (FDR ≤ 0.50) (9). We identified 
74 colocalized gene-trait pairs (posterior probability of sharing the same causal variant, PP4 > 0.5; 
Fig. 5A). Of these, 58 were colocalized (PP4 > 0.5) in one sex but not in the other - 36 for females 
and 22 for males - corresponding to 36 unique genetic loci and 27 distinct traits (Fig. 5, A and B, 
Table S15). For 24/36 (67%) female- and 10/22 (45%) male-stratified cis-eQTL-trait pairs, 
evidence for colocalization was also found using the male and female combined GTEx v8 cis-
eQTLs (Fig. S10A). For these 34 loci that colocalized in the sex-combined approach, we provide 
evidence that the colocalization signal is driven by regulatory effects in a single sex. The remaining 
12/36 (33%) female and 12/22 (55%) male gene-trait colocalizations were not discovered with the 
sex-combined approach.  
The strongest colocalizations between a trait and a female-stratified cis-eQTL were identified for 
CCDC88C and breast cancer, and for HKDC1 and birth weight (Fig. 5C). Conversely, the strongest 
colocalizations between a trait and a male-stratified cis-eQTL were identified for DPYSL4 and 
percentage of body fat, and for CLDN7 and birth weight (Fig. 5D). CCDC88C is a negative 
regulator of the Wnt signalling pathway, a key mechanism in cancer progression (49) and the 
CCDC88C female cis-eQTL signal in breast colocalizes with risk of breast cancer (Fig. 5C, left), 
a trait with highly sex-differentiated incidence and presentation (50). For breast cancer, we 
identified two additional female-driven (PP4F > PP4M) colocalized sb-eGenes, NTN4 and CRLF3 
(Table S15), previously reported as breast cancer-relevant genes (51, 52).  
We also discovered a preferential colocalization of blood and immune traits with female-stratified 
compared to male-stratified cis-eQTLs (odds ratio = 2.22, Fisher's exact test P = 0.047). This 
includes inflammatory bowel diseases, which show a higher prevalence in females with increasing 
age (53), and immune cell abundances in blood, which also exhibit sex differences (30, 31). 
Together, these results suggest that sex-biased genetic regulation of gene expression may 
contribute to the etiology of diseases with marked sex differences.  
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Moreover, we identified colocalization signal for eQTLs and GWAS of sex-specific traits and 
signal possibly derived from sex-specific conditions, e.g., pregnancy in females and balding 
patterns in males. The C9orf66 male-stratified cis-eQTL signal in breast colocalized with balding 
patterns in males, and the HKDC1 female-stratified cis-eQTL signal in liver colocalized with birth 
weight, which is strongly influenced by maternal factors (Fig. 5C, right) (54). The sb-eQTL for 
this locus in liver was replicated in an independent dataset (55) (rs35696875-HKDC1 PF = 2.73e-
08, PM = 1.60e-04, z-test P = 0.004, Fig. S10B). HKDC1 encodes a member of the hexokinase 
protein family and is involved in glucose metabolism. Multiple variants in perfect or high linkage 
disequilibrium with rs35696875 that cause reduced expression of HKDC1 have been associated 
with gestational diabetes mellitus risk (56) and glycemic traits during pregnancy (54). Here, we 
confirm that the HKDC1 female eQTL signal in the liver colocalizes with maternal glucose levels 
in plasma during pregnancy (PP4=0.92, Fig. S10C). Recently, regulatory variants spanning 
multiple enhancers were found to have a coordinated allelic effect on HKDC1 expression in 
hepatocyte-derived cells (57). Estimates of hepatocyte abundance in GTEx liver samples did not 
differ by sex (P = 0.30) and the rs35696875-HKDC1 sb-eQTL showed no evidence of being a 
hepatocyte ieQTL (PG×Hepatocytes = 0.11) (29). Thus, unlike many sb-eQTLs in breast, the HKDC1 
sb-eQTL in liver did not seem to be driven by sex-differentiated cell-type abundances. The 
HKDC1 sb-eQTL alternative allele is associated with lower HKDC1 expression, higher maternal 
glucose levels and increased birth weight. These results suggest that the HKDC1 female cis-eQTL 
influences glucose metabolism in the pregnant female, which is reflected in the birth weight of the 
offspring. Further investigation is needed, however, to prove causality. 
Additionally, the DPYSL4 male-stratified cis-eQTL signal in skeletal muscle colocalized with 
genetic signal associated with percentage of body fat (Fig. 5D, right). DPYSL4 is linked to the 
pathophysiology of obesity and cancer: p53-inducible DPYSL4 associates with mitochondrial 
supercomplexes and regulates energy metabolism in adipocytes and cancer cells. Low DPYSL4 
expression is associated with poor survival of breast cancer patients (58). Of note, while the 
colocalizing signal was detected with the male-stratified cis-eQTL signal, the low probability of 
colocalization appears to be due to the presence of an additional cis-eQTL in females that is absent 
in males. These results suggest that characterizing sex differences in the genetic associations of 
complex traits and molecular phenotypes can prove useful to dissect allelic heterogeneity.  
For five colocalized sb-eGenes (CLDN7, CCDC125, FAM53B, PLEC, SOWAHC), corresponding 
cell-type interaction cis-eQTL (cell-type ieQTL) signals also colocalized with reported GWAS 
signals (birth weight, blood cell counts, height, platelet counts and schizophrenia, respectively) 
(29). For instance, the male-biased cis-eQTL rs34958987-CLDN7 in breast (Fig. 5D, left; Fig. 
S10D) was identified as an epithelial cell ieQTL in breast (29). Both the sb-eQTL and cell-type 
ieQTL signals colocalize with the birth weight GWAS signal (Fig. S10E). This suggests that the 
origin of these sex differences in gene-trait associations may be in sex-differentiated cell-type 
abundances. 
Finally, to assess whether sex-biased eQTL signals are reflected in sex-biased GWAS effects we 
obtained sex-stratified GWAS data for 36 of the 58 colocalized gene-trait pairs ((9), Table S15). 
We identified two out of 36 loci with sex differences in GWAS effect size (FDR ≤ 0.05, Bonferroni 
correction). These two signals correspond to RNASET2 and CELSR2 genes, more strongly 
associated to hyperthyroidism in females and to heart attack in males, respectively. However, with 
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the current GWAS sample sizes, we observed that, in general, sex-biased effects at the eQTL level 
do not readily translate into sex-biased effects at the GWAS level, in line with recent power 
calculations where millions of GWAS samples are estimated to be needed to address this question 
(37).    
Overall, our colocalization results identified loci where sex-differentiated cell-type abundances 
mediate genotype-phenotype associations, and also loci where sex may play a more direct role in 
the underlying molecular mechanism of the association, as in the HKDC1 locus. For future studies, 
accounting for context or environment (sex, in the present study) in colocalization approaches is a 
promising approach to discover gene-trait associations and their underlying origins. 
Discussion 
Here we performed an extensive characterization of sex-biased gene expression and sex 
differences in the genetic regulation of gene expression in cis across 44 human tissue sources and 
characterized sex differences in tissue cell-type composition for seven cell types.  
We identified widespread sex-biased gene expression in all tissues, with 37% of genes exhibiting 
sex bias in at least one tissue, but with overall small (median FC=1.04) sex effects. These results 
derive from overlapping male and female distributions of interindividual expression variation, 
indicative of differential expression as opposed to completely dimorphic expression. These genes 
represent diverse molecular and biological functions, and include genes relevant to disease and 
clinical phenotypes. As expected, the strongest sex bias was observed for X-chromosome genes, 
while the vast majority of sex-biased genes were autosomal, suggesting the influence of sex on 
genome-wide regulatory programs. As reported in (59) but not well characterized to date, we 
discovered that a portion of these genes were non-randomly distributed across the genome, 
suggesting sex differences in regional regulation. Integration of these results with sex-aware 
analysis of epigenetic and Hi-C data may provide mechanistic insights into these patterns. 
Although we identified a set of X-linked genes with sex-biased expression across many tissues, 
the overall tissue-sharing of sex-biased expression was strongly skewed toward tissue-specificity, 
with 18.2% of sex-biased genes discovered in only a single tissue. The high tissue-specificity of 
sex-biased gene expression and the enrichment of TFBSs in sex-biased gene promoters implicates 
specific TFs in mediating sex-biased expression. Functional experiments to assess sex-
differentiated TF binding are needed to evaluate the role of TF function in observed patterns. 
In contrast to the large impact of sex on gene expression levels, the overall extent of sex effects on 
genetic regulation in cis is much less (369 sb-eQTLs). This observation is consistent with an 
overall weaker role of sex on genetic regulation, but is also impacted by differences in power of 
the two analyses (60). For sb-eQTLs, the combination of small genotype-by-sex interaction effect 
sizes, high interindividual expression heterogeneity, and the sex imbalance in the GTEx collection 
affect the power of the interaction test. This implies that, to fully characterize this phenomenon, 
much larger cohorts are needed, particularly to assess sex effects for all cis-variants and genes. 
The relatively modest number of G×Sex interactions for a factor as impactful as sex suggests that 
other, more subtle genotype-interacting environmental factors are likely to be challenging to 
identify (as noted in (39)). The sb-eQTL analysis is also impacted by cell-type heterogeneity within 
tissues. We demonstrate that a portion of sb-eQTLs are mediated by cell-type composition, 
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suggesting that a portion of the sb-eQTL signal may derive from the combination of cell-type-
specific eQTLs and sex differences in the tissue’s cell-type composition. The remaining loci for 
which we had no evidence of cell-type mediation may represent true sex differences in genetic 
regulation of these genes, but might also derive from unknown factors confounded with sex, 
including cell types that were not part of our analysis. Thus, the full impact of cell-type differences 
across tissues remains to be determined. The identification of sb-eQTLs that are, unequivocally 
not derived from sex differences in cell-type abundances cannot be assessed with analysis of sb-
eQTLs in bulk tissue.  We anticipate that single cell sb-eQTL analysis will help disentangle sex 
effects on the genetics of gene expression that derive from sex differences in tissue composition 
versus those that derive from sex chromosome status. However, this approach also has limitations 
due to the removal of cells from the in situ tissue environment, including, for example, the presence 
of other cell types and diverse hormonal environments.  
To understand the molecular basis of sex differences in disease and other phenotypes, it is 
important to note that the connection between the molecular changes observed here and complex 
phenotypes is likely to be complicated by many compensatory and buffering effects (61). Despite 
extensive sex differences at the transcriptome level, we highlight that the majority of biology at all 
phenotype levels is shared between males and females. Furthermore, the sex differences observed 
here are based on a snapshot of mostly older individuals. Sex differences that occur during different 
developmental stages, in specific environments, or in specific disease states are not well 
represented in our analysis. For example, sex biases are observed in many cancers (1). Our results 
provide a resource of sex effects in ‘non-diseased’ tissues to compare with those of disease cohorts. 
We note that sex is highly correlated with many features of behavior and external environments, 
e.g. smoking (62), and disentangling sex differences driven by inherent biology versus gendered 
environments is an important further challenge.  
Beyond gene expression, sex-biased genetic regulation may also contribute to higher order 
phenotypes such as complex traits and diseases; colocalization analysis of sex-stratified cis-eQTLs 
and sex-combined GWAS summary statistics yielded variant-gene-trait associations that were not 
detected in combined-sex cis-eQTL colocalization analysis. In general, context-aware 
colocalization analyses may help to elucidate the origin of gene-trait associations, as hypothesized 
here for HKDC1’s impact on birth weight through alteration of glucose metabolism in a pregnant 
female’s liver. We show that sex-biased gene-trait associations are likely either due to allelic 
heterogeneity in the combined-sex cohort or genetic effects on gene expression that are 
(predominantly) driven by a single sex; colocalized sb-eGenes cannot be considered as proxies of 
loci harbouring sex differences in the genetic architecture of the linked trait. Since sex-aware 
colocalizations can provide insights into the sex-differentiated genetic architecture of disease, we 
expect future work in this area combining sex-stratified cis-eQTLs with summary statistics from 
sex-stratified GWAS to fully comprehend the impact of sex on human health and disease. 
Extension of analytical approaches to facilitate widespread genetic analysis of sex chromosomes 
is an important step to enable these new research directions.  
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Materials and Methods summary 
Sex-differential expression was performed with voom-limma (63) and MASH (64) (Fig. S1A). Sex-
differential effect sizes and gene expression levels were investigated for tissue specificity with the 
Tau index (65), clustered with pvclust (66) and compared with dendextend (67) (Fig. S3A). Sex 
predictivity of sex-biased genes per tissue was quantified through gradient boosted tree classifier 
models (68) (Fig. S4A). Positional gene enrichment analysis of sex-biased genes was performed 
with PGE (18) (Fig. S5A). Transcription factor binding site enrichment in promoter regions of 
sex-biased genes was performed with Unibind (22) and runLOLA (69) (Fig. S5E). Gene set 
enrichment analysis was performed with fgsea (70) (Fig. S6A) and results characterized with 
Cytoscape (71). Sex differences in cell type abundances and their effect on histopathological 
phenotypes were explored using linear regression. sb-eQTL mapping was implemented using an 
adaptation of FastQTL (72) (Fig. S8A); sb-eQTLs validated using haplotype-level allelic 
expression data generated with phASER and allele-specific expression modeling using EAGLE. 
Characterization of sex-specific cis-eQTL effects was performed with linear regression. Mediation 
of G×Sex by G×Epithelial interactions was tested with mediation R package. Colocalization of 
GWAS and eQTLs was performed with coloc (48). Further details for each analysis are provided 
in (9). 
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Fig. 1. Sample, data types and discovery sets in the study of sex differences in GTEx v8. 
Illustration of the tissue types (including 11 distinct brain regions and 2 cell lines), with sample 
numbers from GTEx v8 genotyped donors in parentheses (females:males) and color coding 
indicated in the adjacent circles. N=44 tissue sources present in both sexes with ≥70 samples were 
included in this study. Tissue sources comprise two cell lines, 40 tissues and two additional 
replicates for brain cerebellum and cortex tissues. Tissue name abbreviations are shown in bold. 
The specific number of donors used in each analysis is stated in the corresponding Supplementary 
Methods section (9). 
 
Fig. 2. Sex-differential gene expression. (A) Number of sex-differentially expressed genes (sex-
biased genes) per tissue. See Fig. 1 for the legend of tissue colors. (B) Sex-biased gene discovery 
(histogram, number of sex-biased genes) and characteristics of sex-biased genes (stacked bar plots) 
as a function of tissue-sharing. The characteristics are: Chr. for the proportion of X-linked and 
autosomal sex-biased genes, Sign for the proportion of female-biased (F) and male-biased (M) 
genes. (C) Hierarchical clustering of tissues based on gene expression (left) and the effect size of 
sex-biased genes (right). See (9) for further details. 
 
Fig. 3. Regulatory mechanisms and biological functions of sex-biased genes. (A) Genomic 
position enrichment of sex-biased genes; based on male-biased (blue), and female-biased (red) 
genes across all chromosomes (left) and chromosome X (right). The y-axis represents the tissue-
sharing of the significant genomic enrichment signal and ranges from 1 to 44 (number of tissue 
sources). See (9) for further details. (B) Transcription Factor Binding Site (TFBS) enrichment in 
promoter regions of sex-biased genes. Out of 92 enriched TFBS profiles, the top 40 with the largest 
difference across all tissues in the enrichment profile derived from male-biased and female-biased 
genes are displayed. Values represent the TFBS enrichment ranking transformed to [0, 1] per tissue 
and per sex; a value of 1 corresponds to the highest enrichment. See (9) for further details. (C) 
Clusters (grey circles) of gene sets enriched for genes highly expressed (blue and red balloons) in 
females (red) or males (blue) across tissues. Balloon size corresponds to the p-value for the across-
tissue meta-analysis of GSEA. Faint lines connecting balloons correspond to shared leading edge 
genes between gene sets. See (9) for further details. 
 
Fig. 4. Sex-biased eQTLs (sb-eQTLs). (A) Number of sb-eQTLs discovered per tissue. Square-
root transformation was applied to the x-axis. See Fig. 1 for tissue abbreviations. (B) Association 
p-values of the female- (top) and male-stratified (bottom) cis-eQTLs in the ADRA1A locus in 
adipose subcutaneous tissue (top panels, βF = -0.78, PF = 4.64e-18, βM = -0.47, PM = 3.98e-10, 
PG×Sex = 1.05e-05) and C4BPB locus in breast mammary tissue (lower panels, βF = 0.40, PF = 2.68e-
07, βM = -0.02, PM = 8.90e-01, PG×Sex = 7.22e-05). Linkage disequilibrium between loci is 
quantified by squared Pearson coefficient of correlation (r2). Diamond-shaped point represents the 
top significant eQTL variant across sex-stratified p-values. (C) sb-eQTL mediation analysis of 261 
breast sb-eQTLs. Point coordinates represent the effect size of the terms G×Sex (x-axis) and 
G×Epithelial cells (y-axis) derived from a linear regression model with both interaction terms. 
Grey lines represent confidence intervals of the effect sizes of G×Sex (horizontal lines) and 
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G×Epithelial cells (vertical lines) terms. Point size represents sb-eQTL significance and color 
corresponds to mediation significance. See (9) for further details. 
Fig. 5. Colocalization of sex-biased eQTLs (sb-eQTLs) with GWAS traits (A) Posterior 
probability (PP4) of 74 colocalized gene-trait pairs where a GWAS shows evidence of 
colocalization with the female- and/or the male-stratified cis-eQTL signal (PP4 > 0.5).  Legend: 
in parentheses, number of colocalizing loci per tissue. (B) Number of colocalizing loci for female 
and male cis-eQTLs. (C) GWAS-eQTL colocalizing genes (PP4 > 0.5) color-labeled by eQTL 
tissue of origin according to labels in Fig. 5A (x-axis), are categorized by the sex where the 
colocalization signal is maximized with the corresponding GWAS trait (y-axis). Comparing the 
colocalization PP4 values for male and female cis-eQTL signal, the estimates can be maximum in 
females (red) or males (blue). (D) Genotype-phenotype association p-values of the CCDC88C (left 
panel) and HKDC1 (right panel) loci. For the CCDC88C locus, panels illustrate GWAS signal for 
breast cancer (top) and CCDC88C cis-eQTL signal for females (middle) and males (bottom) in 
breast mammary tissue. For the HKDC1 locus, panels illustrate GWAS signal for birth weight 
(top) and HKDC1 cis-eQTL signal for females (middle) and males (bottom) in liver. (E) Genotype-
phenotype association p-values of the CLDN7 (left panel) and DPYSL4 (right panel) loci. For the 
CLDN7 locus, panels illustrate GWAS signal for birth weight (top) and CLDN7 cis-eQTL signal 
for females (middle) and males (bottom) in breast mammary tissue. For the DPYSL4 locus, panels 
illustrate GWAS signal for body fat (top) and DPYSL4 cis-eQTL signal for females (middle) and 
males (bottom) in muscle skeletal tissue. In (D) and (E), linkage disequilibrium between loci is 
quantified by squared Pearson coefficient of correlation (r2). Diamond-shaped point represents the 
top significant cis-eQTL variant across sex-stratified p-values. 
 
Note: 
GTEx Consortium author information has been omitted for brevity. See the published version 
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In Section 1.1.4 we discussed the importance of characterizing gene expression at
the cell type level. However, there is yet another critical component when trying
to understand the underlying mechanisms of biological systems: spatial information.
The physical location of cells plays a role in gene expression, for example, in the case
of tumours where the cells constituting it can differ with respect to the histological
patterns of the tissue, and these changes been shown to correlate with alterations at
the molecular level [167]. This also means that characterizing spatial patterns can
lead to the identification of cell type markers, allowing to refine existing descriptions of
the molecular organization of organs and tissues, such as the one proposed in Chapter
4. Several technologies have been developed to disentangle the spatial organization
of molecular features, and can be divided into five categories, which we briefly enlist
and summarize (based on the descriptions in [168]):
1. microdissected gene expression (laser capture microdissection, NICHE-Seq, Prox-
imID): gene expression profiles are obtained from small isolated regions of a
sample, presenting challenges to understand spatial organization across a com-
plete tissue but also allowing to analyze isoform presence.
2. in situ hybridization technologies (smFISH, seqFISH, MERFISH): RNA molecules
are visualized directly in the environment through labeled probe hybridization,
allowing to detect a large set of transcripts but suffering from spectral overlap.
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3. in situ sequencing technologies (ISS with padlock probes, BaristaSeq, STARmap,
FISSEQ): sequencing is directly performed on the RNA of a cell within the tis-
sue, using DNA balls to amplify the signal allowing to resolve the subcellular
location of the transcript but with limits for transcript discrimination.
4. in situ capturing technologies (spatial transcriptomics/10x Visium, Slide-Seq,
APEX-Seq, microfluidic barcoding): transcripts are captured in situ but se-
quenced ex situ, allowing unbiased analyses of the whole transcriptome, but
subject to RNA capture inefficiencies. The spatial transcriptomics technique
was first introduced by Ståhl et al. [169], where they performed RNA-seq man-
taining 2D-positional information in the tissue through arrayed reverse tran-
scription primers with unique positional barcodes, over mouse brain and human
breast cancer tissues. See Fig. 6-1 for an example.
5. in silico reconstruction of spatial data: computational approaches used to assign
a spatial location to dissociated single cells based on their expression profiles,
either using a reference map (gene signatures) or de novo, through assumptions
of how the gene expression will vary across the tissue and modeled through
optimization problems that seek to preserve distances both with respect to
gene expression feature space but also with respect to the spatial organization.
Spatial localization of gene expression has already proven useful in the context
of disease: for example, Maniatis et al. [170] have examined mouse spinal cords and
postmortem human tissue affected by amyotrophic lateral sclerosis (ALS), using the
spatial transcriptomics technique to spatiotemporally characterize gene expression,
identifying shared transcriptional pathways perturbated in the context of ALS in




0.0 2.5 5.0 7.5
Ttr
Figure 6-1: Visium (10x Genomics) spatial transcriptomics. Sagital mouse
brain slice generated with Visium v1 chemistry. The left plot shows the total number
of molecular counts, while the right plot shows the normalized expression for Ttr, a
marker of the choroid plexus. Data obtained from [171], with figures reproduced as
described in the Seurat R package vignette [172].
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6.1 A framework for in-silico spatial transcriptomics
In this chapter, we aim to design and implement a framework to spatially resolve
gene expression, similarly to the spatial transcriptomics protocols described before,
but in an in-silico (data driven) manner, with matched sample pairs of histological
images and molecular traits such as bulk RNA-seq gene expression. In other words,
the goal is to implicitly verify if it is possible to associate patterns of gene expression
variation with histological patterns encoded in the WSIs of the corresponding tissue
samples, at a level of resolution that is reasonable enough to identify subregions of
tissues that are known to be associated with specific patterns of gene expression. To
this end, we will use the GTEx data resource since it is currently one of the largest














Figure 6-2: In-silico spatial transcriptomics pipeline. In the preprocessing steps,
the WSIs corresponding to samples from many tissues will be divided into square tiles.
The second step consists in mapping the pixel representation of a tile into a feature
vector of reduced dimensionality that encodes the relevant histological features of
the tile. The third step is the association of the matrix of tile features (or their
summarization) with molecular traits.
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Although here we do not have experimental data of spatially-resolved gene expres-
sion, our working hypothesis is that if the gene expression patterns (even if at a bulk
level) are consistent with variation in histological primitives, it might be possible to
pinpoint the expression of specific genes (at least, those with known tissue specificity
and relatively high levels of expression) in the WSIs. Without considering specific
implementation details for now, such a framework might consist of at least the fol-
lowing three general steps, as illustrated in Fig. 6-2. The first one corresponds to
the preprocessing of the WSIs. We have introduced in Section 1.1.6 the generalities
of how WSIs are constituted and how their large size poses constraints in deciding
how any computation over them will be performed, since, at least in a GPU-based
computational model, due to hardware limitations it is currently not possible to fit
many WSIs entirely in memory (since memory allocation occurs not only for data
but also for model parameters).
In the second step, we aim to learn a function 𝜑(·) that maps a tile P ∈ R𝑛×𝑝×3
(where 𝑛 and 𝑝 correspond to the tile width and height across three color channels,
and in practice, with 𝑛 = 𝑝) into a compressed representation in the form of feature
vector 𝑥 ∈ R𝑞 that would ideally capture the histological patterns encoded in the
image tile.
Lastly, in the third step we use these compressed representations to characterize
associations with molecular traits (such as gene expression). This last step poses
several questions, such as, for example, determining a way to aggregate tile represen-
tations from a single sample into a summarization at the WSI-level, or how to choose
an initial set of genes to validate the framework. The specific details for these steps
will be discussed in the next sections, together with a discussion of the computational
experiments performed so far, since this is still a work in progress.
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6.2 Image preprocessing
Before delving into the problem of linking gene expression variation with patterns in
histological images, a practical consideration needs to be addressed: the preprocessing
of the WSIs. Since these are large in terms of size (pixels, and also in storage space),
for most types of histological image analysis techniques it is unfeasible to process
them at once as a single unit. Thus, it is common procedure in the histological image
analysis literature to break down the image into square tiles and perform the relevant
modeling at that level. Since this also holds true for the particular methodology to
attempt in-silico spatial transcriptomics, this section will describe considerations in
the problem of extracting tiles from histological images. The process of extracting tiles
from a WSI is not standardized and researchers often need to develop custom software
to perform this task whenever building a model. In the problem we explore in this
chapter, we do not need to consider background tiles. Discarding these is desirable
since background tiles do not add anything to the model: associations between gene
expression and the background should not exist, and even if we included them when
training a model and it correctly learned to recognize that these tiles do not contribute
anything, we would still be incurring in unnecessary computational overhead.
6.2.1 Tile extraction generalities
To this end, as an initial experiment, we propose to frame tile extraction as a classi-
fication problem at the tile level: we aim to keep foreground tiles (positive class) and
discard the background tiles (negative class). First, we define a whole slide image I
and a patch P as:
P𝑖𝑗 ∈ R𝑛×𝑝×3; 𝑖 ∈ {1, . . . , 𝑎}, 𝑗 ∈ {1, . . . , 𝑏} (6.1)
I =
⎡⎢⎢⎢⎢⎢⎢⎢⎢⎣
P11 P12 . . . P1𝑏
P21 P22 . . . P2𝑏
... ... . . . ...




where 𝑎 refers to the number of tiles in the height axis, 𝑏 to the number of tiles in
the width axis, and 𝑛 and 𝑝 to the number of pixels in the respective axes across the
three color channels.
To generate a response vector y with the ground truth labels for tiles, we sort
the tiles by increasing file size, and keep the top 𝑘 and bottom 𝑘 tiles, assigning
them positive and negative labels, respectively. The rationale behind this is that at
the top and bottom of the ranking, tiles are likely to have large amounts of tissue
content while the ones at the bottom will be mostly empty, as illustrated in Fig. 6-3.
This works since more complex images need to encode more information and are thus
larger in file size (at least when using compressed image file formats).
y = [0            0           0         ...          1           1           1] 
Bottom  k         Top  k 
Figure 6-3: Tile label assignment. Examples of tiles sorted by their increasing file
size. The top and bottom 𝑘 tiles are chosen to be part of the dataset, assigning them
positive and negative labels, respectively.
We generate a feature matrix X to use in a classifier model by vectorizing each
patch into a row vector and stacking them into a matrix, in such a way that X = I→
R(𝑎×𝑏)×(𝑛×𝑝×3). Then, PCA can be performed over X to obtain principal components
T out of which a limited number can be used as a final set of features. Note that this
process has to be performed independently for tiles assigned into training, testing and
validation sets in order to avoid data leakage. Then, any machine learning algorithm,
for example a random forest, can be used to predict a response vector ŷ for these tiles
indicating if they should be kept or not.
Although this approach is quite naive and works reasonably well for many different
types of tissue, it has two main drawbacks: i) as discussed in Section 2.1.1 the spatial
relationships are lost, and ii) it can prove troublesome to use for slides where the
background could easily be mistaken for part of the tissue, such as for example,
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adipose tissue (see Fig. C-10). Thus, modeling tile extraction as a classification
problem would require careful labeling of the training data for the tiles, as well as
using a more sophisticated approach (for example, a neural network) to perform
feature extraction from the tiles in order to classify them.
To propose a more robust and lightweight solution for the tile extraction problem,
and to provide flexibility in the way that image tiles can be generated, we developed a
software solution: PyHIST: A Histological Image Segmentation Tool, which is covered
in the article that follows.
Summary of my key contributions
• A command-line based Python tool to extract custom-sized square tiles from
WSIs in SVS/TIFF/NDPI/VMS formats. The native resolution of the WSI can
be used to perform the extraction, but resizing operations to other resolutions
(in powers of 2) are also supported.
• Mask generation for the tissue foreground: to identify tissue slices in the WSI
to retrieve the tiles, a mask for the WSI is generated to discriminate the back-
ground from the foreground. Three methods are available to generate the mask:
graph-based segmentation, adaptive thresholding, and Otsu thresholding. Tiles
are then extracted from the foreground.
• Segmentation overview: The tool generates an overview image to quickly iden-
tify how the tiling grid appears when overlaid on top of the WSI, as well as
indicators of which tiles were selected as foreground.
• Random tile sampling: For those applications that do not need to distinguish
foreground from background, the tool also provides the possibility to sample
tiles from random starting positions in the WSI.
• Containerization: All the dependencies to run the tool are bundled in a Docker
image to provide cross-platform support (Windows/macOS/Linux).
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• An use-case demonstrating the applicability of the tool: we create a classifier
model using transfer learning with a ResNet-152 convolutional neural network
to identify the tissue of origin for 7163 tiles extracted from WSIs of six cancer-
affected tissues from The Cancer Genome Atlas (glioblastoma in brain, infil-
trating duct carcinoma in breast, adenocarcinoma in colon, clear cell carcinoma
in kidney, hepatocellular carcinoma in liver, and malignant melanoma in skin).
We demonstrate that the generated feature vectors for the tiles recapitulate tis-
sue morphology by observing the presence of six tissue clusters. This use case
is documented in three reproducible Jupyter notebooks.
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Abstract
The development of increasingly sophisticated methods to acquire high-resolution images
has led to the generation of large collections of biomedical imaging data, including images of
tissues and organs. Many of the current machine learning methods that aim to extract bio-
logical knowledge from histopathological images require several data preprocessing stages,
creating an overhead before the proper analysis. Here we present PyHIST (https://github.
com/manuel-munoz-aguirre/PyHIST), an easy-to-use, open source whole slide histological
image tissue segmentation and preprocessing command-line tool aimed at tile generation
for machine learning applications. From a given input image, the PyHIST pipeline i) option-
ally rescales the image to a different resolution, ii) produces a mask for the input image
which separates the background from the tissue, and iii) generates individual image tiles
with tissue content.
Author summary
Histopathology images are an essential tool to assess and quantify tissue composition and
its relationship to disease. The digitization of slides and the decreasing costs of computa-
tion and data storage have fueled the development of new computational methods, espe-
cially in the field of machine learning. These methods seek to make use of the
histopathological patterns encoded in these slides with the aim of aiding clinicians in
healthcare decision-making, as well as researchers in tissue biology. However, in order to
prepare digital slides for usage in machine learning applications, researchers usually need
to develop custom scripts from scratch in order to reshape the image data in a way that is
suitable to train a model, slowing down the development process. With PyHIST, we pro-
vide a toolbox for researchers that work in the intersection of machine learning, biology
and histology to effortlessly preprocess whole slide images into image tiles in a standard-
ized manner for usage in external applications.
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Introduction
In histopathology, Whole Slide Images (WSI) are high-resolution images of tissue sections
obtained by scanning conventional glass slides [1]. Currently, these glass slides of fixed tissue
samples are the preferred method in pathology laboratories around the world to make clinical
diagnoses [2], notably in cancer [3]. However, the increasing automation of WSI acquisition
has led to the development of computational methods to process the images with the goal of
helping clinicians and pathologists in diagnosis and disease classification [4]. As an increasing
number of larger WSI datasets became available, methods have been developed for a wide
array of tasks, such as the classification of breast cancer metastases, Gleason scoring for pros-
tate cancer, tumor segmentation, nuclei detection and segmentation, bladder cancer diagnosis,
mutated gene prediction, among others [5–10]. Besides of being important diagnostic tools,
histopathological images capture endophenotypes (of organs and tissues) that, when correlated
with molecular and cellular data on the one hand, and higher-order phenotypic traits on the
other, can provide crucial information on the biological pathways that mediate between the
sequence of the genome and the biological traits of the organisms (including diseases) [11].
Because of the complexity of the information typically contained in WSIs, Machine Learn-
ing (ML) methods that can infer, without prior assumptions, the relevant features that they
encode are becoming the preferred analytical tools [12]. These features may be clinically rele-
vant but challenging to spot even for expert pathologists, and thus, ML methods can prove
valuable in healthcare decision-making [13].
In most ML tasks, data preprocessing remains a fundamental step. Indeed, in the domain of
histological images, there are several issues when preprocessing the data before an analysis:
due to the large dimensions of WSIs, many deep learning applications have to break them
down into smaller-sized square pieces called tiles [14]. Furthermore, a significant fraction of
the area in a WSI is often uninformative background that is not meaningful for the majority of
downstream analyses. To circumvent this, some applications apply a series of image transfor-
mations to identify the foreground from the background (see, for example, [15]), and perform
relevant operations only over regions with tissue content. However, this process is not stan-
dardized, and customized scripts have to be frequently developed to deal with data preparation
stages (see, for example [10,15]). This is cumbersome and may introduce dataset specific-
biases, which can prevent integration across multiple datasets.
Currently available tools for WSI processing focus mostly on the analysis of human-inter-
pretable features by means of nuclei segmentation, object quantification and region-of-interest
annotation [16–18]; but WSI preparation into tiles for external ML applications has not yet
been directly addressed. To systematize the WSI preprocessing procedure for these applica-
tions, and in order to streamline the data preparation stage at the initial phase of a ML project
by avoiding the need of creating custom image preprocessing scripts, we developed PyHIST, a
command-line based pipeline to segment the regions of a histological image into tiles with rel-
evant tissue content (foreground) with little user intervention. PyHIST was developed to pro-
cess Aperio SVS/TIFF WSIs due to this format being supported by large slide databases such
as The Cancer Genome Atlas (TCGA) which has approximately 31,000 WSIs [19] and The
Genotype-Tissue Expression Project (GTEx) with approximately 25,000 WSIs [20]. PyHIST
currently has experimental support for other image formats (see S1 Text).
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Design and implementation
PyHIST is a command-line Python tool based on OpenSlide [21], a library to read high-resolu-
tion histological images in a memory-efficient way. PyHIST’s input is a WSI encoded in SVS
format (Fig 1A), and the main output is a series of image tiles retrieved from regions with tis-
sue content (Fig 1E).
The PyHIST pipeline involves three main steps: 1) produce a mask for the input WSI that
differentiates the tissue from the background, 2) create a grid of tiles on top of the mask, evalu-
ate each tile to see if it meets the minimum content threshold to be considered as foreground
and 3) extract the selected tiles from the input WSI at the requested resolution. By default,
PyHIST uses a graph-based segmentation method to produce the mask. In this method, first,
tissue edges inside the WSI are identified using a Canny edge detector (Fig 1B), generating an
alternative version of the image with diminished noise and an enhanced distinction between
the background and the tissue foreground. Second, these edges are processed by a graph-based
segmentation algorithm [22], which is used here to identify tissue content. In short, this step
evaluates the boundaries between different regions of an image as defined by the edges;
Fig 1. PyHIST pipeline. (a) The input to the pipeline is a Whole Slide Image (WSI). Within PyHIST, the user can decide to scale down the
image to perform the segmentation and tile extraction at lower resolutions. The WSI shown is of a skin tissue sample (GTEX-1117F-0126) from
the Genotype-Tissue Expression (GTEx) project [20]. (b) An alternative version of the input image is generated, where the tissue edges are
highlighted using a Canny edge detector. A graph segmentation algorithm is employed over this image in order to generate the mask shown in
(c). PyHIST extracts tiles of specific dimensions from the masked regions, and provides an overview image to inspect the output of the
segmentation and masking procedure, as shown in (d), where the red lines indicate the grid generated by tiling the image at user-specified tile
dimensions, while the blue crosses indicate the selected tiles meeting a certain user-specified threshold of tissue content with respect to the total
area of the tile. In (e), examples of selected tiles are shown.
https://doi.org/10.1371/journal.pcbi.1008349.g001
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different parts of the image are represented as connected components of a graph, and the
"within" and "in-between" variations of neighboring components are assessed in order to
decide if the examined image regions should be merged or not into a single component. From
this, a mask is obtained in which the background and the different tissue slices are separated
and marked as distinct objects using different colors (Fig 1C). Finally, the mask is divided into
a tile grid with a user-specified tile size. These tiles are then assessed to see if they meet a mini-
mum foreground (tissue) threshold with respect to the total area of the tile, in which case they
are kept, and otherwise are discarded. Optionally, the user can also decide to save all the tiles
in the image.
Of note, tile generation can be performed at the native resolution of the WSI, but downsam-
pling factors can also be specified to generate tiles at lower resolutions. Additionally, edge
detection and mask generation can also be performed on downsampled versions of WSIs—
reducing segmentation runtimes (S1 Fig, S1 Text). A segmentation overview image is gener-
ated at the end of the segmentation procedure for the user to visually inspect the selected tiles
(Fig 1D). With the set of parameters available in PyHIST (S2 Text), the user can specify regions
to ignore when performing the masking and segmentation (S2 Fig), and have a fine-grained
control over specific use-cases.
By default, PyHIST uses the graph-based segmentation method described previously due to
its robustness in detecting tissue foreground in WSIs that do not have a homogeneous compo-
sition. However, alternative tile-generation methods based on thresholding that tend to work
well on heterogeneous WSIs are also implemented (S3–S5 Figs, see S1 Text for details and
benchmarking information). PyHIST also has a random tile sampling mode for those applica-
tions that do not necessarily need to distinguish the background from the foreground. In this
mode, tiles at a user-specified size and resolution will be extracted from random starting posi-
tions in the WSI.
Results
To demonstrate how PyHIST can be used to preprocess WSIs for usage in a ML application,
we generated a use case example with the goal of building a classifier at the tile-level that allows
us to determine the cancer-affected tissue of origin based on the histological patterns encoded
in these tiles. To this end, we first retrieved a total of 36 publicly available WSIs, six from each
of the following human tissues hosted in The Cancer Genome Atlas (TCGA) [23]: Brain (glio-
blastoma), Breast (infiltrating ductal carcinoma), Colon (adenocarcinoma), Kidney (clear cell
carcinoma), Liver (hepatocellular carcinoma), and Skin (malignant melanoma). Slides within
each tissue have the same cancer primary diagnosis as established by TCGA. Second, these
WSIs were preprocessed with PyHIST, generating a total of 7163 tiles with dimensions
512x512. These tiles were then partitioned into training and test sets (constraining all the tiles
of a given WSI to be in only one of the two sets), and we then fit a deep learning convolutional
neural network model over these tiles with weighted sampling at training time (S6 Fig), achiev-
ing a classification accuracy of 95% (Fig 2A, S1 Table, S2 Table, see S3 Text for data prepara-
tion and model details, and a detailed assessment of Fig 2A).
We also inspected the feature vectors generated by the deep learning model: for each tile,
we retrieved the features corresponding to the linear layer of the last (fully connected) sequen-
tial container of the model, and performed dimensionality reduction (t-SNE) over the stacked
matrix of these vectors. From here, we infer that the learned features recapitulate tissue mor-
phology since tile clusters corresponding to each tissue are formed (Fig 2B, S7 Fig). We note
that this classifier is only an exercise to show end-users how to quickly prepare WSI data using
PyHIST to generate tiles, reducing the overhead to start performing downstream analyses:
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further tuning of the model with more data is desirable to ensure that the classifier is robust
enough to generalize to different types of unseen WSIs for a real application.
Availability and future directions
The example use case described above is documented and fully available at https://pyhist.
readthedocs.io/en/latest/testcase/, and divided into three Jupyter notebooks: 1) Data prepro-
cessing with PyHIST, 2) Constructing a deep learning tissue classifier, and 3) Dimensionality
reduction. The TCGA WSIs in the use case were downloaded from the Genomic Data Com-
mons (GDC) repository (https://gdc.cancer.gov/) using the GDC Data-transfer tool (https://
gdc.cancer.gov/access-data/gdc-data-transfer-tool).
PyHIST is a generic tool to segment histological images automatically: it allows for easy and
rapid WSI cleaning and preprocessing with minimal effort to generate image tiles geared
towards usage in ML analyses. The tool is available at https://github.com/manuel-munoz-
aguirre/PyHIST and released under a GPL license. Updated documentation and a tutorial can
be found at https://pyhist.readthedocs.io/. PyHIST is highly customizable, enabling the user to
tune the segmentation process in order to suit the needs of any particular application that
relies on histological image tiles. The software and all of its dependencies have been packaged
in a Docker image, ensuring portability across different systems. PyHIST can also be used
locally within a regular computing environment with minimal requirements. Future directions
and improvements include adding support for more histological image formats and features to
save tiles into specialized data structures, as well as the inclusion of a graphical user interface
to ease the learning curve for users who are new to the field of image processing for ML analy-
ses. Finally, PyHIST is open source software: all the code and reproducible notebooks for the
example use case are available in GitHub and will continue to be improved based on user
feedback.
Supporting information
S1 Text. PyHIST overview. General description of the pipeline: supported file formats, tile
generation methods, and execution times.
(PDF)
S2 Text. Parameter description. Description of supported arguments in PyHIST.
(PDF)
S3 Text. TCGA tissue classification use case. Description of data preprocessing, model train-
ing and analysis for the TCGA tissue classification use case.
(PDF)
S1 Fig. WSI scaling steps in PyHIST. (a) WSI at its original resolution (1x). (b) The mask can
be generated and processed at a given downsampling factor. A smaller resolution will lead to a
faster segmentation. (c) The output can be requested at a given downsampling factor. (d) The
segmentation overview image can also be generated at a given downsampling factor. The
dimensions in all steps are matched to ensure that the tile sizes and grid are consistent. The
Fig 2. TCGA use case. (a) Examples of the top 5 most accurately predicted tiles per cancer-affected tissue (rows) from the
TCGA use case test set. The label above each tile shows the predicted cancer-affected tissue type (GB: glioblastoma, DC:
infiltrating ductal carcinoma, AC: adenocarcinoma, CC: clear cell carcinoma, HC: hepatocellular carcinoma, MM:
malignant melanoma), followed by the probability of the ground truth label. All of these tiles were correctly classified. (b)
Dimensionality reduction of TCGA tiles. t-SNE performed with the feature vectors of each tile that were derived from the
deep learning classifier model. Each dot corresponds to an image tile.
https://doi.org/10.1371/journal.pcbi.1008349.g002
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downsampling choices for all the steps are independent of each other.
(PNG)
S2 Fig. Image in graph-based segmentation test mode. Test mode allows the user to see how
the image mask will be with the chosen segmentation parameters and tile dimension configu-
ration, before proceeding to generate the individual tile files. The black border defines the
region of exclusion for tissue content placed within the edges of the slide (see—borders and—
corners arguments, and section 2.2 in S2 Text).
(PNG)
S3 Fig. Comparison of mask generation methods. (a) Adipose tissue WSI from the GTEx
project, from sample GTEX-111CU-1826. Thresholding-based masks (b-d) are generated by
first converting (a) into grayscale and then applying the corresponding thresholding method.
Note that simple thresholding is shown here for completeness but only Otsu and adaptive are
implemented in PyHIST due to their overall better performance when compared to simple
thresholding. In the graph-based method, an image with highlighted edges is first generated
through a Canny edge detector (e, left) and then the connected components are labeled
through graph-based segmentation (e, right).
(PNG)
S4 Fig. Runtime benchmarks for random sampling and graph-based segmentation. (a) Exe-
cution time to perform random sampling (y-axis) of a varying number of tiles (x-axis) at differ-
ent downsampling factors for the WSI shown in S1 Fig. For each combination of number of
tiles and downsampling factor, the sampling was repeated 30 times. Each dot represents the
average running time across the 30 runs, while the interval shows the range between the maxi-
mal and minimal running time. (b) Execution time to perform random sampling of 1000 tiles
(y-axis) at different tile dimensions (x-axis) at different downsampling factors for the same WSI
in (a). Each combination was repeated 50 times, with each dot showing the average runtime. (c)
Segmentation runtime of 50 Stomach WSIs from the GTEx project, at different downsampling
factors, at a tile size of 256x256. Each dot represents the average execution time. Each interval
shows the range between the fastest and slowest segmentations, while the labels show the
dimensions of the corresponding WSIs. (d) Segmentation runtime (y-axis) at 1x resolution for
the 50 Stomach WSIs, with respect to the number of pixels in the WSI (x-axis).
(PNG)
S5 Fig. Runtime comparison of mask-generating methods. Tile extraction was evaluated for
the three different methods at four different settings of tile size. Each method + tile size combi-
nation was repeated ten times to show runtime variability.
(PNG)
S6 Fig. Tile distribution per class in a training epoch in the TCGA example use case.
Within each training epoch, weighted random sampling is performed to create batches with a
fair distribution of tiles among the classes. Even if the sample sizes in the training dataset are
different among the classes, the balance in the number of tiles per epoch is obtained through
data augmentation.
(PNG)
S7 Fig. Correlation matrix of TCGA tiles based on their feature vectors. Heatmap of Pear-
son’s correlation matrix between the feature vectors obtained for each TCGA tile. Rows and
columns are reordered with hierarchical agglomerative clustering.
(PNG)
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S1 Table. Tile distribution across classes in the TCGA use case training and test sets.
(PNG)
S2 Table. Confusion matrix for the tiles in the test set of the TCGA use case.
(PNG)
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6.2.2 Tile extraction for spatial transcriptomics
To perform the experiments, we will start from a set of 23,952 WSIs from 36 different
tissues that were considered acceptable for further use from the pathology review
(see Fig. C-9 for the size distribution of all 25,446 available WSIs). As we first want
to validate the feasibility of the idea of linking gene expression variation with image
patterns, we will attempt to demonstrate the computational model with downsampled
versions of the WSIs by a factor of 4x. The microns per pixel are consistent across
all slide scans, therefore the obtained resolutions are comparable when performing a
scaling by the same factor.
Since the histological composition of each tissue is different, this means that the
tile extraction pipeline needs to be configured to extract the tiles in a way that allows
for difference foreground-background tolerances across tissues. For example, in the
case of stomach and skin, we might be interested in preserving the edges of the tissue
segments since they contain valuable information: in stomach (Fig. 6-4a), the edges
can help determine the specific type of tissue that was captured when obtaining
the sample which could be either from mucosal origin (lamina propria mucosae) or
composed by layers of smooth muscle fibers (lamina muscularis mucosae). In the case
of skin (Fig. 6-4b), the outermost layer of the epidermis (i.e. the edges of the tissue
sample) which is known as stratum corneum is recognized as playing a fundamental
role in the maintenance of healthy skin, and abnormalities in this layer have been
associated with disease states [173].
Although in these cases the segmentation is relatively straightforward as the tissue
is solid and strongly distinguished from the background, we also encounter tissues
where this does not happen, such as in the case of adipose samples (Fig. 6-4c)
where it is more difficult to perform the background-foreground discrimination. With
PyHIST, we can tune parameters in the segmentation pipeline to account for these
different types of cases: through a combination of image smoothing with gaussian
kernels and different tolerance values for merging connected components, we are able
to segment all the tissue types available in GTEx. In Fig. 6-4d an example of a
175
segmented testis sample is shown, with selected tiles marked with a blue cross. All
the selected tiles are saved individually to disk. The tiles are extracted with a size of
224 × 224 pixels, since this is the standard input shape for many CNN models that
perform image classification.
a b c 
d 
Figure 6-4: Tile extraction. (a) Subregion of a stomach sample, with the outermost
layer corresponding to mucous membrane. (b) Subregion of a skin sample, with the
stratum corneum layer aligned towards the center. (c) Full view of an adipose tissue
sample. Panels a-c are shown at different scales only for visualization purposes. (d)
Segmentation output of a testis sample.
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6.3 Feature learning
Once the tiles have been extracted, the next step is compressing them into a lower-
dimensional representation in order to be able to link them to molecular traits. His-
torically, the task of extracting features that describe an image was performed through
methods such as template matching, Fourier descriptors, Gabor features, among oth-
ers [174]. As discussed in Section 2.3, deep learning advances, specifically those based
on convolutional operations, allow learning complex characteristics of the input im-
ages, and are now generally favored over classical approaches for feature extraction,
at least for tasks that require the usage of these features for other downstream goals,
such as image classification.
6.3.1 Conceptualizations
The compressed representation can be obtained through several means. One of them
is through the use of convolutional autoencoders, which is an unsupervised technique
with a neural network consisting of two main parts: an encoder, which transforms
the input image into a lower-dimensional representation, and a decoder, which maps
this representation back into the shape of the input image, with the loss function
quantifying the difference between the input image and its reconstruction. The main
difference between a traditional autoencoder and a convolutional autoencoder is that
the latter takes into account the spatial structure of the image when computing the
feature maps, while a standard autoencoder does not.
Another way to generate vectors of features is by employing pretrained CNNs as
fixed feature extractors. Implementations of many network architectures for classifica-
tion problems exist in deep learning frameworks such as PyTorch [175] or Tensorflow
[176], with pretrained weights generated by training each of these models over large
collections of images of general, non-domain-specific objects such as the Imagenet
database [177]. For a given architecture, when performing the forward pass for an
image, we retrieve the generated activations, usually at the last fully connected layer
of the network, discarding the softmax and classification part. Note that when using
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a model as a fixed feature extractor, the weights of the model are frozen, meaning
that no training is performed and the existing (pretrained) weights of the model are
used to perform inference. The size of the extracted feature vector will depend on
the model architecture, as well as the position in the network from which we decide
to retrieve these features.
Lastly, the features can also be extracted through transfer learning and finetun-
ing an existing network. We expose the underlying concept briefly using the for-
malization introduced in [178]: consider a data domain 𝒟 with feature space 𝒳
and marginal probability density function 𝑃 (𝑋) such that 𝒟 = {𝒳 , 𝑃 (𝑋)}, with
𝑋 = {𝑥1, . . . , 𝑥𝑛} ∈ 𝒳 . A task 𝒯 on this domain could be to learn a predic-
tive function 𝑓 that assigns an instance label 𝑦𝑖 ∈ 𝒴 on the basis of the feature
vector 𝑥𝑖, so that 𝒯 = {𝒴 , 𝑓(·)}. With these definitions, we consider a source do-
main 𝒟𝑠 = {(𝑥𝑆1 , 𝑦𝑆1), . . . , (𝑥𝑆𝑛 , 𝑦𝑆𝑛)}, 𝑥𝑆𝑖 ∈ 𝒳𝑆, 𝑦𝑆𝑖 ∈ 𝒴𝑆 of tuples of data in-
stances and their labels. We define the target domain in the same way, as: 𝒟𝑇 =
{(𝑥𝑇1 , 𝑦𝑇1), . . . , (𝑥𝑇𝑛 , 𝑦𝑇𝑛)}, 𝑥𝑇𝑖 ∈ 𝒳𝑇 , 𝑦𝑇𝑖 ∈ 𝒴𝑇 , with the corresponding source and
target tasks being 𝒯𝑆 and 𝒯𝑇 . Finally, transfer learning consists in improving 𝑓𝑇 by
reusing information from 𝒟𝑠 and 𝒯𝑠, despite that 𝒟𝑠 ̸= 𝒟𝑇 and 𝒯𝑆 ̸= 𝒯𝑇 .
In our problem, 𝒟𝑆 can refer, for example, to the ImageNet dataset with 𝒴𝑆 having
a large number of classes, while in our problem, the target domain 𝒟𝑇 is specific to
histological image tiles, with 𝒴𝑇 being the label set of human tissues. In deep neural
networks, transfer learning is achieved by initializing a model with weights pretrained
on 𝐷𝑆 and it is trained for some epochs over 𝒟𝑇 (as opposed to feature extraction
were no additional training is performed). It has been shown that transfer learning
helps in achieving good performances when the set of available data 𝑋𝑇 ∈ 𝒳𝑇 is not
large enough to train a complete architecture from scratch [179].
6.3.2 Model training
Here, we will use the last idea to construct the compressed representations for the
WSI tiles by framing the feature extraction through a classification problem, as we
would like to have these representations to be as different as possible from each other
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whenever that makes sense with respect to the shared morphological traits among
tissues. To train our classifier models, we sample 50 WSIs from each of the 36 tissues
(independently of the WSI having associated RNA-seq data or not) and break them
down into tiles using PyHIST, generating a total of 1,075,411 tiles. For each tissue,
we partition them into training, validation and testing splits of roughly 70%, 15%
and 15%, amounting to 35, 8 and 7 WSIs. Since the classification will be performed
at the tile level, all the tiles from a WSI are assigned the WSI-level label. Note that
this is not optimal for the task of classification at the tile level, since some tissues
might have shared histological components (such as for example, mammary tissue
and adipose tissue), and other frameworks exist such as Multiple Instance Learning
which can be used in the context of classification to generate a WSI-level label by
using bags of tiles and weighting them according to their associations with the class.
However, here we are mostly interested in the model as means for feature extraction
rather than obtaining the most accurate classification performance at the tile level.
When training the model, we perform data augmentation, which refers to a set of
transformations applied over the data both to enhance the size of the dataset as well
as to improve model generalization (by reducing the chance of overfitting). Such a set
of transformations can encompass operations such as color space modifications, im-
age mixing, random erasing, among others [180]. When the transformation is applied
over an image, the resulting augmented version of the image is assigned the label of
the original image. For training our models, we use the following sequence of trans-
formations (with the probability of each transform ocurring indicated in parenthesis):
horizontal flip (𝑝 = 0.5) → vertical flip (𝑝 = 0.5) → shift/scale/rotate (𝑝 = 0.25) →
random brightness/contrast (𝑝 = 0.2) → normalize (𝑝 = 1). We observe that a tile
has relatively low probability (𝑝 = 0.15) of passing unchanged through the sequence
of transformations. The exact sequence of transforms applied to each image will vary
across training epochs, decreasing the chance of overfitting (since it is not as likely
that the exact same version of the image is seen many times). In Fig. 6-5 examples
of input tiles are shown on the columns indicated by the label “Original”, while the
column right to these shows the augmented version of the tiles.
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Original Augmented Original Augmented
Figure 6-5: Data augmentation. Examples of input tiles with their augmented
versions, using the sequence of transforms described previously but excluding nor-
malization.
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Note that at the end of the chain of transforms, a normalization step is applied: for
an input image tensor X ∈ Z𝑁×𝐻×𝑊 with 𝑁 channels, we will first elementwise divide
it by 255 to normalize it to a [0, 1] range, and then, given a vector of channelwise pixel
means 𝜇 = [𝜇1, 𝜇2, . . . , 𝜇𝑁 ] and standard deviations 𝜎 = [𝜎1, 𝜎2, . . . , 𝜎𝑁 ], each channel
𝑖 is elementwise-normalized as X′𝑖,∙,∙ = (X𝑖,∙,∙ − 𝜇𝑖)/𝜎𝑖. The specific values used are
𝜇 = [0.485, 0.456, 0.406] and 𝜎 = [0.229, 0.224, 0.225] since these values correspond
to the means and standard deviations of the source task (ImageNet) [181].
Five architectures are independently fit in order to verify that the model per-
formance metrics are robust enough for the same training-validation-testing split:
ResNet-18, ResNet-50, ResNet-101 [182], VGG-11 with batch normalization [183],
and Densenet-121 [184]. Training is performed in a distributed manner (with the
parallelization container DistributedDataParallel, see [185] and the PyTorch doc-
umentation for details) using the NVIDIA Collective Communication Library (NCCL)
across at most 10 GeForce RTX 2080 Ti GPUs. Mini-batch sizes used for the
above architectures are 96, 96, 64, 48, and 48, respectively. In a distributed set-
ting, several copies of the training process (at least as many as GPUs that are going
to be used) are spawned and initialized under the same conditions, except for the
DistributedDataLoader object which is specific to each rank (process) and which
is used to handle how the tiles are split into mutually exclusive batches of the corre-
sponding size and assigned evenly across GPUs until the data is exhausted. Note that
image augmentation is performed on the fly for each batch (as was mentioned earlier,
since this increases the chances that different epochs might see different augmented
versions of the same input image). An independent copy of the model and the op-
timizer is held by each GPU which will process the tile batches assigned to it, then
the gradients are synchronized (all-reduced average, which means that no explicit pa-
rameter broadcasting is necessary) across GPUs while performing the backward pass,
so that the model state will be equal in all GPUs before starting the next training
epoch.
For each model, the training is performed in two stages: in the first stage, all the
pretrained weights of the model backbone are frozen, while the head is replaced by a
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linear (fully-connected) layer with of the appropriate size to map the previous layer
to an output vector corresponding to the 36 tissue classes. Cross-entropy loss is then
used to evaluate the model output with respect to the true labels for each tile: for
example, for a mini-batch of size 𝑀 , the model output tensor is of shape (𝑀, 36) with
each row corresponding to the raw scores for each class for a tile; if we define a row
vector as x and the corresponding true class index 𝑐 ∈ [0, 35], then the loss for a tile
in the mini-batch can be computed as:






The loss is computed for all the tiles in the mini-batch and then reduced to a single
scalar by averaging, which is used to compute the backward pass. The first stage of
training is performed only for a few epochs, since we want to update the gradients
for the new fully connected layer put in place. In the second stage of training, we
unfreeze all the parameters of the model and resume training normally for a larger
number of epochs. Early discussions about layer freezing were presented in [179],
which has led to variations in the way that models can be trained when performing
transfer learning such as the two-stage process used here, for which some libraries (for
example, see [186]) have developed convenience functions. In all of the experiments
performed here, optimization is performed with the Adam, a stochastic objective
function optimization algorithm based on first-order gradients [187].
At the beginning of each stage, we try to estimate a reasonable starting learning
rate for the optimizer by creating a dummy copy of the model and optimizer, defining
a lower and upper bound for the learning rate and an exponentially-spaced grid of
learning rate trial points between these two boundaries (a variation of the work first
described in [188]). A small subset of the data is then evaluated using the learning
rates in this grid. For example, in Fig. 6-6, in the range of small learning rates
(10−6 − 10−3) we see that the loss is stable, meaning that it is difficult for the model
to perform any learning; from 10−3 − 10−2 the loss starts decreasing quickly, while
towards the end of the curve the loss explodes due to the learning rate being too large
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which means that the gradient updates might also be very large and thus likely to
lead to divergence. The point marked in red shows an example of a good candidate
for a starting learning rate (here, chosen as the steepest gradient).
Figure 6-6: Learning rate tuning. Learning rate finding for the first training stage
of ResNet-50.
In each training epoch, we assess the losses for the training and validation sets
(see Fig. C-11a). In general, after 20 epochs, the train loss stops decreasing, with
the validation loss following the same trend, but with a gap in the loss between
both curves (this will be described later). Model accuracy for the five architectures
at the tile level over the test set, which is completely independent of the training-
validation process, is similar (77.41%, 78.01%, 76.81%, 77.69%, 78.51%, respectively
for the architectures mentioned previously), indicating that there is a stable zone
of accuracy which is limited by the nature of the data. From now on, we focus on
describing the results of ResNet-50, since it provides a good tradeoff between model
complexity (in terms of number of parameters) and performance.
In Fig. 6-7, we show the row-normalized multi-class confusion matrix, with squares
in the diagonal being the tissue classification accuracies and off-diagonal squares being
misclassified pairs, with numerical values shown only for combinations > 0.1. Tissues
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Figure 6-7: Multi-class confusion matrix at the tile level. Row-normalized
confusion matrix derived by assessing the tile predictions in the test set.
that are homogeneus and unique with respect to their histological features tend to
be classified correctly, for example, testis, thyroid gland, brain cerebellum, etc. (see
Fig. C-11b for precision, recall and f1-scores), while tissues that fail are those that
have shared histological traits, for example, adipose tissue and mammary tissue.
The classification failure for these tissues is due to the fact that the slide label
is assigned to all tiles (and thus the term “true label” should be interpreted with
care), while these tissues tend to have at least a bivariate composition: for example,
mammary tissue also contains a significant amount of adipocytes. The same is true
for tissues from the digestive tract, that, despite having specific properties in each
tissue, their walls tend to share a basic structure composed by four tunics: mucosa,
184
Figure 6-8: Label-probability visualization for a testis WSI. The probability
with which the true label (testis) was predicted is shown numerically and with a
discretized color scale. Tiles in red were predicted incorrectly, while the rest of the
tiles are predicted correctly. Squares without a value were considered as background
by PyHIST and thus not evaluated by the model.
submucosa, muscularis, and serosa [189]. To demonstrate this, we visualize the pre-
diction probabilities for the slide label for each tile by overlaying the values over the
tiled WSI, like in Fig. 6-8 where a WSI for a testis sample is shown and on the top
of Fig. 6-9 where a liver sample is shown. Both of these tissues have an overall high
prediction accuracy at the tile level across samples since their histological features
also tend to be tissue-specific, and the tile prediction failures tend to be concentrated
towards the edges of the tissue, for which some of these tiles tend to have a large
amount of background content.
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Figure 6-9: Label-probability visualization for liver and adipose WSIs. WSIs
for liver (top) and adipose tissue (bottom). The probability with which the true label
was predicted is shown numerically and with a discretized color scale. Tiles in red
were predicted incorrectly, while the rest of the tiles are predicted correctly. Squares
without a value were considered as background by PyHIST and thus not evaluated
by the model.
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Prediction failures, such as some of the tiles in the adipose sample shown at the
bottom of Fig. 6-9 tend to occur in heteregenous tissues, as described previously. In
the case of this sample, the “incorrectly” classified tiles are connective tissue and not
adipose, highlighting the caveat of assigning the WSI-label slide to all tiles. This is
also reflected on the gap of the loss functions in training and validation sets described
before, as learning cannot be performed successfully for these types of tiles. Never-
theless, here we emphasize that the main interest of building the classifier model is to
use it as a feature generator rather than producing the most accurate model. Label
predictions at the slide level are verified by assigning the most frequently predicted
class across the tiles of each WSI. At the WSI level, accuracy is higher (see Fig. C-12
and C-13 for metrics at the slide level), with most tissues having an accuracy close
to 100%, observing that the tissues that tend to fail are also those which fail at the
tile level, as expected.
To verify that the activations obtained from the last fully connected layer of the
model are as specific to each tissue as possible, we evaluate all the test set tiles
(forward pass) and stack their activation vectors into a matrix which is then used
to perform dimensionality reduction at tile level. In Fig. 6-10, we observe that
tissue identity is preserved with respect to these activations, with tissues with shared
histological traits being in the same neighborhood: for example, the two skin types
(exposed to sun and not exposed to sun, on the two shades of blue with the inverted ‘U’
shape) are neighboring, with an interconnecting segment with the types of tiles that
tend to be shared between both tissue types. Tissues from the digestive tract as well
as those with adipose content (in the center, with shades of brown and orange) tend
to have more similarities, and thus also have a less defined identity when compared
with tissues that are morphologically very distinct, such as brain (in yellow) or testis
(in grey).
In order to verify that the distribution of the learned features is relatively con-
sistent across tiles, for each WSI, we average all the learned features across all tiles,
reducing the WSI representation to a single vector of features. We then perform
clustering over the correlation matrix obtained from all sample comparisons based
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Figure 6-10: UMAP of tile activations in the test set. UMAP generated over
the stacked matrix of the output vectors from the fully connected layer in the model,
for all the tiles in the test set. Each dot represents a tile, color coded by the GTEx
tissue convention (see Table B.1).
on their averaged features in order to verify that the WSIs are grouped by tissue
identity, as shown in Fig. 6-11. Tissues that had a high prediction accuracy have
high sample correlations (in the diagonal), while tissues that have shared features
have a correlation substructure as shown in the block in the lower right corner of
the figure, exhibiting higher correlations also with samples of other tissues. We now
have the feature vectors needed to start performing the association analyses with gene
expression. Possible improvements on model training are discussed in Chapter 7.
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Figure 6-11: Correlation heatmap of mean activations. Pearson’s correlation
is computed between all pairs of samples (across the averaged features at the WSI
level), and this matrix is then hierarchically clustered.
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6.4 Linking image features with molecular traits
In this section, we briefly describe the current progress on performing the association
of gene expression with the learned features. Existing work in the literature has
mostly focused on examining multimodal relationships on the basis of correlation,
as discussed earlier in Section 2.3.2, and in the case of gene expression, pinpointing
specific tiles whose histological features might be related to the expression of that
specific gene. Here, we instead aim to spatially deconvolute bulk RNA-seq gene
expression and visualize it over the complete WSI. We begin by exploring the idea of
how to attribute features in the predicted feature vectors to specific parts of the input
image, with the assumption that tiles are summarized with an aggregating function
at the WSI level, in such a way that there are one-to-one relationships between WSI
feature vectors and bulk RNA-Seq gene expression vectors for a given sample. The
need to do this arises because if we identify (gene, image feature) association pairs,
we would like to see which parts of the image are associated with that gene, and as
such, it is necessary to disentangle what the specific image feature is identifying in
the input image.
Although it is not straightforward to interpret a neural network model when com-
pared to classical stastical and machine learning models, algorithms based either on
gradients and perturbations have been recently developed to aid in model prediction
debugging and interpretability (see for example, [190] which is a compendium of inter-
pretability methods, and used to perform the experiments described here). In general,
these methods seek to attribute the output of the model to the input features: if we
consider a classifier model 𝜑 : x → [0, 1] with an input x = [𝑥1, 𝑥2, . . . , 𝑥𝑛] ∈ R𝑛, an
attribution is then a comparison of the input vector x with respect to a baseline input
x′, 𝐴𝜑(x, x′) = [𝑎1, 𝑎2, . . . , 𝑎𝑛], with each component 𝑎𝑖 definining the contribution of
𝑥𝑖 to 𝜑(x). The baseline input should be set so that the prediction is neutral and can
be domain specific, for example, a tensor filled with zeros, in the case of an image.
Here, we focus on the specific case of attributions computed through integrated gra-
dients [191], which refers to the cumulation of the gradients along all the points in the
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straightline path from x′ to x. The integrated gradient for the 𝑖-th component in the
input, and with 𝜕𝜑(x)
𝜕𝑥𝑖
being the gradient of the model output along that component,
is defined as:
IG𝑖(x) = (𝑥𝑖 − 𝑥′𝑖)
∫︁ 1
𝛼=0
𝜕𝜑(x′ + 𝛼(x− x′))
𝜕𝑥𝑖
𝑑𝛼 (6.4)
with 𝛼 being a scaling coefficient. In practice, this can be approximated through a











Note that here, integrated gradients are computed for each component in the input
with respect to the model output, but we are interested in examining the output of
a specific neuron, and thus, it suffices to compute the integral of the gradients with
respect to the neuron of interest (which, in our case, should be ideally correlated with
the expression of a given gene) instead of the model output.
For a given WSI, we generate the attributions for each tile for one of the neurons
with highest layer conductance [192] (which can be interpreted as a way to measure
neuron importance with respect to other neurons) in the fully connected layer. The
tile attributions are computed through neuron integrated gradients for each channel,
obtaining a tensor with the same shape of the input data (i.e. 224× 224× 3) for each
tile, indicating the relevance of each pixel for that neuron. Then, all the attribution
tiles are stitched together and overlaid over the WSI. In this way, for a given neuron,
we can visualize what parts of the image are relevant for a given neuron (feature),
establishing a basis to spatially resolve gene expression, at least for those (gene,
image feature) pairs that are highly correlated. In Fig. 6-12 we show an example
of tile attribution computation for all the tiles of the same testis WSI displayed in
the previous section, observing that the chosen neuron is mostly capturing the gaps
between seminiferous tubules.
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Figure 6-12: Neuron attributions in a testis sample. The attributions (shown
here in purple) for a specific neuron are computed for all tiles through neuron inte-
grated gradients.
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In this attribution example, we see that the image feature captured by the neuron
is spatially consistent, despite that the tile attribution evaluations are independent.
At the time of writing, we are examining the neuron visualizations in order to de-
termine if they have enough resolution and specificity to serve as a proxy for gene
expression visualization. As mentioned earlier, this is an approach based on the as-
sumption that correlation is a good measure to capture associations between image
features and expression. As an alternative conceptualization of the spatial deconvo-
lution of gene expression problem, we also propose to treat it under the framework
of prediction: it has been shown in the literature that attention mechanisms can be
useful to derive the contribution of each tile in classification problems in the context
of Multiple Instance Learning (MIL) [193]. In fact, derivatives of the MIL classifier
framework incorporating attention mechanisms have already been shown to be of use
to determine WSI regions that are useful for class discrimination [194]. We are work-
ing towards extending the MIL framework with attention mechanisms to the setting
of regression, in order to predict vectors of gene expression from bags of tiles, while
examining the specific contribution of each tile to the prediction.
It is worth mentioning that the spatial expression of several sets of genes has
already been determined experimentally in the literature, and in our own work (in
Chapter 4) we have described sets of genes linked to the muscularis and mucosa
layers in stomach tissue. Through these resources, we plan to validate the results of
the computational in-silico spatial transcriptomics pipeline.
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7.1 Distilling high-dimensional spaces to examine
human phenotypes
With the rapid advances in sequencing technologies from the perspectives of speed,
cost and resolution, it has been possible to generate large troves of biological data.
Coupled with statistical learning tools, we are able to generate insights about human
biology, especially with respect to molecular traits and their relationship with vari-
ation in human phenotypes. In this thesis, we examined transcriptome-phenotype
relationships with a bottom-up approach through four case studies, linking high-
dimensional biological components at different orders of complexity: from RNA, to
cell types and finishing with histological texts and images.
In the first case study, presented in Chapter 3, we investigated transcriptional
changes in bulk RNA-seq samples as a function of post mortem interval (PMI), and
showed that these changes are tissue-specific, with variation in how these are exhibited
across time and with most tissues having shifts in gene expression a few hours after
death. Our observation has been acknowledged in posterior literature in the context
of single cell data, for example, when discussing concerns in sample handling and
the possible impact on clustering analyses [195], as well as when characterizing tissue
stability after preservation [196] and even when designing guidelines for the logistics
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of autopsy programs [197].
We discussed how PMI-related changes could confound gene expression analyses,
highlighting the importance of taking into account PMI as a covariate. This consider-
ation can also be extended for studying related data types, for example, RNA-protein
correlations [198]. Post-mortem transcriptional changes can have consequences up to
the level of assessing drug targets, as discussed in a study where the authors hypoth-
esize about possible effects of variability in gene expression on the effectiveness and
safety profiles of drug targets [199].
Based on PMI-dependent gene expression variability, we developed computational
models to estimate PMI for a given individual and propose a concept of a protocol
that could be used in an hypothetical forensic scenario. Our study focused on demon-
strating how tissues could potentially carry the footprint of the time since death. We
also hypothesized on whether the cause of death could have an effect on the tran-
scriptome, but acknowledge that we cannot carry out exhaustive analyses on this
due to sample size limitations. Subsequent work in the literature has evaluated the
effect of the cause of death through spectroscopy in animal models, finding different
sensitivities to the cause of death across organs and discussing how these might affect
PMI estimation [200], although with a sample size that is still not enough to draw a
solid conclusion, and how this generalizes to humans is still unknown.
We emphasize that there are several areas of improvement that need to be ad-
dressed in order to fully determine the viability of the PMI prediction protocol for a
real application. The cohort we used to study post-mortem changes in expression has
a limited PMI timeframe, and thus, we do not have a clear picture of these effects
after longer times since death across all tissues, which also means that we cannot
make inferences about the reliability of the gene expression-based PMI predictions
beyond the range that we studied. Nevertheless, our work has already served as a
building block and point of comparison for further literature seeking to improve the
reliability of PMI prediction, either through other data types such as metabolomics
[201] and composition of microbial communities [202] as well as for studies examining
the thanatotranscriptome through samples with longer PMI in specific tissues [203].
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In the second case study, presented in Chapter 4, we analyzed primary cells
from the ENCODE project together with GTEx data to describe how cells in the
human body cluster together in five major cell types based on their transcriptional
profiles: endothelial, epithelial, mesenchymal, blood and neural. These types have a
close but not exact correspondence to the histological types traditionally defined in
the literature to classify organs and tissues. We also analyzed single cell RNA-seq
gene expression from 20 mouse organs and tissues and found that most cells and cell
types cluster into these five major cell types, providing a degree of evidence on how
these transcriptional programs might generalize to mammalian organisms. Further
examination of the transcriptional landscape of other organisms is necessary to con-
firm this hypothesis, especially with regards on characterizing how often specialized
cell types might fall outside the observed major cell types, since specialized cell types
are likely to have a particular transcriptional signature, as we observe in our work
with melanocytes in human and with hepatocytes in mouse.
Using marker genes corresponding to each major cell type, we estimated cellular
enrichments in normal tissue samples (from GTEx). We found that each tissue has
a specific cell type enrichment signature, which recapitulates gene expression-based
tissue organization. Due to the way the enrichments are calculated, a limitation
is that they should be interpreted only as a point of comparison between samples
within the same major cell type rather than across cell types, and thus, they cannot
be strictly considered as a composition. Nevertheless, we found that the enrichment
values strongly correlate with estimates derived from using deconvolution methods,
such as constrained least squares or support vector regression-based methods such as
CIBERSORT. We relied on orthogonal validation measures to ensure that the esti-
mated enrichments for the five major cell types were biologically meaningful through
the examination of the GTEx histological data, both from the image and text per-
spectives.
First, through the examination of histological images, we validated the differences
we observed in cell type composition in stomach and transverse colon tissues, in which
the sampling process might capture different regions from either mucosal or smooth
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muscle origin. We roughly quantified the tissue composition with respect to these
two layers in stomach tissue and trained a support vector machine over stomach im-
age features to discriminate the presence of these layers, and applied the model over
colon tissue, observing that samples are separated almost identically when compared
to the separation based on major cell type enrichment scores. This highlights the
importance of considering cell type composition when analyzing gene expression, as
in some situations it might act as an undesirable confounding variable. Second, we
parsed the pathology review comments associated to each sample using a combina-
tion of part-of-speech tagging, rule creation and fuzzy string search in order to derive
a set of histological phenotype keywords, generating a resource for the community
to study the intermediate nature of histological phenotypes with respect to molec-
ular and other traits. Through these annotations, we found that deviations in cell
type enrichments are associated with pathological states. The annotations we de-
rived from the free-text pathology comments have already been used in the literature
to examine the predictive power of a few machine learning models for phenotypic
variation based on the integration of histological images and genomics [204]. In that
study, the authors also mention how these histological phenotypes are associated with
gene expression variability, for example, in the case of atherosclerosis in tibial artery,
in agreement with our observations about differences in cell type enrichments with
respect the same phenotype and tissue. They also observe predictive power for phe-
notype status when using histological images as input of the models, which is likely to
underlie changes in gene expression, supporting the in-silico spatial transcriptomics
hypothesis described in Chapter 6 and discussed in the next section. With this work,
we have hopefully provided an example of how data integration across different modal-
ities can help to understand the relationship between the human transcriptome and
phenotypes through intermediate examinations, here, referring to cell type compo-
sition and histology. With the rapid generation of single cell data resources, such
as the Human Cell Atlas [205], we will soon learn more about the taxonomy of not
only global transcriptional programs, but also about the hierarchical organization of
specialized cell types and how this relates to gene expression spatialization in tissues.
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In the third case study, presented in Chapter 5, we generated a compendium
of sex-differentiated effects in gene expression and its genetic regulation. We per-
formed a sex-differential gene expression analysis controlling for the effects of known
covariates, including surrogate variables which we showed to be correlated to tissue
cell-type composition. We derived posterior estimates of the effect sizes using an em-
pirical Bayes meta-analysis approach and found that the effect sizes of sex-differential
expression are small, tissue-specific but ubiquitous across tissues. This observation
has already been replicated in an independent study which repurposed the GTEx
dataset to explore sex-differential expression in COVID-19 related genes [206].
We found that effect sizes were stronger in X-linked genes as expected. In re-
lation to this, we built gradient boosted tree classifier models in order to predict
sex from autosomal and X-linked genes. The latter had high sensitivity and speci-
ficity for the prediction in all tissues (as expected, since their effect sizes are also
larger in the differential expression analysis), while this was not the case for auto-
somal genes, in concordance to the observation that the tissue-wide sex-differential
autosomal expression effects are generally small. We interpreted the models through
Shapley values and found that top predictive autosomal genes are involved in sex-
differentiated traits. In addition, we performed cell type enrichment estimation with
xCell signatures, which are different from the ones used in Chapter 4, and replicated
the findings of histological differences between males and females in breast tissue,
as well as differences between males that had annotated with gynecomastia in the
pathology review commments.
In our study, we find sex-differentially expressed genes represented in several bio-
logical and molecular functions related to disease and clinical phenotypes, reinforcing
the already-known relevance of considering sex as a biological variable when trying
to understand disease mechanisms, especially in cases where these effects might be
tissue-specific. For example, a recent study about androgen regulation and bowel
function has acknowledged our observations about the effects of biological sex on
gene expression [207], and in fact, sex differences in gut-brain axis disorders are well
documented in the literature [208]. On the other hand, there are also situations in
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which it is still unclear how sex differences observed at the clinical level within a
disorder are reflected at the molecular level. For example, another study explored
the effects of sex differences in the brain transcriptome in schizophrenia and found
that these effects were small, with their sex-specific findings showing high replication
rates with our sex-differential expression analyses [209].
Understanding disease signatures, especially with respect to genetic effects, is still
a challenging topic due to the lack of statistical power. This becomes even harder
when considering interaction terms, and this is also a limitation we acknowledge in
our work for the tests performed to discern the effects of sex on genetic regulation,
which we found to be weak. Another point of improvement is the incorporation of
environmental factors that are correlated with sex, such as smoking [210], and for
which we did not have data to examine here. Despite these limitations, we believe
that our study can be a useful resource of sex effects in non-diseased tissues.
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7.2 A data-driven approach to human histology
Advances in storage and computation capabilities have incentivized the adoption of
slide digitization across pathology laboratories around the world, making it easier
for clinicians to share data as well as empowering the development of computer-
aided procedures [211] as the ones mentioned in Section 6.2.1, ranging from disease
classification to quality assurance. Models to analyze whole slides can also be a tool to
resolve conflicts in cases of interobserver disagreement with respect to the evaluation
a specific pathology, which can arise due to differences in detection methods especially
in the case when a categorial evaluation scale is used [212].
On the other hand, through single cell sequencing, it has been possible in the last
years to expand our knowledge about the composition and organization of cell types
across tissues in human and other organisms, but what we can learn about the spatial
context solely from this technology is limited since the information about the cellu-
lar spatial context is lost. To fill the gap, in situ spatial transcriptomics techniques
have been recently developed and applied to spatially resolve gene expression across
a variable number of cells, visualizing it over the histology of the sample in order to
draw inferences. But there still exists data from paired bulk RNA-seq samples with
histological images that could be potentially used to deconvolute the spatial assigna-
tion of gene expression, that, if successful, could prove a valuable and cost-effective
tool to broaden our understanding of the molecular organization of tissues. To this
end, in Chapter 6, we propose to replicate the spatial transcriptomics experimental
protocol in a data-driven way through the use of matched samples of bulk RNA-seq
gene expression and whole slide histological images; in other words, the goal is to
associate variation in gene expression with variation in histological patterns. We dis-
cuss how this might be achieved through a three step procedure that involves i) data
preprocessing, ii) feature extraction and iii) linking variation in image features with
variation in gene expression, and present the results of the computational experiments
performed up to this point.
The first step is covered in Section 6.2.1, where we highlight the lack of a standard-
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ized way to extract tiles from WSIs for machine learning applications, and developed
a software tool to address this: PyHIST, a Histological Image Segmentation Tool. We
demonstrate through an example with slides from the The Cancer Genome Atlas that
PyHIST is able to successfully preprocess the data, which is then used to train a con-
volutional neural network in the context of a classification problem. We recover the
activations of the last fully-connected layer in the model in order to show that these
feature vectors cluster together with respect to morphological tissue traits within the
context of cancer. Next, we described the considerations for applying the tool over
GTEx WSIs in Section 6.2.2. We then presented in Section 6.3 the procedure to
train convolutional neural networks to classify the tissue of origin of a tile, which are
then used as a proxy to extract compressed representations of the image tiles in the
GTEx dataset, similarly to what we showed in the TCGA example, but with a more
controlled training framework to scale up to a larger number of tiles. We show that
classification at the tile level is accurate (as measured by accuracy and f1-score) and
robust for tissues with clear histological patterns such as liver, testis and spleen, but
underperforms in tissues with shared traits, such as those belonging to the digestive
tract. We discuss how this is a limitation within the context of classification since
we assign to all tiles the WSI-level label, but also highlight that we only use the
classifier as means for feature vector generation. Through dimensionality reduction
of tile activations and hierarchical clustering of mean tile activations, we show that
the distribution of image features preserve tissue identity and relatedness whenever
appropriate. Finally, in Section 6.4 we present the result of an early exploration on
how to examine the input image ↔ feature mapping through integrated gradients,
and mention an alternative framework to directly predict gene expression from an
aggregated representation of the image tiles.
We decided to spend a significant amount of time in the first two steps of the
pipeline, since both preprocessing and the generation of feature vectors are critical for
the stability of the third step. There are several points of improvement and additional
questions that we aim to cover in the final version of the study with regards to these.
For example, although we have already demonstrated that the fitted classifier models
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are able to generalize reasonably within the context of the GTEx histological image
dataset through the use of an independent data partition, the final models need to
be cross-validated in order to guarantee their robustness, especially for the remaining
parts of the analysis with respect to gene expression spatialization. Another measure
to be taken is the implementation of early stopping when training the models. The
current classification experiments indicate that tissues with clear histological features
that are mostly non-overlapping with other tissues already have a good classification
performance, suggesting that it might be unnecessary to include further data for those
tissues, while the rest of the tissues may not benefit from larger sample sizes either
due to the limitations of assigning the WSI-label to all tiles, as discussed previously.
However, this does not mean that we cannot further test the generalization of the
model by evaluating a larger set of unseen WSIs.
This also raises the topic of model generalization to other sets of H&E-stained
WSIs: most large WSI databases focus on diseased tissue whereas here we examine
tissues extracted from healthy individuals, but these other slides could still serve as a
control, for example, to see that the spatialized gene expression is within the bound-
aries of the tissue. One consideration for this is that there exists color variation across
datasets generated by different pathology laboratories: albeit the color appearance of
the WSIs is globally quite similar, variations in the stain are not uncommon. Despite
this, recent research has shown that, at least in the case of CNNs, omitting stain
normalization affects model performance only in a very limited way, but suggesting
that color augmentations are actually more useful in terms of model robustness and
generalization [213], and this is a step that can certainly be incorporated in our data
augmentation transformations.
Here, we have chosen a specific resolution that is coarse enough to validate the
outcome of the pipeline with orthogonal measures, but it might be worth comparing
gene expression spatialization performance with respect to the chosen resolution to
perform the analyses, since at each downsampling factor, the amount of global in-
formation captured by each tile is different: at lower resolutions (i.e. global view of
the WSI), we are able to capture structural information that is obviated at higher
203
resolutions and thus likely to lead to better model performance for the tissue classifi-
cation problem, as has already been attempted in the literature [214], at the expense
of being less interesting in the context of gene expression spatialization.
Through the generation of image features we can also explore questions that grav-
itate towards the topic of understanding tissue complexity and organization: how
different is tissue taxonomy when comparing the histological and transcriptomic per-
spectives? Although a traditional histological classification of tissues exists as dis-
cussed on Chapter 4 and redefined in our work through the proxy of gene expression,
using the image features derived in Chapter 6 we could possibly quantify the de-
gree of similarity between the transcriptomic and histological data modalities, for
instance, through the comparison of the hierarchical clustering dendrogram derived
from median tissue transcriptome profiles against the dendrogram built from image
representations at the WSI level.
The analysis of multimodal data, such as the gene expression and histological im-
age pairs examined here, has the potential to open different lines of research in com-
putational biology and biostatistics: recent work has modeled spatial arrangement
of nuclei in a WSI through graph convolutional neural networks for classification of
disease states with high concordance with observations made by pathologists [215].
One can easily see that these WSI-derived graphs, besides being useful to identify dif-
ferences between tissue classes, could serve to validate models of cellular composition
that are computationally inferred through bulk RNA-seq.
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7.3 The road to precision medicine
In this thesis, we have provided examples on how big and heterogeneous data in biol-
ogy can be used in conjunction with statistical learning to derive biological knowledge.
For example, in Chapter 4 we showed how histological images and text annotations
can be used together with gene expression to identify disease states and their changes
at the molecular level, specifically with respect to computational inferences of cellular
enrichments. Multimodal data types, such as gene expression, histological images and
medical reports have potential to generate knowledge that can translate into clinical
practice by personalizing treatment decisions, in other words, precision medicine.
Indeed, in Chapter 5 we have identified sex-differentially expressed genes that are
involved in different biological functions as well as some of them having relevance
for disease and in clinical phenotypes, highlighting the importance of taking sex into
account in the context of studying disease. There is an immediate example of this
in the very relevant (and unfortunate) situation of COVID-19 at the time of writing:
possible mechanistic explanations for the sex biases present in this disease have al-
ready been discussed in the literature (see [216]) with the authors pointing out the
relevance of the differences between males and females at the level of treatment and
care. Our observations about the effects of post-mortem interval on gene expression
have also been referred to within the context of the disease with respect to concerns
about RNA viability when examining FFPE tissue samples through RT-PCR [217].
Studies like these serve as a basis to consider how, in the future, when the neces-
sary technology scales up and becomes more accessible, gene expression and other
molecular traits such as cell type composition (in conjunction with other covariates)
might be analyzed in a personalized way, leading to individualized clinical decisions
and treatments with respect to the features and products of an individual’s genome.
There is an important thought that should not be obviated before closing this
thesis work and it is that of the ethical concerns of using AI and related methods in life
sciences and healthcare applications. Although the possibilities of examining big data
with statistical learning methods are exciting, care must be exerted when developing
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models with clinical goals. Even though we do not derive clinical models in this work,
it should not go unsaid that whenever there is a combination of modelization (through
any statistical method) and biological data, there exists potential for misuse and bias,
either explicitly or implicitly. To deploy a model in a production setting, thorough
testing should be performed to ensure that performance is comparable across different
strata of the population, for example, when considering different combinations of sex,
age and ethnicity, and it is often the case that models in the literature are developed
with constrained cohorts. This also implies that a consistent regulatory framework for
production models needs to be developed (see, for example, the European Commision
discussions about AI [218]), taking into account a wide array of possible legal issues
that may arise. Many ML-based models that are now prevalently used fall under the
category of what is known as a “black box”, certainly helping in the task of prediction
and function estimation to solve scientific questions, but with the inner workings of
the model still being relatively obscure. Interpretability methods, such as the ones
applied in this thesis work, aim to provide more transparency in this regard, but
their power is currently limited especially when considering the ever-growing size of
models in terms of parameters: for example, GPT-3, which is a recently published
autoregressive language model, has around 175 billion parameters [219]. Although its
capabilities to produce human-like language are impressive, the authors acknowledge
that data biases are encoded in the model which can also potentially translate to
biases in decision-making with respect to population strata, thus highlighting the
need to have balanced data cohorts and careful model design, as well as having cross-
disciplinary teams to cover the big picture of the problem at hand.
Statistical learning helps us to understand the nature of the data as long as the
necessary precautions are taken, since the generated results also provide educated
guesses about strengths and weaknesses to account for in future research, because
after all, science is an iterative process.
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7.4 Conclusions
This thesis work has performed an exploration on how to link transcriptomic changes
with human phenotypes at different orders of magnitude, from RNA, to computationally-
inferred cell types and histological images, with four specific contributions:
1. Development of models to estimate human post-mortem intervals based on tis-
sue gene expression.
2. A transcriptional-based definition of major cell types in the human body which
correspond broadly to the basic histological types of tissue classification, vali-
dated through a bridge between gene expression, computationally-inferred ma-
jor cell type enrichments, histopathology images and pathology review com-
ments in free-text form, as well as through the independent examination of
single cell data of mouse organs and tissues.
3. An extensive chacterization of the transcriptional landscape of sex-differential
gene expression, finding that effects are small and tissue-specific, but ubiquitous
across tissues.
4. An end-to-end conceptualization to associate variation in bulk RNA-seq gene
expression with variation in histological image patterns through matched sam-
ple pairs. We develop a software tool for whole slide image preprocessing, and
demonstrate its usage through a classification example with slides from The
Cancer Genome Atlas. We build CNN models to classify image tiles in the
GTEx dataset and extract compressed representations to associate image fea-
tures with gene expression, and perform an early experiment to visualize tile
attributions.
207




1. List of publications covered in the chapters of this thesis, in order of
presentation ([*] indicates co-first authorship):
This thesis is submitted as a compendium of four articles, which are enlisted
here:
• Ferreira, P. G., Muñoz-Aguirre, M., Reverter, F., Sá Godinho, C. P.,
Sousa, A., Amadoz, A., Sodaei, R., Hidalgo, M. R., Pervouchine, D.,
Carbonell-Caballero, J., Nurtdinov, R., Breschi, A., Amador, R., Oliveira,
P., Çubuk, C., Curado, J., Aguet, F., Oliveira, C., Dopazo, J., . . . , Guigó,
R. (2018). The effects of death and post-mortem cold ischemia on human
tissue transcriptomes. Nature Communications, 9(1).
https://doi.org/10.1038/s41467-017-02772-x
JIF (2019): 12.121, JIF (5-year): 13.610
In collection: Top 50: Life and Biological Sciences (2018)
• Breschi, A.*, Muñoz-Aguirre, M.*, Wucher, V.*, Davis, C. A., Garrido-
Martín, D., Djebali, S., Gillis, J., Pervouchine, D. D., Vlasova, A., Dobin,
A., Zaleski, C., Drenkow, J., Danyko, C., Scavelli, A., Reverter, F., Snyder,
M. P., Gingeras, T. R., Guigó, R. (2020). A limited set of transcriptional
programs define major cell types. Genome Research, 30(7), 1047-1059.
https://doi.org/10.1101/gr.263186.120
209
JIF (2019): 11.093, JIF (5-year): 12.010
• Oliva, M.*, Muñoz-Aguirre, M.*, Kim-Hellmuth, S.*, Wucher, V., Gewirtz,
A. D. H., Cotter, D. J., Parsana, P., Kasela, S., Balliu, B., Viñuela, A.,
Castel, S. E., Mohammadi, P., Aguet, F., Zou, Y., Khramtsova, E. A.,
Skol, A. D., Garrido-Martín, D., Reverter, F., . . . , Guigó R., Stranger B.
E. (2020). The impact of sex on gene expression across human tissues.
Science, 369(6509).
https://doi.org/10.1126/science.aba3066
JIF (2019): 41.845, JIF (5-year): 44.372
Perspective of this work: Wilson, M.A. (2020). Searching for sex differ-
ences. Science, 369(6509). https://doi.org/10.1126/science.abd8340
• Muñoz-Aguirre, M.*, Ntasis, V. F.*, Rojas, S. Guigó, R. (2020). Py-
HIST: A Histological Image Segmentation Tool. Cold Spring Harbor Lab-
oratory.
https://doi.org/10.1101/2020.05.07.082461
JIF (2019): 4.7, JIF (5-year): 5.26
2. Other contributions:
• Kim-Hellmuth, S.*, Aguet, F.*, Oliva, M., Muñoz-Aguirre, M., Kasela,
S., Wucher, V., Castel, S. E., Hamel, A. R., Viñuela, A., Roberts, A.
L., Mangul, S., Wen, X., Wang, G., Barbeira, A. N., Garrido-Martín, D.,
Nadel, B. B., Zou, Y., Bonazzola, R., . . . , Guigó R., . . . , Lappalainen
T. (2020). Cell type–specific genetic regulation of gene expression across
human tissues. Science, 369(6509).
https://doi.org/10.1126/science.aaz8528
• Research perspective: Muñoz-Aguirre, M., Ferreira, P. G., Guigó R.
(2018). Determinación de la hora de la muerte a partir del patrón de
expresión de los genes en múltiples tejidos.
https://genotipia.com/genetica_medica_news/post-mortem-expresion/
210
3. Publications as part of the GTEx consortium:
• The GTEx Consortium. (2020). The GTEx Consortium atlas of genetic
regulatory effects across human tissues. Science, 369(6509), 1318–1330.
https://doi.org/10.1126/science.aaz1776
• The GTEx Consortium. (2017). Genetic effects on gene expression across
human tissues. Nature 550, 204-213
https://doi.org/10.1038/nature24277
4. Conferences and other activities:
Talks:
• LifeTime Unconference. July 22-23, 2019. Barcelona, Spain. Talk: Con-
necting bulk transcriptomic variation with human phenotypes by integrat-
ing RNAseq with histopathology images.
• ISBER’s 2nd Biospecimen Research Symposium: Focus on Quality and
Standards. February 5-6, 2019. Berlin, Germany. Talk: The effects of
death and post-mortem cold ischemia on human tissue transcriptomes.
• GTEx Project Community Meeting. June 27-28, 2017. Rockville, MD,
USA. Talk: Leveraging the GTEx histological data: phenotype extraction.
Posters:
• Biology of Genomes. May 8-12, 2018. Cold Spring Harbor, NY, USA.
Poster: Characterizing transcriptomic variation across human phenotypes
by integrating RNAseq data with histopathology images and annotations.
• B-Debate: Enhancing the Usage of Human Genomics for the benefit of
all. April 20-21, 2017. Barcelona, Spain. Poster: Leveraging the GTEx
histological data: phenotype extraction
• CRG PhD Symposium. 2017. Barcelona, Spain. Poster: Exploring the
relationship between the transcriptome and human phenotypes.
211
• Biostatnet. 2016. Barcelona, Spain. Collaborative poster: Exploring the
relationship between the transcriptome and human phenotypes.
Other:
• Barcelona Citython 2019: Rethinking mobility in cities. Winner of the
Comprehensive Cities category. Using deep Q-learning to propose a traffic
and pedestrian mobility solution. Work presented at the Smart City Expo
World Congress.
• Accenture Digital Healthcare Hackaton 2019. Prediction of mortality rate
in melanoma patients: Finalist (4th place), developed a gradient-boosting
based survival model.
• Jornadas de Cooperación CONACyT-Catalunya. 3MT Contest (3-minute
thesis). Winner of the Barcelona Supercomputing Center prize.
• Barcelona Citython 2018: Winner of the CISCO tech prize. Anonymously
identifying crowds of people through deep learning. Work presented at the
Smart City Expo World Congress.
Detailed author contributions are stated within each article, as well as in bullet-






Tissue Abbreviation Color Tissue group
Adipose - Subcutaneous ADPSBQ Adipose Tissue
Adipose - Visceral (Omentum) ADPVSC Adipose Tissue
Adrenal Gland ADRNLG Adrenal Gland
Artery - Aorta ARTAORT Blood Vessel
Artery - Coronary ARTCRN Blood Vessel
Artery - Tibial ARTTBL Blood Vessel
Brain - Amygdala BRNAMY Brain
Brain - Anterior cingulate cortex (BA24) BRNACC Brain
Brain - Caudate (basal ganglia) BRNCDT Brain
Brain - Cerebellar Hemisphere BRNCHB Brain
Brain - Cerebellum BRNCHA Brain
Brain - Cortex BRNCTXA Brain
Brain - Frontal Cortex (BA9) BRNCTXB Brain
Brain - Hippocampus BRNHPP Brain
Brain - Hypothalamus BRNHPT Brain
Brain - Nucleus accumbens (basal ganglia) BRNNCC Brain
Brain - Putamen (basal ganglia) BRNPTM Brain
Brain - Spinal cord (cervical c-1) BRNSPC Brain
Brain - Substantia nigra BRNSNG Brain
Breast - Mammary Tissue BREAST Breast
Cells - Cultured fibroblasts FIBRBLS Fibroblasts
Cells - EBV-transformed lymphocytes LCL Blood
Colon - Sigmoid CLNSGM Colon
Colon - Transverse CLNTRN Colon
Esophagus - Gastroesophageal Junction ESPGEJ Esophagus
Esophagus - Mucosa ESPMCS Esophagus
Esophagus - Muscularis ESPMSL Esophagus
Heart - Atrial Appendage HRTAA Heart
Heart - Left Ventricle HRTLV Heart
Kidney - Cortex KDNCTX Kidney
Liver LIVER Liver
Lung LUNG Lung
Minor Salivary Gland SLVRYG Salivary Gland
Muscle - Skeletal MSCLSK Muscle
Nerve - Tibial NERVET Nerve
Pancreas PNCREAS Pancreas
Pituitary PTTARY Pituitary
Skin - Not Sun Exposed (Suprapubic) SKINNS Skin
Skin - Sun Exposed (Lower leg) SKINS Skin




Whole Blood WHLBLD Blood
Table B.1: GTEx tissues and their abbreviations. Through this thesis, we use
























Figure C-1: Cost of human genome sequencing through time. The y-axis is
the log10-spaced cost of sequencing a complete human genome as estimated by the
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Figure C-2: Overlap of xCell cell type signatures. For each cell type, a unique
list of marker genes is generated as the union of all marker lists across data sources,
with the length indicated in parenthesis. Hierarchical clustering is performed over
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Figure C-3: Individual medical history. Co-occurrence of medical history phe-
notypes across all individuals. Only phenotypes with an incidence larger than 10












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure C-4: GTEx sample availability. Individual RNAseq sample availability
























Figure C-5: GENCODE v26 gene types. Frequency of the top 15 gene types in
the GENCODE v26 annotation.
220
Protein coding lincRNA























































log10 (TPM + 0.01)
Figure C-6: Protein coding and lincRNA gene expression distribution. Den-
sity for the log10(TPM + 0.01) median gene expression (across samples) per tissue,
for protein coding and lincRNA genes.
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Figure C-7: Protein coding and lincRNA gene expression distribution. a) Di-
mensionality reduction of 17382 RNA-Seq samples based on the expression of protein

































































































































































































































































































































































0.6 0.7 0.8 0.9 1
Figure C-8: Correlation between tissue transcriptional profiles. Spearman’s
correlation of median gene expression profiles (across samples) between all tissue
pairs. Hierarchical clustering (see section 2.2.1) is performed with complete linkage
over a distance matrix calculated with Euclidean distance.
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Figure C-9: Histological image size distribution. Width × height for the native
resolution level of 25,446 histological image slides from 39 different tissues of the
GTEx project.
224
Figure C-10: WSI snapshot of an adipose tissue sample. The inset is zooming
into a small region of the WSI containing adipocytes, which could potentially be
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Figure C-11: ResNet-50 performance metrics at the tile level. On top, the
loss curves for the training and validation sets are shown. The bottom plot shows the
precision, recall and f1-scores for the test set tiles in each tissue.
226
Figure C-12: ResNet-50 performance metrics at the slide level. Precision,
recall and f1-scores computed at the WSI level by assigning to each slide the label of
the most commonly predicted class across test set tiles.
227
Figure C-13: Multi-class confusion matrix at the slide level. Row-normalized
confusion matrix derived from the predicted WSI-level labels (by assigning the most




Figures 1-2, 1-11, 1-16, 6-2, 6-3, 6-12 and C-10 were generated (either partially or to-
tally) using BioRender. Figures 2-12 and 2-13 were partially generated with NN-SVG
[220]. The rest of the figures were generated with R (ggplot2), Python (matplotlib)
and Inkscape. This thesis was written with emacs using LATEX and is based on the
MIT thesis template. All the computational analyses carried out in this thesis work
were performed in Linux-based distributions, with computing resources provided by
the Center for Genomic Regulation (CRG) and the Barcelona Supercomputing Cen-
ter (BSC). The research carried out in this thesis work was supported by the FPU
programme (Formación de Profesorado Universitario) from Ministerio de Educación,
Cultura y Deporte (MECD) with predoctoral fellowship FPU15/03635.
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